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General Introduction
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1The worldwide prevalence of chronic kidney disease has risen to about 13%, partly due 
to the increase of diabetes and hypertension (1). In end-stage renal disease (ESRD), the 
patient’s kidney function is reduced to less than 10%, and renal replacement therapy 
is needed for survival. For these patients, two treatment options are available, namely 
dialysis and transplantation. Kidney transplantation has major advantages for patients 
in comparison to dialysis treatment, namely a higher life expectancy and better health-
related quality of life (HRQoL) (2-4). Also, healthcare costs for patients after transplanta-
tion are lower than during dialysis treatment (5). Since the availability of deceased donor 
kidneys does not meet the demand, there is a waiting list for a deceased donor kidney. 
Currently, the mean waiting time in the Netherlands is between 2 and 3 years, depend-
ing on ABO blood group type (6). A solution for this shortage of deceased donor kidneys 
is increasing the pool of living donors. Living donor kidney transplantation is currently 
the best treatment option for most patients with ESRD, as it has higher patient and graft 
survival rates as compared to deceased donor kidney transplantation (7). Furthermore, 
the availability of a living donor kidney enables pre-emptive transplantation (i.e., be-
fore the start of dialysis treatment), whereas this is seldom possible with a deceased 
donor kidney. In recent decades, the number of living donor kidney transplantations 
has increased strongly, with more living than deceased donor kidney transplantations 
currently being performed in the Netherlands (Figure 1) (8).
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Figure 1. The number of kidney transplantations from both deceased and living donors in the Netherlands
Source: Dutch Transplant Foundation, Annual reports 2000-2016
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Donor nephrectomy is an invasive procedure causing temporary physical limitations. 
Moreover, donating a kidney can have an impact on the psychosocial wellbeing of do-
nors and their relatives. In general, donor candidates are highly motivated to undergo 
this surgery in order to help the ESRD patient, who is mostly a spouse, child, parent, 
sibling, or friend, as they have witnessed the influence of the disease on the daily life 
of the recipient from close-by, and have shared the emotional consequences thereof. 
There are also anonymous donors who do not know the recipient and who donate 
altruistically (9-11). Donors can experience the donation as beneficial because of the 
improved wellbeing of their recipient, which results in a potential improvement of their 
own HRQoL (12-14), and the enhancement of their self-esteem (14, 15). However, a 
small group of donors experiences difficulties prior to the surgery or after donation. 
An early psychosocial screening of donor candidates could minimize these negative 
consequences of donation. There is currently insufficient data to determine whether 
there are specific donor risk factors for impaired psychosocial functioning after dona-
tion, due mainly to the lack of large and encompassing prospective prediction studies in 
this population. Consequently, current international guidelines for psychosocial donor 
evaluation are not standardized. They mostly focus on the assessment of previous or 
current mental illness, personality characteristics, the ability to give informed consent 
for donation, decision-making, social-relational factors, and financial issues (16-21). 
Some guidelines for donor evaluation include certain psychosocial risk factors as abso-
lute contra-indications for donation, while others recommend assessing psychosocial 
risk factors to identify donors who might benefit from additional support during or after 
the donation procedure, for example in the case of early graft failure or recipient death 
(17, 18).
To summarize, living donor kidney transplantation is currently the preferred treatment 
for most patients with ESRD. Due to the lack of large prospective prediction studies, 
guidelines for psychosocial donor evaluation are currently not standardized. It is there-
fore important to identify the most relevant risk factors for impaired longer-term HRQoL 
after donation, in order to be able to develop psychosocial screening instruments on the 
basis of these risk factors and to develop tailored interventions for donors who are at risk 
of psychosocial adjustment problems during or after the donation.
HealtH-related quality oF liFe oF living kidney donors
Donor candidates are screened for the eligibility to donate, taking both medical and 
psychosocial aspects into account. Consequently, accepted donors are generally rela-
tively healthy before the donation, mostly healthier than the general population (22-24). 
Despite a temporary decline in physical health due to the consequences of the surgery, 
General introduction 11
1most donors recover within a few weeks, without persistent physical or psychosocial 
problems (15, 25). However, a subgroup of donors (5-23%) experiences elevated levels 
of fatigue or more depressive symptoms after donation, potentially caused by factors 
such as pre-donation psychological problems (e.g., excessive worrying), donor or recipi-
ent complications (26-28), unmet expectations about the donation (14, 29), or problems 
in the relationship with the recipient or other relatives (17, 30). There is currently insuf-
ficient evidence to indicate which factors influence the course of HRQoL during the 
donation procedure.
Previous studies on the HRQoL of kidney donors have mostly been retrospective, de-
scribing a relatively favorable post-donation functioning in the majority of donors (14, 
31-36). The prospective studies that have been conducted assessed the course of HRQoL 
before and after donation using validated questionnaires (15, 37-45). These studies 
showed somewhat inconsistent results, which may be due to a number of reasons. First, 
developments in donor nephrectomy techniques, especially the introduction of laparo-
scopic nephrectomy, have led to smaller wounds and shorter recovery periods, which 
could have influenced the donor’s physical and potentially also psychosocial recovery 
after surgery (43, 46-48). Second, there has been a shift in acceptance criteria of donors, 
resulting in a higher proportion of donors with a higher age, body mass index, or blood 
pressure (49), which may impact on physical and psychosocial long-term outcomes of 
donors (50, 51). Third, the increasing number of genetically unrelated and anonymous 
donors will be associated with specific types or the absence of donor-recipient relation-
ships, which might influence differences in donor HRQoL described in prospective stud-
ies (10, 35, 52). Therefore, this thesis describes in a systematic review and meta-analysis 
a systematic evaluation of the course of HRQoL before and after kidney donation as 
reported in previous studies (Chapter 2).
From a methodological point of view, the course of HRQoL before and after donation 
has mainly been assessed using generic quality of life instruments (e.g., Short Form 
Health Survey-36 or World Health Organization Quality of Life Questionnaire) that are 
not specifically focused on the donor’s situation (38, 41, 43). However, specific donation-
related outcomes that are not captured by generic measures could be of significant value 
in the clinical care for living kidney donors (e.g., recipient-related functioning or feelings 
of regret after donation) (29). Consequently, in the current thesis, the HRQoL course 
from before to after donation was examined in a large prospective study conducted in 
seven Dutch transplantation centers, using a comprehensive set of both generic and 
donation-specific measurements (Chapter 3).
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Pre-donation Cognitions oF donor Candidates
Before donor candidates are registered at the transplantation center for a possible 
donation, a process of decision-making has taken place in which the perceived risks 
and benefits of a potential donation are weighed. During this decision-making process, 
cognitions about the motivation for donation, the expectations of the donation and 
transplantation, and potential worries are explored. The motivation for donation is gen-
erally based on a desire to improve the wellbeing of a relative suffering from ESRD. Other 
donor motives could include personal beliefs or religious convictions, an increase in the 
donor’s self-esteem, or an improvement of the donor’s own wellbeing by decreasing 
the disease burden of the intended recipient (12, 13, 53). Also, motivations for donation 
could be influenced by feelings of moral duty or perceived external pressure, e.g., when 
someone is the only suitable donor within the family of the recipient (12, 54). Besides 
donor motives, donor expectations could determine the decision to donate. Most do-
nors expect to improve the recipient’s health, but some donors also expect personal 
benefits or advantages in social relationships as a consequence of the donation (55). In 
the majority of cases, the expectations relating to donation are realistic and, retrospec-
tively, donors perceived the donation procedure to be in line with their expectations 
(15). When the expectations of donors are not met, this can be related to disappoint-
ment about recipient outcomes (29). Concerning potential worries about the donation, 
previous studies reported concerns about the physical functioning of the recipient after 
transplantation, about the function of the donor’s remaining kidney, about the results of 
the medical evaluation as part of the donor eligibility screening (54), and about physical 
consequences of donation (14).
Such pre-donation cognitions could potentially influence the course of HRQoL during 
or after the donation procedure. To date, pre-donation cognitions have mainly been as-
sessed using qualitative methods, because quantitative instruments that examine donor 
motivations, expectations, and donation-related worries were limited to those focusing 
on specific aspects of these cognitions (55). A valid instrument that assesses various pre-
donation cognitions of donor candidates could be used to improve the psychosocial 
donor evaluation, for example to make potential donors aware of their own thoughts 
and feelings regarding the upcoming donation. A questionnaire measuring the donor’s 
motivation for donation, the expectations of donation, and potential worries about 
the donation was therefore developed as part of this thesis; this questionnaire was 
subsequently validated in a large sample of potential living kidney donors (Chapter 4). 
In addition, the predictive value of these pre-donation cognitions on impaired longer-
term HRQoL after donation was examined for the first time as part of an encompassing 
set of predictors in the large prospective study (Chapter 5).
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1PrediCtors oF longer-term adjustment Problems
Traditionally, the eligibility screening of potential living kidney donors has mainly been 
medically oriented, focusing on physical characteristics to judge whether potential do-
nors are suitable for donation. Psychosocial evaluation was often conducted only when 
indications were found during the medical screening. Nowadays, there is consensus that 
besides this medical donor evaluation, a psychosocial donor evaluation should also be 
conducted as part of the standard screening procedure, due to the impact of donation 
on the donor’s physical and psychological functioning and relationships with others 
(56-58). However, prospective studies that systematically investigate potential predic-
tors of impaired longer-term functioning after donation are scarce (59, 60), as indicated 
in the systematic review in Chapter 2. As a result, current guidelines on psychosocial 
donor evaluation are mostly not evidence-based, which leads to inconsistencies in the 
content and assessment methods of psychosocial evaluation among transplantation 
centers. More comprehensive prospective prediction studies are needed to identify the 
most relevant donor characteristics predictive of impaired longer-term functioning after 
donation.
Due to the scarcity of scientific evidence about potential risk factors for longer-term 
adjustment problems in living kidney donors, current psychosocial screening is mainly 
based on the clinical judgment of transplant professionals. However, the accuracy of 
these mostly intuitive and implicit risk judgments is unknown. Furthermore, it is un-
known how the predictive value for longer-term HRQoL after donation of these clinical 
risk judgments compares with that of screening questionnaires and whether the ad-
dition of brief standardized screening questionnaires could improve the prediction 
of longer-term HRQoL after donation to a relevant degree. Therefore, the (additive) 
predictive value of clinical risk judgments and donor self-report questionnaires up to 12 
months after donation was examined in a large sample of living kidney donors (Chapter 
5).
interventions For donors witH a risk ProFile
A number of studies on the psychosocial wellbeing of donors emphasize the importance 
of psychosocial care for specific donors or potential donors with elevated distress levels 
(26, 61, 62). However, there are currently hardly no interventions available for (potential) 
donors (63), and those available are mostly focused on stimulating donor recruitment 
(64, 65).
Based on the types of problems that are reported by some donors, such as fatigue, 
depressed mood, and social-relational difficulties, psychosocial interventions for this 
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group should focus on strategies to deal with the impact of the donation on daily life. 
Cognitive-behavioral therapy (CBT) is an evidence-based psychological treatment 
paradigm, which is used to treat mental health conditions, focusing on the replacement 
of maladaptive cognitions and coping strategies into more adaptive cognitions and be-
haviors (66-68). Previous research found that cognitive-behavioral therapy provided via 
the internet (Internet-based Cognitive-Behavioral Therapy or ICBT) could be as effective 
as face-to-face treatments in improving physical and psychological functioning in pa-
tients with mental and physical health problems (69-71). When these ICBT interventions 
for patients with somatic conditions are slightly adjusted and include donation-related 
themes, they could also be useful for potential donors and donors with adjustment 
problems. The acceptability and effectiveness of (I)CBT can be possibly further increased 
by tailoring the interventions to the specific risk and resilience factors of individuals as 
well as by therapist guidance (72, 73). There is currently no encompassing cognitive-
behavioral intervention available for donors and potential donors with a high-risk profile 
for longer-term adjustment problems. As part of this thesis, a guided and tailored ICBT 
intervention, directed at treating donation-related adjustment problems, is developed 
and evaluated in a small group of donors (Chapter 6).
aim and outline oF tHe tHesis
The main purpose of the research performed in this thesis was to identify and guide 
potential donors at risk of experiencing adjustment problems on the longer-term after 
donation. Therefore, the main objectives of the studies presented in this thesis were to 
develop and validate a psychosocial screening instrument and tailored intervention to 
identify and treat donors at risk of longer-term adjustment problems.
Chapter 2 includes a review and meta-analysis summarizing the existing literature 
on longer-term HRQoL of living kidney donors. In this chapter, the current state of 
the knowledge on the course of HRQoL of donors and potential risk factors for poorer 
longer-term functioning after donation was deduced from previous literature. Chapter 
3 presents the results of a prospective multicenter study on the course of HRQoL of 
living kidney donors before donation and 6 and 12 months after donation using both 
generic quality of life instruments as well as donation-specific questionnaires. Donor- 
and recipient-related donation consequences from the donor’s perspective, and regret 
about the donation decision are also examined. Chapter 4 describes the development 
of a new questionnaire on pre-donation cognitions (the motivation for donation, the 
expectations of donation, and worries about donation). This chapter also reports the 
validation of the newly developed questionnaire in a large group of potential kidney 
donors from seven Dutch transplantation centers. Chapter 5 presents the relative 
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1contribution of clinical risk judgments by transplant professionals, a comprehensive 
account of pre-, intra-, and post-donation characteristics of the donor, and the donor’s 
self-report measures to the prediction of impaired longer-term HRQoL of living kidney 
donors. Chapter 6 describes the transition from donor assessment to donor interven-
tion, and comprises the development and feasibility testing of an eHealth intervention 
for donors and potential donors with a high-risk profile. Concluding this thesis, Chapter 
7 summarizes the main findings of the studies described, and Chapter 8 provides a 
general discussion of these findings, as well as a critical reflection on the theoretical and 
clinical implications, and directions for future research.
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abstraCt
A better understanding of the course and risk factors for impaired long-term health-
related quality of life (HRQoL; i.e., physical, psychological, and social-relational function-
ing) after kidney donation might help clinicians improve the care of live kidney donors. 
This systematic review and meta-analysis summarizes prospective studies about the 
course and predictors of HRQoL in living kidney donors. Studies indicate that shortly af-
ter donation, donors have lower HRQoL, with minor to moderate changes in psychologi-
cal and social-relational functioning and major changes in physical functioning. At 3-12 
months after donation, HRQoL returned to baseline or was slightly reduced, particularly 
for fatigue, but scores were still comparable to general population norms. Results were 
mainly robust across surgery techniques. A limited number of studies examined risk 
factors for impaired HRQoL, with low psychological functioning before donation as the 
most consistent predictor. Based on these results, clinicians can inform potential donors 
that, on average, kidney donors have high long-term HRQoL; however, donors with 
low psychological functioning at baseline are those most at risk of impaired long-term 
HRQoL. Future studies should focus on other potentially relevant predictors of post-
donation HRQoL, including donor eligibility criteria and donor-recipient relationships, 
to optimize screening and interventions for donors at risk.
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introduCtion
The high percentages of living donor kidney transplantations worldwide have prompted 
research into kidney donors’ health-related quality of life (HRQoL), consisting of physi-
cal, psychological and social-relational functioning (1). Donors have been found to have 
high HRQoL before donation (2-4), often better than that of the general population, 
probably because of the stringent medical screening for kidney donor eligibility. After 
donation, however, approximately 5%-25% of donors experience problems with physical 
or psychosocial functioning, such as depressed mood, fatigue or pain (5-7). A previous 
systematic review of mostly cross-sectional and a few prospective studies concluded 
that most donors experienced no change or improvement in psychosocial functioning 
on average at 4 years after donation but that a small group of donors reported adverse 
psychosocial outcomes (5).
After this previous review, new prospective studies and randomized controlled tri-
als were published addressing the HRQoL of living kidney donors (8-14). Moreover, 
advances in surgery techniques, such as minimally invasive techniques, and expansion 
of donor eligibility criteria (e.g., acceptance of donors at higher ages, body mass index 
(BMI), or blood pressure), may have affected HRQoL (15-17). In addition, because im-
paired HRQoL after donation has been found, it is relevant to know potential predictors 
to guide screening and interventions for donors at risk to prevent impaired functioning 
after donation. Currently, guidelines to select eligible living kidney donors are based 
mainly on physical and not on psychosocial criteria (2, 15 ,18-22). Consequently, we 
conducted an updated systematic review and meta-analysis of the current literature 1) 
on the course of HRQoL of living kidney donors from before to after donation and 2) on 
predictors of post-donation HRQoL.
metHods
literature search strategy and inclusion criteria 
PubMed, Embase, Cinahl, and PsycINFO databases from 1990 until February 2014 were 
systematically searched, using living kidney donors, psychological factors, and quality of 
life as keywords. In addition, the reference lists of included studies and review articles 
were examined for other potentially relevant articles. All prospective studies published 
in English peer-reviewed journals investigating HRQoL before and after donation and 
using validated self-report questionnaires were included. Details of the protocol for this 
systematic review and meta-analysis were registered on PROSPERO (http://www.crd.
york.ac.uk/ PROSPERO/display_record.asp?ID=CRD42013006517).
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Hrqol domains
The questionnaires used to assess different HRQoL domains are reported in Table 1. 
Physical functioning was assessed as physical disability, defined as physical limitations in 
daily activities due to health; pain, defined as the frequency and interference of pain and 
discomfort in performing daily activities; and fatigue, defined as a lack of energy and dif-
ferent fatigue dimensions (physical and mental fatigue, reduced activities and motiva-
tion). Psychological functioning included feelings of anxiety, nervousness or depression. 
Social-relational functioning concerned limitations of social activities due to health.
table 1. Questionnaires and timing of pre-donation and post-donation HRQoL assessments of the studies 
assessing the course of HRQoL
author (year) Hrqol 
questionnaires
timing pre-
donation Hrqol 
assessment 
(time to donation)
timing post-donation Hrqol 
assessment(s)
(time after donation)
Aguiar et al. (2007) SF36 NA 1 and 3 months
Andersen et al. (2007) SF36 1-2 day(s) 1 and 12 months
Bahler et al. (2013) SF36 NA 1, 4, and 7 months
Bergman et al. (2005) SF36 NA 4 weeks (M= 29 days)
Chien et al. (2010) SF36 92.9 ± 5.0 days 3 months (80.4 ± 16.6 days) 
Dols et al. (2010) SF36
MFI-20
NA 6 years (range 1-8)
Dols et al. (2014) SF36 NA 1, 3*, 6*, and 12 months
Frade et al. (2008) SF36
SAS
SDS
NA 18.8 ± 12.8 months 
Garcia et al. (2013) SF36 20 ± 27 days 3 months (126 ± 89 days) and 12 
months (445 ± 164 days)
Guleria et al. (2011) WHOQOL Bref
HADS
2 weeks 6 months
Klop et al. (2013-I) SF36 NA 1, 3, 6, and 12 months*
Klop et al. (2013-II) SF36 1 day 1 and 12 months
Kok et al. (2006-I) SF36
MFI-20
1 day 1, 3, 6, and 12 months
Kok et al. (2006-II) SF36
MFI-20
EQ-5D
1 day 1, 3, 6, and 12 months*
Kroencke et al. (2012) SF36
HADS
126 ± 112 days 3 months (96 ± 22 days) and 12 months 
(381 ± 31 days) 
Kurien et al. (2011) SF36 1 month 6 months 
Lopes et al. (2011) SAS
SDS
NA ≥ 12 months* 
Lopes et al. (2013) SF36 NA ≥ 12 months 
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data extraction and study quality assessment
The following data were extracted from the included studies: data collection period and 
country, number of living donors, demographic variables, donor-recipient relationship, 
surgery techniques, questionnaires, assessment points and HRQoL outcome measures. 
Short Form-36 Health Survey (SF-36) physical and mental component summary scores 
were categorized as physical disability and psychological functioning, respectively (11, 
23). When surgery techniques were not mentioned, study authors were contacted.
For the course analyses, post-donation assessments were classified into three periods: 
the early postoperative period (months 1-2), short-term functioning (months 3-6), and 
long-term functioning (≥12 months).
Two authors (LW and HvM) independently assessed the risk of bias of included studies 
using the Cochrane risk of bias criteria (24). Potential differences were discussed until 
table 1. Questionnaires and timing of pre-donation and post-donation HRQoL assessments of the studies 
assessing the course of HRQoL (continued)
author (year) Hrqol 
questionnaires
timing pre-
donation Hrqol 
assessment 
(time to donation)
timing post-donation Hrqol 
assessment(s)
(time after donation)
Lumsdaine et al. (2005) WHOQOL NA 6 weeks and 12 months 
Massey et al. (2010) SCL-90 NA 2.3 years (3-97 months) 
Minnee et al. (2008) SF36
MFI-20
VAS Pain
NA SF36: 1, 3, 6, and 12 months
MFI-20: 1, 3, 6, and 12 months
VAS pain: 28 days
Minz et al. (2005) BDI
STAI
SSQ
NA 3 months
Nicholson et al. (2011) SF36 1 day 6 weeks
Smith et al. (2003) SF36 NA 4 months
Smith et al. (2004) SF36 NA 4 and 12 months
Timmerman et al. (2013) SCL-90 9 months (range 
2-13)
19 months (range 3-36)
Vemuru Reddy et al. (2011) WHOQOL 2 weeks 6 months
Virzi et al. (2007) SF36 1 month 4 months
Walton-Moss et al. (2007) SF36 NA 6 and 12 months*
Note. NA: data not available, *: data not available for meta-analysis
BDI, Beck Depression Inventory (Beck, 1961); EQ-5D, EuroQol 5D (The Euroqol group, 1990); HADS, Hospi-
tal Anxiety and Depression Scale (Zigmond & Snaith, 1983); MFI-20, Multidimensional Fatigue Inventory 
(Smets, 1995); SAS, Zung Self-rating Anxiety Scale (Zung, 1971); SCL-90, Symptom Checklist-90 (Derogatis, 
1973); SDS, Zung Self-rating Depression Scale (Zung, 1965); SF36, Short Form-36 Health Survey (Ware & 
Sherbourne, 1992); SSQ, Social Support Questionnaire (Sarason, 1983); STAI, State-Trait Anxiety Inventory 
(Spielberger, 1983); VAS, visual analogue scale (Freyd, 1923); WHOQoL-Bref, World Health Organization 
quality of life brief questionnaire (The WHOQOL Group, 1994).
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consensus was reached. Two domains were scored: 1) attrition bias, based on incomplete 
outcome data (low risk: donors with and without missing data were compared on out-
comes; high risk: no reasons for dropout mentioned or data missing potentially related 
to outcomes; unclear risk: insufficient information) and 2) other potential sources of bias, 
namely, range of post-donation assessment period (low risk: standardized timing; high 
risk: very broad standard deviation of timing; unclear risk: broad variation of timing but 
within one period) and the use of validated questionnaires (low risk: validated question-
naires; high risk: no validated questionnaires; unclear risk: potentially biased assessment). 
Initially, studies with either a high or low risk of bias (study quality) were all included to 
assess the course of HRQoL. Subsequently, sensitivity analyses were used to explore the 
robustness of the main findings using high- and low-quality studies separately.
data synthesis and analyses
The generic inverse variance analysis methodology for meta-analysis of within-subject 
designs was applied to analyze HRQoL changes from pre-donation to the three post-
donation assessment periods, using standardized mean differences (SMDs or Hedges’ 
g) and standard errors or standard deviations of the SMDs to calculate effect sizes (ESs). 
An ES of 0.2 represented a small effect, 0.5 represented a medium effect, and 0.8 repre-
sented a large effect (25). If data to calculate ESs were not reported, study authors were 
contacted; some studies had to be excluded because of authors’ non-response (18,26) or 
data not being provided (4,27). Because of repeated assessments within donors, an aver-
age correlation of r=0.5 was imputed between pre- and post-donation HRQoL. Because 
correlations were generally not reported, correlation coefficients of 0.1 and 0.9 were 
also examined to explore the robustness of the effects. All HRQoL scores were scaled 
in the direction of negative SMDs representing a decline of HRQoL over time. In case 
of between-study heterogeneity (I2) <70%, fixed-effects models were used; otherwise, 
random-effects models were used (28).
Analyses were conducted using Review Manager version 5.3 (29). To frame the results, 
the clinical significance of the pre- to post-donation assessment changes was exam-
ined by comparing change scores with clinical relevance norms of the psychometric 
instruments applied in the included studies. The SF-36, for example, was the most used 
instrument to assess HRQoL, with manuals reporting a 5-point difference as clinically 
relevant (30-34).
To explore the impact of surgery techniques on HRQoL course, they were categorized 
as laparoscopic donor nephrectomy (LDN; standard laparoscopic and hand-assisted lapa-
roscopic donor nephrectomy [HALN]), mini-incision donor nephrectomy (MIDN; incisions 
<15 cm), and open donor nephrectomy (ODN; with or without rib resection). When data 
were reported on two surgery techniques within one category (e.g., HALN and LDN), 
the data of the overall most frequently used technique was included for meta-analysis, 
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after which it was explored whether results changed when the other technique was 
included. If multiple questionnaires within one HRQoL domain were assessed, the over-
all most frequently used questionnaire across all studies was initially included in the 
meta-analysis. Subsequently, sensitivity analyses were conducted to test the robustness 
of the main findings when using the other questionnaires.
results
literature search
Our search yielded 2845 publications, of which 57 full-text articles were reviewed for 
eligibility; 23 were excluded (Figure 1). The 34 remaining studies had at least one assess-
ment before and after donation: 25 (74%) on HRQoL course, five (15%) on predictors, 
and four (12%) on course and predictors.
Table 2 describes characteristics of the 34 included studies, which were published 
between 2002 and 2014. In total, 3201 living kidney donors participated in the included 
studies, with sample sizes varying from 14 to 501 (median sample size: n=97). Two stud-
ies assessed the same cohort of donors (18,46). Donors had a median age of 47.4 years 
(range 18-94 years), and an average of 60% of donors were female (range 43%-100%). 
The largest percentage of studies was conducted in the Netherlands (29%), followed by 
the United States (15%) and India (12%). Response rates at the first assessment varied 
between 37% and 100%, and dropout rates at the follow-up assessment varied between 
0% and 81%.
study quality assessment
The response rates of the included studies were generally high, with a mean response 
rate across all studies of 89%. The mean of percentage of dropouts on the last assess-
ment point was 20%. The attrition bias was low in 47% of studies, unclear in 38% of 
studies, and high in 15% of studies. Other sources of bias (i.e., range of post-donation 
assessment period and the use of validated questionnaires) were low in 70% of studies, 
unclear in 9% of studies, and high in 21% of studies (Figures S1 and S2).
study results
Course of HRQoL: The timing of pre-donation HRQoL assessments was not specified in 
16 studies (55%) and varied between 1 day and 9 months before donation in the other 
studies. The timing of post-donation assessments varied between 1 month and 6 years 
after donation (Table 1).
Table 3 summarizes the meta-analytical findings on the course of the physical, psycho-
logical and social-relational HRQoL domains.
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Figure	  1.	  Study	  flow	  chart	  
	  
Records	  identified	  through	  database	  searching	  (n=4886)	  
Records	  after	  duplicates	  removed	  (n=2845)	  
Records	  	  excluded:	  
-­‐	  	  	  Recipient-­‐related	  studies	  (n	  =821)	  
-­‐	  	  	  Not	  prospective	  studies	  (n=330)	  
-­‐	  	  	  Different	  organ	  transplantation	  (n=265)	  
-­‐	  	  	  Non-­‐English	  language	  (n=259)	  
-­‐	  	  	  Different	  physical	  condition	  (n=169)	  
-­‐	  	  	  Overview	  studies	  (n=158)	  
-­‐	  	  	  Only	  physical	  conditions	  of	  donors	  described	  (n=155)	  
-­‐	  	  	  Animal	  studies	  (n=144)	  
-­‐	  	  	  Deceased	  donor	  kidney	  transplantation	  (n=122)	  
-­‐	  	  	  Abstract	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-­‐	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-­‐	  	  	  Health-­‐professionals	  related	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-­‐	  	  	  Qualitative	  studies	  (n=54)	  
-­‐	  	  	  Public	  opinion	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  transplantation	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  (n=37)	  
-­‐	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   Results	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Figure 1. Flow Chart
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table 3. Meta-analytic results of studies assessing the change in health-related quality of life of living kid-
ney donors at different post-donation assessment periods as compared to pre-donation functioning
timing postdonation 
Hrqol assessment
sample size Heterogeneity3 effect sizes
k1 n2 I2 (%)4 p5 SMD6 95% CI7 z8 p9
1-2 months
Physical Disability 13 625 49 .02 -1.03 [-1.12, -0.93] 20.65 <.001
ODN 3 121 6 .35 -1.20 [-1.44, -0.97] 10.09 <.001
MIDN 2 79 0 .97 -1.26 [-1.55, -0.96] 8.43 <.001
LDN 8 425 54 .03 -0.95 [-1.06, -0.83] 16.12 <.001
Pain 12 588 83 <.001 -1.05 [-1.31, -0.80] 8.16 <.001
ODN 2 83 93 <.001 -1.40 [-2.55, -0.26] 2.40 .02
MIDN 2 79 0 .39 -0.89 [-1.15, -0.63] 6.73 <.001
LDN 8 426 84 <.001 -1.02 [-1.32, -0.71] 6.58 <.001
Fatigue 12 586 49 .03 -0.93 [-1.03, -0.83] 18.69 <.001
ODN 2 81 0 .67 -1.04 [-1.31, -0.77] 7.59 <.001
MIDN 2 79 36 .21 -0.66 [-0.90, -0.42] 5.40 <.001
LDN 8 426 50 .05 -0.97 [-1.09, -0.86] 16.39 <.001
Psychological Functioning 13 626 73 <.001 -0.22 [-0.38, -0.06] 2.72 .007
ODN 3 121 73 .02 -0.38 [-0.75, 0.00] 1.97 .05
MIDN 2 79 0 .56 -0.40 [-0.63, -0.17] 3.37 <.001
LDN 8 426 75 <.001 -0.13 [-0.33, 0.07] 1.27 .20
Social-relational Functioning 13 628 67 <.001 -0.69 [-0.78, -0.61] 15.42 <.001
ODN 3 123 89 <.001 -0.48 [-0.67, -0.28] 4.84 <.001
MIDN 2 79 0 .85 -0.62 [-0.86, -0.37] 4.96 <.001
LDN 8 426 29 .20 -0.78 [-0.89, -0.67] 14.05 <.001
3-6 months
Physical Disability 14 683 87 <.001 -0.16 [-0.39, 0.07] 1.38 .17
ODN 3 140 76 .02 -0.13 [-0.48, 0.22] 0.73 .46
MIDN 6 360 94 <.001 -0.15 [-0.64, 0.33] 0.63 .53
LDN 5 183 0 .44 -0.17 [-0.31, -0.02] 2.25 .02
Pain 8 345 58 .02 -0.36 [-0.47, -0.25] 6.48 <.001
ODN 1 48 - - -0.69 [-1.00, -0.38] 4.31 <.001
MIDN 3 139 61 .08 -0.36 [-0.53, -0.19] 4.13 <.001
LDN 4 158 51 .10 -0.28 [-0.44, -0.12] 3.41 <.001
Fatigue 8 346 82 <.001 -0.22 [-0.49, 0.05] 1.63 .10
ODN 1 48 - - 0.56 [0.25, 0.87] 3.50 <.001
MIDN 3 139 71 .03 -0.20 [-0.52, 0.13] 1.19 .23
LDN 4 159 0 .65 -0.43 [-0.60, -0.27] 5.27 <.001
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table 3. Meta-analytic results of studies assessing the change in health-related quality of life of living kid-
ney donors at different post-donation assessment periods as compared to pre-donation functioning (con-
tinued)
timing postdonation 
Hrqol assessment
sample size Heterogeneity3 effect sizes
k1 n2 I2 (%)4 p5 SMD6 95% CI7 z8 p9
Psychological Functioning 15 684 93 <.001 0.18 [-0.10, 0.47] 1.26 .21
ODN 3 140 85 .002 -0.30 [-0.73, 0.13] 1.37 .17
MIDN 6 360 96 <.001 0.35 [-0.22, 0.91] 1.20 .23
LDN 5 184 85 <.001 0.32 [-0.09, 0.73] 1.51 .13
Social-relational Functioning 11 519 80 <.001 0.03 [-0.16, 0.22] 0.34 .73
ODN 1 48 - - 0.81 [0.48, 1.14] 4.76 <.001
MIDN 5 312 57 .05 -0.02 [-0.20, 0.16] 0.21 .84
LDN 4 159 9 .35 -0.14 [-0.31, 0.03] 1.64 .10
≥12 months
Physical Disability 15 703 65 <.001 -0.12 [-0.20, -0.05] 3.17 .002
ODN 3 141 60 .08 -0.30 [-0.48, -0.13] 3.46 <.001
MIDN 6 270 80 <.001 -0.13 [-0.25, -0.01] 2.09 .04
LDN 6 292 0 .61 -0.03 [-0.15, 0.08] 0.57 .57
Pain 13 617 0 .50 -0.10 [-0.18, -0.02] 2.54 .01
ODN 2 103 0 .41 -0.24 [-0.44, -0.04] 2.34 .02
MIDN 5 220 0 .82 -0.06 [-0.19, 0.08] 0.84 .40
LDN 6 294 27 .23 -0.09 [-0.21, 0.02] 1.59 .11
Fatigue 13 615 19 .26 -0.26 [-0.35, -0.18] 6.41 <.001
ODN 2 101 13 .28 -0.39 [-0.59, -0.19] 3.83 <.001
MIDN 5 220 15 .32 -0.19 [-0.32, -0.05] 2.76 .006
LDN 6 294 18 .30 -0.28 [-0.40, -0.16] 4.64 <.001
Psychological Functioning 17 778 49 .01 -0.11 [-0.18, -0.04] 2.95 .003
ODN 3 141 0 .42 -0.24 [-0.41, -0.07] 2.76 .006
MIDN 6 270 56 .05 -0.08 [-0.20, 0.04] 1.27 .21
LDN 8 367 54 .03 -0.08 [-0.18, 0.03] 1.49 .14
Social-relational Functioning 16 730 35 .09 .04 [-0.03, 0.12] 1.17 .24
ODN 3 143 3 .35 -0.13 [-0.30, 0.04] 1.50 0.13
MIDN 5 220 44 .13 0.14 [0.00, 0.28] 1.99 0.05
LDN 8 367 10 .35 0.05 [-0.05, 0.15] 1.03 0.30
HRQoL, health-related quality of life; LDN, laparoscopic donor nephrectomy; MIDN, mini-incision donor 
nephrectomy; ODN, open donor nephrectomy.
*Estimated correlation between pre-donation and post-donation assessment of HRQoL was 0.5
1 number of comparisons, 2 number of donors included in analysis, 3 the variation in study outcomes be-
tween studies, 4 the percentage of variation across studies that is due to heterogeneity rather than chance, 
5 significance level of heterogeneity, 6 standardized mean difference pre-donation vs. post-donation (Effect 
Size), 7 Confidence Interval, 8 Test for overall effect, 9 significance level of effect assessment
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Physical functioning
Physical disability
During the first 2 months after donation, physical disability was higher than at baseline, 
with a large ES (-1.03 [95% confidence interval (CI) -1.12 to -0.93]) (9,12,14,47-53). At 3-6 
months after donation, physical disability was comparable to baseline (small ES -0.16 
[95% CI -0.39 to 0.07]) (2,3,11,23,49-52,54-58); however, long-term physical disability 
was higher again (small ES -0.12 [95% CI -0.20 to -0.05]) (2,3,9,10,14,23,46,48,49,51,53,59) 
(see forest plot in Figure S3). Clinically significant changes between pre- and post-
donation assessments were found during the early postoperative recovery period in all 
studies but in only 17% of studies long term. Long-term physical disability was compa-
rable to general population norms.
Pain
During all post-donation periods, higher pain levels were found than at baseline, with 
a large ES during the first two post-donation months, and small ESs at the other as-
sessments (ES range: -1.05 to -0.10 [95% CI range (-1.31 to -0.80) to (-0.18 to -0.02)]) 
(2,3,9,10,12,14,46,47,49-53,55,56,59) (Figure S4). Clinically significant changes between 
pre- and post-donation assessments were found in the early postoperative recovery 
period in all studies but in only 20% of studies long term. Pain levels long term were 
comparable to general population norms.
Fatigue
During the first 2 months after donation, higher fatigue levels were found than at 
baseline, with a large ES (-0.93 [95% CI -1.03 to -0.83]) (9,12,14,47,49-53). At 3-6 months 
after donation, fatigue was comparable to baseline (-0.22 [95% CI -0.49 to 0.05]) (3,49-
52,55,56); however, long-term fatigue was higher again (small ES -0.26 [95% CI -0.35 
to -0.18]) (2,3,9,10,14,46,49,51,53,59) (Figure S5). Clinically significant changes between 
pre- and post-donation assessments were found in the early postoperative recovery 
period in all studies and in 50% of studies long term after donation; however, long-term 
fatigue levels were also comparable to general population norms.
Psychological functioning
During the first 2 months after donation, psychological functioning was reduced in com-
parison to that before donation (small ES -0.22 [95% CI -0.38 to -0.06]) (9,12,14,47-53). 
At 3-6 months after donation, psychological functioning was comparable to baseline 
(ES 0.18 [95% CI -0.10 to 0.47]) (2,3,11,23,49-52,54-58,60). Long-term psychological 
functioning was reduced again (small ES -0.11 [95% CI -0.18 to -0.04]) (2,3,9,10,14,23,46, 
48,49,51,53,59,61,62) (Figure S6). Clinically significant changes between pre- and post-
donation assessments were found in 50% of studies during the early recovery period 
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and in 7% of studies long term after donation. Long-term psychological functioning was 
comparable to general population norms.
social-relational functioning
During the first 2 months after donation, social-relational functioning was reduced com-
pared with baseline, with a moderate ES (-0.69 [95% CI -0.78 to -0.61]) (9,12,14,47-53), 
but similar to baseline for the later periods (ES 0.03 [95% CI -0.16 to 0.22] and 0.04 [95% 
CI -0.03 to 0.12], respectively) (2,3,9,10,14,46,48-53,55-62) (Figure S7). Clinically signifi-
cant differences were found during the early postoperative recovery period in 90% of 
studies but in only 8% of studies long term after donation. Long-term social functioning 
was comparable to that of the general population.
In summary, results show that shortly after donation, as expected, donors have a 
HRQoL reduction in comparison to the level before donation, with small to moderate 
ESs for psychological and social functioning and large ESs for physical functioning, with 
scores that correspond with norms for clinically relevant changes. In the short term, 
HRQoL returned to baseline on all domains except pain, which was still slightly reduced 
(small ES). In the long term, donors on average showed somewhat reduced physical and 
psychological functioning compared with functioning before donation (small ES), but 
levels were comparable to general population norms, and differences between pre-and 
post-donation assessments were not clinically relevant. In the longer term, slightly 
elevated scores of fatigue were found in 50% of studies, but fatigue scores were still 
comparable to general population norms. The individual results of studies that had to be 
excluded due to missing data were overall in the same line (see Table S1).
secondary analyses
Subgroup analyses were conducted to study differences in pre- and post-donation HRQoL 
changes for different surgery techniques. Results were generally comparable for the dif-
ferent surgery techniques, with a few exceptions that did not show a consistent pattern 
of better or worse functioning for one surgery technique compared with others (Table 3).
Because of the heterogeneity between studies, sensitivity analyses were conducted 
on the use of different questionnaires within one HRQoL domain and study quality as-
sessment. Studies could not be compared with regard to applying more or less stringent 
donor eligibility criteria because these criteria were not reported in most studies. Results 
were mainly robust across the use of different questionnaires and study quality. Finally, 
HRQoL outcomes were similar for imputing low (r=0.1) or high (r=0.9) correlation coef-
ficients instead of the average (r=0.5) correlation coefficients between pre- and post-
donation assessments.
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table 4. Physical and psychological predictors of longer-term HRQoL of living kidney donors
source Predictors Psychosocial outcome 
assessment
Physical outcome 
assessment
outcome p outcome p
Bahler et al. 
(2013)
Physical: SF36 MCS 1 month 
post-donation• pre-donation BMI NS   
• nephrectomy side NS   
• use of a hand-assistance port NS   
• surgery duration NS   
• length of hospital stay NS   
Psychological:
 • psychiatric history  <.05   
social-relational:
 • relation to the recipient  NS   
 • recipient complications  <.05   
other:
 • age  NS   
 • female gender  <.05   
 • marital status  NS   
Chien et al. 
(2010)
Physical: Change in SF36 MH 
before-3 months 
post-donation
• pre-donation body weight NS   
• pre-donation BMI NS   
• serum creatinine 2 days post-donation NS   
• 24h creatinine clearance <.01   
• hospital stay NS   
social-relational:
 • relationship with recipient  NS   
other:
 • age  NS   
 • gender  NS   
Fukunishi et 
al. (2002)
Psychological: Post-donation 
psychiatric syndrome• pre-donation alexithymia NS   
Glotzer et 
al. (2013)
Physical: SF36 MCS SF36 PCS post-
donation• pre-donation BMI post-donation NS NS 
• pre-donation creatinine level NS NS 
other:
 • age  NS  NS 
de Groot et 
al. (2012)
Physical: SF36 MCS post-
donation
SF36 PCS post-
donation• pre-donation BMI NS NS 
• pre-donation smoking NS <.01 
• pre-donation blood pressure NS NS 
• pre-donation renal clearance NS NS 
• pre-donation cardiovascular events NS NS 
Gross et al. 
(2013)
Physical: SF36 MCS 
post-donation 
SF36 PCS post-
donation• pre-donation BMI - NS <.001 
Psychological:
 • history of psychiatric difficulties -  <.001  <.001 
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table 4. Physical and psychological predictors of longer-term HRQoL of living kidney donors (continued)
source Predictors Psychosocial outcome 
assessment
Physical outcome 
assessment
outcome p outcome p
other:
 • age +  <.001  NS 
 • non-white race  NS  <.01 
Massey et 
al. (2010)
Physical: Satisfaction with 
donation 
• self-rated health scores post-donation NS   
Psychological:
 • inadequacy in thought and action  <.05   
 • mental health history  NS   
Physical: Perceived impact 
of donation on 
psychological well-
being post-donation
 • self-rated health scores NS   
Psychological:
• pre-donation psychological complaints  NS 
• mental health history NS 
Psychological: Worse satisfaction 
with supervision 
during admittance to 
the hospital 
post-donation 
 • pre-donation phobic anxiety <.05   
 • pre-donation depression <.05   
 • pre-donation hostility <.01   
Rodrigue et 
al. (2013)
social-relational: Overestimation 
expectancies of: 
• recipient graft failure •  personal growth <.05   
•  interpersonal 
benefit 
NS   
•  spiritual growth NS   
Smith et al. 
(2004)
Physical: Psychiatric caseness 
12 months post-
donation
• surgery technique NS   
• length of hospital stay NS   
• pre-donation SF36 PCS NS   
• SF36 PCS 4 months post-donation <.01   
Psychological:
 • psychiatric caseness lifetime  NS   
 • psychiatric caseness previous 12 months  NS   
 • pre-donation SF36 MCS  <.05   
 • SF36 MCS 4 months post-donation  <.01   
 • psychiatric caseness 4 months post-donation <.01   
social-relational:
• recipient hospital stay NS 
• recipient graft failure NS 
• donor-recipient relationship NS 
other:
• age NS 
• gender NS 
• marital status NS 
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Prediction of Hrqol 
Nine studies investigated pre- or post-donation predictors for long-term HRQoL after 
kidney donation, with each predictor being included in up to five studies at most (Table 
4). Reduced post-donation physical functioning was related to non-white race (63), 
smoking (21) and a history of psychiatric difficulties (63), whereas it was not related to 
age (63,64), pre-donation creatinine levels (21,64), blood pressure and cardiovascular 
events (21). Inconsistent results were found for BMI, which was related to physical func-
tioning in one (63) of three studies (21,63,64).
Reduced post-donation psychological functioning was related to worse self-reported 
physical functioning 4 months after donation and to worse psychological functioning 
before and 4 months after donation (2). Reduced psychological functioning was not 
related to pre-donation self-rated health (61), marital status (2,52), non-white race 
(63), pre-donation BMI (21,52,56,63,64), creatinine level (64), smoking, blood pressure, 
cardiovascular events (21), surgery technique (2,52) or duration (52), nephrectomy side, 
use of a hand-assistance port (52), length of hospital stay (2), inability to distinguish 
and verbalize emotions (alexithymia) (65), the donor-recipient relationship or recipient 
length of hospital stay (2,52,56). Inconsistent results were found for recipient complica-
tions (related in two [52,66] of three studies [2,52,66]), lower age (related in one [63] of 
five studies [2,52,56,63,64]), female sex (related in one [52] of three studies [2,52,56]) 
and psychiatric history (related in two [52,63] of four studies [2,52,61,63]). No predictors 
were examined for post-donation social-relational functioning.
disCussion
This systematic review and meta-analysis investigated prospective studies on the course 
and predictors of HRQoL (i.e., physical, psychological and social-relational functioning) 
after living kidney donation. Results indicated that shortly after donation, donors have 
table 4. Physical and psychological predictors of longer-term HRQoL of living kidney donors (continued)
source Predictors Psychosocial outcome 
assessment
Physical outcome 
assessment
outcome p outcome p
Physical: SF36 MCS 12 months 
postoperatively • surgery technique NS 
Psychological:
• pre-donation TERS scores - <.05 
• SF36 MCS 4 months post-donation + <.01 
- negative correlation coefficient, + positive correlation coefficient, NS not significant.
BMI: Body Mass Index, SF36 MCS: Short Form-36 Mental Component Summary Score, SF36 PCS: Short 
Form-36 Physical Component Summary Score, TERS: Transplant Evaluation Rating Scale.
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lower HRQoL than before donation on all domains, with small to moderate changes in 
psychological and social functioning and large changes in physical functioning. At 3-12 
months after donation, HRQoL returned to baseline or was slightly reduced compared 
with that before donation, particularly for fatigue; however, levels were comparable to 
those of the general population. Results were mainly robust across surgery techniques, 
questionnaires used and study quality. The limited number of prediction studies have 
provided only some rudimentary ideas on potential risk factors for developing longer-
term HRQoL problems; however, results indicated that donors with low psychological 
functioning at baseline were those most at risk of impaired longer-term HRQoL.
The current review extended the findings from the 2006 review on psychosocial HRQoL 
(5) by distinguishing different HRQoL domains, using quantifiable meta-analytic tech-
niques, addressing the influence of surgery techniques and methodological bias, and 
including the prospective results of recent and large cohort studies. Results of the current 
meta-analysis were generally in line with the previous review, showing that HRQoL was 
comparable with general population norms during the long-term post-donation period, 
with slightly reduced scores for physical and psychological functioning (5).
The short-term reduction of post-donation physical HRQoL is not unexpected 
because of the invasive surgical intervention performed in a healthy body. Previous 
research indicated that donors experienced more postoperative pain than expected 
before surgery (67-69), and this underscores the importance of providing appropriate 
pre-surgery information about possible short-term and long-term health outcomes. The 
invasive surgery and resulting short-term physical disabilities may explain, at least in 
part, the early reduction of psychological and social-relational functioning, which could 
also be the result of psychological factors (e.g., anxiety) and social-relational factors 
(e.g., concerns about the recipient’s health) (5).
The results of the current meta-analysis can support guidelines for future donor deci-
sion making, which can be used in donor counselling in clinical practice. Clinicians can 
inform potential donors that although HRQoL scores decrease shortly after donation, 
HRQoL recovers to population norms within several months after donation. Only fatigue 
scores could remain somewhat higher in the long term, but findings are also compa-
rable to general population norms. The possible continuation of higher fatigue levels 
long term is a new finding that requires further investigation. It is not yet clear whether 
these findings might be a consequence of donation; however, it could potentially be the 
consequence of a combination of multiple factors (e.g., aging, living with one kidney, or 
because donors are not familiar with physical limitations and may be inclined to resume 
their daily activities too early after surgery). Although fatigue has been found to cor-
relate with worse psychological functioning in the general population (34,70) and in 
patients with chronic somatic conditions (71,72), the comparison of donors’ HRQoL with 
general population norms in this meta-analysis indicated that post-donation HRQoL 
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scores were comparable to the general population for all dimensions. The description of 
a valid comparison group remains important in future donor research.
From the limited and inconclusive results on prospective predictors of long-term 
HRQoL, no firm conclusions can be drawn, but the most consistent evidence points to 
low psychological functioning as a predictor for impaired long-term HRQoL and under-
scores the relevance of screening of psychological functioning and psychiatric history. 
Consequently, additional counselling might be beneficial for donors with HRQoL scores 
that differ from general population norms in terms of clinically relevant differences; 
however, this systematic review clearly indicates that more prospective research in suffi-
ciently sized samples is required to identify relevant HRQoL risk factors at an early stage 
that may be used to develop and offer interventions to prevent longer-term HRQoL 
problems in living kidney donors.
A number of studies could not be included because of methodological constraints, 
such as recall bias, and because only generic HRQoL scores were provided. Moreover, 
the studies that were included had some limitations. First, the impact of the currently 
applied, more liberal criteria for donor selection on post-donation HRQoL could not be 
examined because studies did not clearly distinguish between the use of strict versus 
more lenient donor eligibility criteria. Second, the timing of pre-donation assessments 
varied from months to a few days before surgery, with 55% of studies not specifying the 
timing of the pre-donation assessment, making it difficult to compare baseline findings 
and preventing the assessment of the impact of timing on HRQoL changes. Because 
pre-donation assessments are often part of the donor selection procedure, elevated 
pre-donation HRQoL scores could be reported out of fear not to pass the screening 
procedure when problems would be reported. In contrast, pre-donation assessments 
a few days before surgery may lead to higher-than-normal distress levels because of 
the upcoming surgery. Third, although response rates for first assessments were gener-
ally high, response rates for repeated assessments were often not reported and may 
have affected the results. Fourth, some potentially relevant predictors of post-donation 
HRQoL have not been examined yet, including donor complications during or after 
surgery, the donor-recipient relationship type (e.g., directed versus non-directed dona-
tion), more lenient eligibility criteria for donors, cultural differences (e.g., with regard 
to health care systems and screening procedures), recipient and graft survival, and 
pre-transplant health status of the recipient (e.g., on dialysis or not). Finally, although it 
cannot be totally excluded that the results after donation are possibly influenced by the 
phenomenon of regression to the mean (73,74), this seems unlikely because repeated 
measures of HRQoL after donation do not show a consistent decrease in HRQoL scores 
over time, and the large number of studies included did not show a similar regression to 
the mean individually.
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In conclusion, this systematic review and meta-analysis showed that HRQoL returned 
to baseline or was only slightly reduced on longer-term assessments, although HRQoL 
scores decreased shortly after donation; however, HRQoL levels were comparable to 
general population norms. On the basis of these results, clinicians can inform potential 
donors that there is generally no risk involved with the donation. Results of prediction 
studies indicate that donors with low psychological functioning at baseline are those 
most at risk of impaired long-term HRQoL.
Future research is required to quantify the extent and identify the reasons for the small 
reduction of long-term HRQoL to estimate the need for future interventions for this 
group. Pre-donation psychological functioning was the most consistent predictor for 
long-term HRQoL after living kidney donation. However, more systematic prospective 
research on predictors of the HRQoL of living kidney donors is required to identify pos-
sible risk factors for longer-term HRQoL problems more reliably. This knowledge could 
provide valid selection criteria in the psychosocial screening of living kidney donors and 
could be used to focus psychosocial interventions before and after donation on donors 
at risk of developing long-term HRQoL problems.
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Figure s1. Risk of bias graph. 
Review authors’ judgments 
about each risk of bias item pre-
sented as percentages across all 
included studies
Figure s2. Risk of bias summary. Review authors’ 
judgments about each risk of bias item for each in-
cluded study.
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Figure s3a. Forest Plot of the standardized mean difference of changes in physical functioning pre-dona-
tion to 1-2 months after donation.
Figure s3b. Forest Plot of the standardized mean difference of changes in physical functioning pre-dona-
tion to 3-6 months after donation.
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Figure s3c. Forest Plot of the standardized mean difference of changes in physical functioning pre-dona-
tion to 12 months or more after donation.
Figure s4a. Forest Plot of the standardized mean difference of changes in pain pre-donation to 1-2 months 
after donation.
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Figure s4b. Forest Plot of the standardized mean difference of changes in pain pre-donation to 3-6 months 
after donation.
Figure s4c. Forest Plot of the standardized mean difference of changes in pain pre-donation to 12 months 
or more after donation.
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Figure s5a. Forest Plot of the standardized mean difference of changes in fatigue pre-donation to 1-2 
months after donation.
Figure s5b. Forest Plot of the standardized mean difference of changes in fatigue pre-donation to 3-6 
months after donation.
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Figure s5c. Forest Plot of the standardized mean difference of changes in fatigue pre-donation to 12 
months or more after donation.
Figure s6a. Forest Plot of the standardized mean difference of changes in psychological functioning
pre-donation to 1-2 months after donation.
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Figure s6b. Forest Plot of the standardized mean difference of changes in psychological functioning pre-
donation to 3-6 months after donation.
Figure s6c. Forest Plot of the standardized mean difference of changes in psychological functioning pre-
donation to 12 months or more after donation.
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Figure s7a. Forest Plot of the standardized mean difference of changes in social-relational functioning pre-
donation to 1-2 months after donation.
Figure s7b. Forest Plot of the standardized mean difference of changes in social-relational functioning pre-
donation to 3-6 months after donation.
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Figure s7c. Forest Plot of the standardized mean difference of changes in social-relational functioning pre-
donation to 12 months or more after donation.
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abstraCt
Previous studies indicated a decrease of health-related quality of life (HRQoL) shortly 
after kidney donation, returning to baseline on the longer-term. However, a subgroup 
experiences persistent HRQoL problems. The current study examined the HRQoL course 
up to 12 months post-donation and donor-perceived consequences of the donation 
for donors, recipients, and donor-recipient relationships. This prospective study was 
conducted in seven Dutch transplantation centers, with 230 donors completing self-
report questionnaires before and 6 and 12 months post-donation. Results indicated 
that donor physical HRQoL was comparable at all time points, except for an increase 
in fatigue that lasted up to 12 months post-donation. Mental HRQoL was decreased 
at 6 months post-donation, but returned to baseline at 12 months. Donors reported 
large improvements in recipient functioning and a smaller influence of the recipient’s 
kidney disease or transplantation on the donor’s life over time. Physical, emotional, and 
relational consequences of donation were limited. A small donor subgroup does experi-
ence negative donation consequences (e.g., regret). Looking more closely into regret, 
donation type and donor-recipient relationship did not differ between donors with and 
without regret, whereas more negative health perceptions and worse social functioning 
six months after donation significantly predicted regret at twelve months after dona-
tion. Future research should examine predictors of donor’s HRQoL after donation, to 
improve screening, and to provide potential interventions in those at-risk donors.
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introduCtion
Prospective studies in living kidney donors have shown small decreases in health-
related quality of life (HRQoL) shortly after donation, generally returning to baseline 
on the longer-term (1-3). However, uncertainty (e.g., regarding recipient outcome) and 
distress about the screening or surgery (4, 5) may lead to more serious HRQoL-problems 
in some donors, such as anxiety or fatigue (1, 6, 7). To identify which HRQoL-aspects are 
impacted most by the donation and identify at-risk (potential) donors, more specific 
insight into the consequences of donation is needed.
Previous research on HRQoL in living kidney donors has mostly used generic HRQoL-
instruments that do not capture specific relevant donation-related domains (8, 9). 
Furthermore, the donor’s perception on donation consequences for themselves, the 
recipient, and their relationship before and after transplantation were mostly described 
in retrospective or qualitative studies (10-14). Also, the presence or absence of regret 
about the donation decision was mostly assessed using a single ad hoc question indicat-
ing that a small subgroup of donors experiences regret (11, 15-17). Previous research 
assessing decisional regret about healthcare decisions in other patient populations 
showed that more regret was related to poorer HRQoL. Adverse health outcomes, more 
ambivalence, and lower satisfaction about information provision are potential predic-
tors of regret (18, 19). Whether such variables also predict regret in kidney donors has 
not been studied.
The current study aims to improve our insight into the potential consequences of liv-
ing kidney donation by prospectively examining the course of generic HRQoL as well as 
donation-specific domains.
materials and metHods
Procedure
During the data collection period (2011-2015) all donor candidates from seven Dutch 
transplantation centers (Radboud university medical center, University Medical Cen-
ter Utrecht, Leiden University Medical Center, University Medical Center Groningen, 
Maastricht University Medical Center, Academic Medical Center Amsterdam, and VU 
University Medical Center Amsterdam) were invited to participate in the study after their 
first screening visit. Illiteracy was the only exclusion criterion. After signing informed 
consent, a questionnaire was sent either by email or on paper. Donors received a similar 
questionnaire six and twelve months after surgery. The Ethics Committee of the Rad-
boud university medical center decided that the study did not fall within the scope of 
the Medical Research Involving Human Subjects Act. Moreover, since the study did not 
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pose any risk for participants, approval by an ethics committee was not required. In all 
participating centers, the executive board approved the study. The clinical and research 
activities being reported are consistent with the Principles of the Declaration of Istanbul 
and the Declaration of Helsinki.
Participants
A total of 588 donor candidates filled out the questionnaire after the first screening visit 
(75% response rate), of whom 361 donors (61%) donated their kidney. The mean time 
between screening and donation was 7.0±5.2 months. Reasons for exclusion from the 
donation procedure are presented in Figure 1. Complete data of 230 donors were avail-
able.
measures
1) Pre-donation demographic, intra- and postoperative characteristics 
Demographic and intra- and post-operative factors were assessed (e.g., surgery type, 
hospital stay, complications). Donor complications were derived from the donor’s medi-
cal files and defined using the Dindo-Clavien classification system (20). Data on recipi-
ent’s pre-transplantation treatment and post-transplantation outcome (i.e., graft failure 
or death) were derived from the Dutch Organ Transplantation Registration system (21).
2) Health-related quality of life (HRQoL)
Physical functioning before, and 6 and 12 months post-donation, was assessed using the 
RAND Short Form-36 Health Status Inventory (RAND-SF36; 22) and Checklist Individual 
Strength-Fatigue Short Version (CIS; 23).
The RAND-SF36 is a 36-item questionnaire assessing eight HRQoL-dimensions. 
Physical HRQoL consists of the subscales Physical Functioning, Role Limitations due 
to Physical Health Problems, Pain, and General Health Perceptions, summarized in the 
Physical Health Composite Score. The Hays norm-based scoring algorithm was applied, 
transforming raw scores into T-scores (M=50±10 in the general population) (22). Higher 
scores represent better HRQoL. Cronbach’s alphas varied between .53 (General Health 
Perceptions) and .91 (Role limitations due to Physical Health Problems).
The CIS short version (23) (4 items) assesses fatigue (e.g., ‘I feel tired’). Higher scores 
represent more fatigue. Cronbach’s alpha was .80.
Psychological functioning before, and 6 and 12 months post-donation was assessed us-
ing the RAND-SF36 mental HRQoL scales Emotional Well-being, Role Limitations due to 
Emotional Problems, Social Functioning, and Energy, summarized in the Mental Health 
Composite Score (22). Cronbach’s alphas varied between .61 (Social Functioning) and 
.83 (Mental Health Composite).
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3) Donor-perceived and recipient-related consequences of donation
Course of donor and recipient-related functioning 
The impact of (intended) donation on the donor, recipient, or donor-recipient relation-
ship was assessed before, and 6 and 12 months post-donation using Visual Analogue 
Scales (VAS; Supplement 1). The domains assessed were donor perspectives on 1) cur-
rent recipient’s physical and emotional functioning, 2) recipient limitations caused by 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Invited donors: N=788 
Non-response or donor refused 
participation: n=67 (9%) 
Donor nephrectomy:  
n=361 (61%) 
No donor nephrectomy: n=227 (39%) 
 
Exclusion from donation procedure: 
 
Medical reasons n=84 (37%) 
Another potential living donor was preferred n=27 (12%) 
Personal reasons n=18 (8%)  
Other reasons n=14 (6%) 
 
 
In donor evaluation procedure when data collection was 
closed n=11 (5%) 
Recipient’s kidney function was not sufficiently impaired 
to schedule transplantation n=50 (22%) 
 
Recipient was not able to receive a transplant n=14 (6%) 
 
Post-mortal donor became available n=9 (4%) 
 
 
 
Completed 6 months 
assessment: N=275 (76%) 
Donation <6 months before close of data 
collection: n=13  (4%) 
6 months assessment was completed >9 
months after donation: n=8 (2%) 
Did not complete 6 months assessment, 
but completed 12 months assessment: n= 
21 (6%) 
 
 
Completed baseline assessment: 
n=588 (75%) 
 
Completed 12 months 
assessment: N=250 (69%) 
Complete data sets available: 
N=230  (64%) 
Donation 6-12 months before close of data 
collection: n=33 (10%) 
12 months assessment was completed >15 
months after donation: n=11 (3%) 
Study drop out: n=23 (7%) 
 
(Temporary) Exclusion from 
donation procedure: n=133 (17%) 
Figure 1. Study Flow Chart
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the kidney disease or transplantation, 3) quality of the donor-recipient relationship, 4) 
influence of recipient’s kidney disease on the donor’s daily life, 5) donor responsibility 
for recipient’s wellbeing, and 6) the extent to which the donor takes care of tasks that the 
recipient cannot accomplish due to the kidney disease/transplantation. Altruistic donors 
did not complete these questionnaires. Donors within a kidney exchange program were 
asked to think about their known recipient when completing the questionnaires.
Perceived donation consequences
We developed a new questionnaire to specifically assess donor perceived conse-
quences of donation and transplantation for the donor, recipient, and their relationship 
(Supplement 2). Relevant items were based on evaluation of scientific literature and 
on clinical practice. The questionnaire was first evaluated by a small group of donors 
to test usability. After revision, Principal Component Exploratory Factor Analysis with 
Promax rotation and Kaiser Normalization was used to identify the scale structure. This 
Perceived Donation Consequences Scale (PDCS) consisted of 29 items measured on a 
5-point Likert scale (1=strongly disagree, 5=strongly agree) and showed a consistent 
four-factor structure in the six and twelve months post-donation assessments. The fac-
tors assessed donor physical consequences (5 items; e.g., ‘My recovery from surgery took 
longer than I expected.’), post-donation worries (5 items; e.g., ‘I am concerned about the 
performance of my remaining kidney in the future.’), recipient consequences (3 items; 
e.g., ‘The disease burden of the recipient in daily life has been reduced.’), and relational 
consequences (5 items; e.g., ‘I expected more appreciation and attention from the recipi-
ent.’). Higher scores represent a greater impact of donation. Eleven items were excluded 
because of factor loadings ≤.40 or cross-loadings ≥.20, leaving a total number of 18 
items. Cronbach’s alphas varied between .65 (post-donation worries) and .86 (recipient 
and relational consequences).
Regret about the donation decision was assessed 12 months post-donation using the 
Decision Regret Scale, measuring distress or remorse about healthcare decisions (19). 
In this 5-item questionnaire (e.g., ‘It was the right decision.’), scores were converted to 
0-100 scales. Higher scores indicate a higher degree of regret. Cronbach’s alpha was .86. 
The percentage of donors experiencing decisional regret was expressed by using a cut-
off score≥30 (18).
statistical analyses
Normal distribution was verified, transforming skewed or kurtosed variables using loga-
rithmic or reflected transformations in order to enable parametric statistics. Generalized 
mixed-model analyses were conducted to examine the HRQoL course from before to 6 
and 12 months post-donation on 1) RAND-SF36 Physical and Mental Health Composite 
Scores and CIS fatigue, and 2) RAND-SF36 subscales. HRQoL scores were also compared 
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with population norms. Clinically relevant differences between time points were defined 
as 5-point differences in T-scores using the RAND-SF36 (22) and 0.5 SD differences of 
norm scores using the CIS (23).
Changes in perceived donor and recipient functioning and donor-recipient interac-
tion (0-10 VAS-scales) were assessed by means of generalized mixed models. In addition, 
VAS-scores were categorized into 4 classes: poor (score 0-0.4), fair (0.5-4.4), moderate 
(4.5-7.4), and good functioning (7.5-10.0) (24). Similarly, for each factor of the PDCS, 
mean scores for donation consequences on 5-point Likert-scales were categorized into 
3 classes: no-few consequences (M=1.0-1.9), some consequences (M=2.0-3.9), and many 
consequences (M=4.0-5.0). Pearson correlation analyses were conducted to examine the 
association of donor demographic characteristics, pre-, intra- and post-operative donor 
and recipient health status, and donor measures with regret about the donation deci-
sion at 12 months post-donation. Subsequently, to examine the relative contribution of 
potential predictors, all variables that showed significant correlations to regret at twelve 
months post-donation were included in hierarchical multiple regression analyses. 
Analyses were conducted using IBM SPSS Statistics 22.0 (25).
results 
donor characteristics
Table 1 presents demographic, intra-operative and postoperative characteristics of 
230 participating donors. The sexes were almost equally represented (59% female), 
mean age was 55.1 (SD=10.7; range 23-76) years, and most participants had secondary 
level education (62%). The majority (83%) donated directly to a recipient they knew and 
underwent laparoscopic surgery (85%). Most donors did not experience complications 
(83%) and in a minority of recipients there was graft failure (6%) or death (3%) within 
the first year after transplantation. Mean post-donation hospital stay was 4.6 (SD=1.6; 
range 1-14) days.
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table 1. Demographic characteristics and donor and recipient intra-operative and postoperative factors
Characteristic mean ± sd (range) n (%)
Baseline demographic characteristics
Age (years) 55.1 ±10.7 (23-76)
Gender 
Female 59% 
Male 41% 
Marital statusa
Single 19% 
Steady partner 81% 
Educational levelb
Primary education 5% 
Secondary education 62% 
Tertiary education 33% 
Donation type 
Direct 83% 
Kidney exchange procedure 8% 
Anonymous 9% 
Donor-recipient relationship
Spouse 30% 
Parent 20% 
Sibling 18% 
Child 3% 
Other - related 17% 
Other - unrelated 3% 
Anonymous 9% 
Religious affiliationb
Religious 53% 
Non-religious 47% 
Ethnicity
Dutch 95% 
Other 5% 
Donor intra-operative and postoperative characteristics 
Surgery type 
Mini-incision donor nephrectomy 15% 
Laparoscopy 85% 
Hospital stay (days) 4.6 ± 1.6 (1-14)
Donor complicationsc
No complications 83% 
Grade I 9% 
Grade II 7% 
Grade III a 0% 
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1) the Hrqol course
Mean physical and mental HRQoL scores pre- and post-donation are reported in Table 2.
table 1. Demographic characteristics and donor and recipient intra-operative and postoperative factors 
(continued)
Characteristic mean ± sd (range) n (%)
Grade III b 1% 
Grade IV a 0% 
Grade IV b 0% 
Grade V 0% 
Recipient complications
Graft failure
No 94% 
Yes 6% 
Patient death
No 97% 
Yes 3% 
a n=228 b n=229
c Categorisation according the Clavien-Dindo classification system; Grade I: no need for therapeutic in-
terventions; Grade II: pharmacological treatment required, Grade III: surgical, endoscopic, or radiological 
intervention required (a) not under general anaesthesia or b) under general anaesthesia); Grade IV: Life-
threatening complication requiring IC/ICU management for (a) single organ dysfunction or b) multi-organ 
dysfunction); and Grade V: patient death (Dindo et al. 2004).
 
4 
6 
8 
10 
12 
14 
before donation 6 months after donation 12 months after donation 
CIS Fatigue 
* * 
Figure 2. The course (means and interquartile range) of CIS Fatigue before, and six and twelve months 
after donation
*significant at p<.05 level in comparison to baseline level
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Physical functioning 
Physical HRQoL (RAND-SF36 PCS) did not significantly change from before to twelve 
months post-donation. Median scores were within 1 SD above population norms at all 
time points.
Fatigue scores changed significantly over time, with higher fatigue levels at six 
(p<.001) and twelve (p<.001) months post-donation as compared to pre-donation, and 
comparable levels of fatigue at both post-donation assessments (Figure 2). Pre-donation 
fatigue scores were comparable to general population norms, but post-donation fatigue 
scores were 0.5 SD higher.
Regarding the specific aspects of physical HRQoL (RAND-SF36 subscales), physical 
functioning changed significantly over time (Figure 3), with a decrease of functioning 
from before to six months post-donation (p<.001), and an increase to baseline from 6 to 
12 months post-donation (p=.001). Also, role limitations due to physical health problems 
changed significantly over time, with an increase of role limitations from before to six 
months post-donation (p<.001), which decreased from six to twelve months post-do-
nation (p=.049) up to a level above baseline (p<.001). Furthermore, significant changes 
in general health perceptions were indicated, with worse general health perceptions 
pre-donation than at six (p=.001) and twelve months (p=.002) post-donation. No dif-
ference between both post-donation assessments was found. Pain did not significantly 
change over time.
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Figure 3a-d: The course (means and interquartile range) of physical HRQoL subscales (RAND-SF36) before, 
and six and twelve months after donation
*significant at p<.05 level in comparison to baseline level 
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Psychological functioning
Mental HRQoL (RAND-SF36 MCS) changed significantly over time (p=.001), with a de-
crease of functioning from before to six months post-donation (p=.01), and an increase 
to baseline from 6 to 12 months post-donation (p=.001). Median scores were within 1 SD 
above population norms at all time points.
Concerning the specific aspects of mental HRQoL (Figure 4), no overall time effects 
were found for emotional wellbeing and role limitations due to mental health problems. 
Energy levels changed significantly over time (p<.001), with higher energy levels before 
donation than six months post-donation (p<.001), which significantly increased from six 
to twelve months post-donation (p=.001) but remained marginally lower than before 
donation at twelve months post-donation (p=.07). Last, social functioning changed 
significantly over time (p=.01), with better functioning pre-donation than six (p=.002) 
and twelve (p=.01) months post-donation, with no significant difference between both 
post-donation assessments.
Clinically relevant HRQoL changes between the three assessment points were only 
found for fatigue. No differences on the outcomes were found between donors who 
completed all three assessments and donors who dropped out of the study.
 
45 
50 
55 
60 
65 
before donation 6 months after 
donation 
12 months after 
donation 
Emotional Functioning 
 
* 
 
45 
50 
55 
60 
65 
before donation 6 months after 
donation 
12 months after 
donation 
Social Functioning 
* * 
 
* 
Figure 4a-d: The course (means and interquartile range) of mental HRQoL subscales (RAND-SF36) before, 
and six and twelve months after donation
*significant at p<.05 level in comparison to baseline level
Consequences of living kidney donation 71
3
ta
bl
e 
3.
 D
es
cr
ip
tiv
e 
st
at
is
tic
s 
(M
ea
ns
 ±
 s
d)
 o
f d
on
or
 p
er
ce
iv
ed
 d
on
or
- a
nd
 re
ci
pi
en
t-
re
la
te
d 
fu
nc
tio
ni
ng
.
be
fo
re
 d
on
at
io
n
6 
m
on
th
s 
af
te
r 
do
na
ti
on
pr
e-
do
na
ti
on
 
vs
. 6
 m
on
th
s 
af
te
r 
do
na
ti
on
12
 m
on
th
s 
af
te
r 
do
na
ti
on
pr
e-
do
na
ti
on
 
vs
. 1
2 
m
on
th
s 
af
te
r 
do
na
ti
on
 
6 
m
on
th
s 
vs
. 
12
 m
on
th
s 
af
te
r 
do
na
ti
on
 
m
ea
ns
 ±
 s
d 
(r
an
ge
)
%
m
ea
ns
 ±
 s
d 
(r
an
ge
)
%
p
m
ea
ns
 ±
 s
d 
(r
an
ge
)
%
p
p
D
on
or
 p
er
ce
iv
ed
 d
on
or
- a
nd
 re
ci
pi
en
t-
re
la
te
d 
fu
nc
tio
ni
ng
 (V
AS
-s
ca
le
s 0
-1
0)
Ph
ys
ic
al
 fu
nc
tio
ni
ng
 o
f t
he
 re
ci
pi
en
t1
4.
8 
± 
2.
0 
(0
.4
-1
0.
0)
7.
6 
± 
1.
9 
(0
.0
-1
0.
0)
<.
00
1
7.
7 
± 
1.
8 
(0
.0
-1
0.
0)
<.
00
1
.8
8
po
or
 (0
.0
-0
.4
) 
1%
 
2%
 
1%
 
fa
ir 
(0
.5
-4
.4
) 
44
%
 
4%
 
4%
 
m
od
er
at
e 
(4
.5
-7
.4
) 
45
%
 
32
%
 
27
%
 
go
od
 (7
.5
-1
0.
0)
 
10
%
 
62
%
 
68
%
 
Em
ot
io
na
l w
el
lb
ei
ng
 o
f t
he
 re
ci
pi
en
t1
6.
6 
± 
1.
7 
(1
.5
-1
0.
0)
7.
9 
± 
1.
7 
(0
.0
-1
0.
0)
<.
00
1
7.
9 
± 
1.
9 
(0
.0
-1
0.
0)
<.
00
1
.8
1
po
or
 (0
.0
-0
.4
) 
0%
 
2%
 
1%
 
fa
ir 
(0
.5
-4
.4
) 
13
%
 
1%
 
4%
 
m
od
er
at
e 
(4
.5
-7
.4
) 
51
%
 
27
%
 
21
%
 
go
od
 (7
.5
-1
0.
0)
 
36
%
 
70
%
 
74
%
 
Li
m
ita
tio
ns
 fo
r t
he
 re
ci
pi
en
t c
au
se
d 
by
 th
e 
ki
dn
ey
 d
is
ea
se
 o
r t
ra
ns
pl
an
ta
tio
n1
4.
4 
± 
2.
2 
(0
.0
-1
0.
0)
6.
9 
± 
2.
1 
(0
.0
-1
0.
0)
<.
00
1
7.
4 
± 
1.
9 
(0
.0
-1
0.
0)
<.
00
1
.0
4
m
an
y 
(0
.0
-0
.4
) 
2%
 
2%
 
1%
 
so
m
e 
(0
.5
-4
.4
) 
52
%
 
10
%
 
7%
 
fe
w
 (4
.5
-7
.4
) 
36
%
 
37
%
 
31
%
 
no
 (7
.5
-1
0.
0)
 
10
%
 
51
%
 
61
%
 
Q
ua
lit
y 
of
 th
e 
do
no
r-
re
ci
pi
en
t r
el
at
io
ns
hi
p1
*
8.
7 
± 
1.
1 
(3
.0
-1
0.
0)
8.
5 
± 
2.
0 
(0
.0
-1
0.
0)
.2
4
8.
7 
± 
1.
6 
(0
.0
-1
0.
0)
.9
7
.2
7
po
or
 (0
.0
-0
.4
) 
0%
 
3%
 
1%
 
fa
ir 
(0
.5
-4
.4
) 
1%
 
2%
 
1%
 
m
od
er
at
e 
(4
.5
-7
.4
) 
7%
 
9%
 
8%
 
go
od
 (7
.5
-1
0.
0)
 
92
%
 
86
%
 
90
%
 
72 Chapter 3
ta
bl
e 
3.
 D
es
cr
ip
tiv
e 
st
at
is
tic
s 
(M
ea
ns
 ±
 s
d)
 o
f d
on
or
 p
er
ce
iv
ed
 d
on
or
- a
nd
 re
ci
pi
en
t-
re
la
te
d 
fu
nc
tio
ni
ng
. (
co
nt
in
ue
d)
be
fo
re
 d
on
at
io
n
6 
m
on
th
s 
af
te
r 
do
na
ti
on
pr
e-
do
na
ti
on
 
vs
. 6
 m
on
th
s 
af
te
r 
do
na
ti
on
12
 m
on
th
s 
af
te
r 
do
na
ti
on
pr
e-
do
na
ti
on
 
vs
. 1
2 
m
on
th
s 
af
te
r 
do
na
ti
on
 
6 
m
on
th
s 
vs
. 
12
 m
on
th
s 
af
te
r 
do
na
ti
on
 
m
ea
ns
 ±
 s
d 
(r
an
ge
)
%
m
ea
ns
 ±
 s
d 
(r
an
ge
)
%
p
m
ea
ns
 ±
 s
d 
(r
an
ge
)
%
p
p
In
flu
en
ce
 o
f t
he
 re
ci
pi
en
t’s
 k
id
ne
y 
di
se
as
e 
on
 
th
e 
lif
e 
of
 th
e 
do
no
r2
4.
9 
± 
2.
8 
(0
.0
-1
0.
0)
3.
2 
± 
3.
0 
(0
.0
-1
0.
0)
<.
00
1
2.
9 
± 
3.
0 
(0
.0
-1
0.
0)
<.
00
1
.0
4
no
 (0
.0
-0
.4
) 
8%
 
16
%
 
18
%
 
lit
tle
 (0
.5
-4
.4
) 
33
%
 
51
%
 
53
%
 
m
od
er
at
e 
(4
.5
-7
.4
) 
37
%
 
17
%
 
15
%
 
m
uc
h 
(7
.5
-1
0.
0)
 
22
%
 
16
%
 
14
%
 
D
on
or
 fe
el
in
gs
 o
f r
es
po
ns
ib
ili
ty
 fo
r t
he
 
w
el
lb
ei
ng
 o
f t
he
 re
ci
pi
en
t2
5.
6 
± 
3.
1 
(0
.0
-1
0.
0)
4.
1 
± 
3.
2 
(0
.0
-1
0.
0)
<.
00
1
4.
3 
± 
3.
5 
(0
.0
-1
0.
0)
<.
00
1
.8
5
no
 (0
.0
-0
.4
) 
9%
 
11
%
 
15
%
 
fe
w
 (0
.5
-4
.4
) 
23
%
 
42
%
 
34
%
 
so
m
e 
(4
.5
-7
.4
) 
33
%
 
23
%
 
24
%
 
m
an
y 
(7
.5
-1
0.
0)
 
35
%
 
24
%
 
27
%
 
D
on
or
 ta
ki
ng
 c
ar
e 
of
 re
ci
pi
en
t t
as
ks
 w
hi
ch
 
ca
nn
ot
 b
e 
ac
co
m
pl
is
he
d 
du
e 
to
 th
e 
ki
dn
ey
 
di
se
as
e2
2.
6 
± 
3.
0 
(0
.0
-1
0.
0)
1.
6 
± 
2.
4 
(0
.0
-1
0.
0)
<.
00
1
1.
4 
± 
2.
1 
(0
.0
-9
.0
)
<.
00
1
.3
2
no
 (0
.0
-0
.4
) 
36
%
 
34
%
 
40
%
 
lit
tle
 (0
.5
-4
.4
) 
36
%
 
50
%
 
48
%
 
m
od
er
at
e 
(4
.5
-7
.4
) 
18
%
 
10
%
 
8%
 
m
an
y 
(7
.5
-1
0.
0)
 
10
%
 
6%
 
4%
 
1 h
ig
he
r s
co
re
s 
re
pr
es
en
t h
ig
he
r w
el
lb
ei
ng
 2 h
ig
he
r s
co
re
s 
re
pr
es
en
t l
ow
er
 w
el
lb
ei
ng
 .
*v
ar
ia
bl
e 
tr
an
sf
or
m
ed
 in
 a
na
ly
se
s 
be
ca
us
e 
of
 n
o 
no
rm
al
 d
is
tr
ib
ut
io
n
Consequences of living kidney donation 73
3
Donor-perceived consequences of donation
The course of donor- and recipient-related functioning 
The quality of the donor-recipient relationship did not change over time and was 
perceived very positively (86-92%). Donors reported that the physical and emotional 
functioning of their recipients markedly improved over time (p<.001). Recipient’s physi-
cal functioning was perceived as good (VAS≥7.5) by only 10% of donors pre-donation, 
and by 62-68% six and twelve months post-donation. Recipient’s emotional wellbeing 
was perceived as good by only 36% of donors pre-donation, and by 70-74% six and 
twelve months after donation. Furthermore, donors perceived fewer recipient limita-
tions in daily life at both six and twelve (p<.001) months after transplantation. Also, after 
transplantation, the donor’s life was less influenced by the recipient’s kidney disease 
(p<.001), with 59% of donors experiencing moderate-much influence pre-donation, and 
29-33% six and twelve months post-donation. Lastly, donors felt less responsible for 
recipient’s wellbeing (p<.001) and donors took over fewer recipient’s tasks than before 
transplantation (p<.001) (Table 3).
Perceived donation consequences (PDCS)
The scores on post-donation negative physical or relational consequences were low. 
Only 5% of donors had a score of 4 or more (on a five-point scale) on negative physi-
cal consequences, and for negative relational consequences this percentage was even 
lower (1%). The majority of donors reported positive recipient outcomes at six (80%) 
and twelve (82%) months after transplantation. Nevertheless, many (57-66%) donors 
reported some degree of post-donation worries (Table 4). Changes in donor perceived 
consequences of donation over time were only found for physical consequences, which 
were perceived to a lesser extent at twelve than six months after donation (p=.003) 
(Table 4).
Regret towards the donation decision
One year post-donation, most donors had no to minimal feelings of regret about the 
donation decision (Median=5.0, IQR 0-20, on a 0-100 scale). Fourteen percent of the 
donors reported substantial feelings of regret. Higher levels of regret were associ-
ated with different pre-donation factors, namely worse emotional functioning of the 
recipient (r=-.15), more donor feelings of responsibility about the recipient (r=.15), 
higher expectations about donor benefits (r=.16), more anxiety (r=.17), and lower age 
(r=-.14). Also, more influence of the recipient’s transplantation on the donor’s life (r=.18), 
worse health perceptions (r=-.15), worse social functioning (r=-.14), and worse surgery 
recovery (r=-.37) six months post-donation were related to more regret twelve months 
post-donation. No significant relationships between regret and different donation types 
or donor-recipient relationships were found. From multiple regression analyses, worse 
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health perceptions (β=-.21, p=.022) and worse social functioning (β=-.23, p=.035) six 
months post-donation were significant predictors of more regret twelve months post-
donation, while no significant predictors on baseline were found.
disCussion
The current study examined the course of HRQoL and donor- and recipient-related do-
nation consequences from the donor’s perspective. Donor physical and mental HRQoL 
was largely comparable at all time points. There was a temporary decrease for some 
aspects of physical and psychological functioning at 6 months post-donation, but most 
levels had returned to baseline at 12 months post-donation. Also, scores were above 
population norms at all time points. Persistent and clinically relevant changes were only 
found for fatigue, which increased post-donation up to one year. The donors reported 
a low rate of negative donation consequences concerning themselves, the recipients, 
or their relationship with the recipient, and reported low levels of regret. Instead, they 
perceived a strong improvement in recipient’s functioning and a reduced influence of 
the kidney disease on their own life.
The stability of physical functioning over time indicates that most donors are physically 
recovered from surgery during the first months post-donation, as was found in previous 
studies (2, 26). However, complaints of fatigue persisted on the longer-term, indicating 
that fatigue is the aspect of physical functioning that is mostly affected by donation, 
which is in line with the conclusion from our meta-analysis on HRQoL consequences 
of kidney donation (2). Potential causes of these elevated fatigue levels are currently 
unknown, with physical (surgery consequences), but also behavioral or cognitive pos-
sible causes (donation or recipient worries, or regret) (27).
The temporary decrease of mental HRQoL six months post-donation might be the 
consequence of the resumption of daily life activities after surgery, which could lead to 
a higher physical and mental burden. Further, donors mostly received a lot of attention 
during the donation procedure, both from the hospital and relatives. However, after-
wards, attention for donors diminishes or shifts back to the recipient, and everything 
is expected to be back to normal (13, 28). Therefore, opportunities of sharing donation 
experiences or potential worries and feelings of social support could decrease, which 
could potentially lead to a poorer mental HRQoL.
Whereas most previous studies have focused primarily on the course of generic HRQoL 
after kidney donation, the current study included a broad range of donation-specific 
consequences, including donor-perceived consequences for both donor and recipient 
and their relationship, post-donation worries, and regret. In line with previous studies, 
donation experiences were mainly positive, with small percentages of donors (0-5%) re-
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porting negative physical and relational consequences and post-donation worries. The 
percentage of donors experiencing a substantial level of regret one year post-donation 
found in the current study (14%) is higher than the levels which were found in previous 
studies. However, it is comparable to percentages reported in a systematic review on 
decision regret with regard to different kinds of healthcare decisions. Potentially, the 
use of a quantitative multidimensional measurement of regret (The Decision Regret 
Scale) could provide other information about the extent to which donors experience 
regret. More regret was associated with different demographic, HRQoL, and recipient-
related factors, but not with donation type or donor-recipient relationship. Because no 
pre-donation predictors but only more negative health perceptions and worse social 
functioning six months after donation predicted longer-term regret, post-donation 
monitoring seems indicated to provide interventions to high-risk donors to prevent the 
onset or deterioration of regret after donation. Furthermore, as was found that regret 
could change over time (18), it would be relevant to examine whether donor regret 
persists or abates on the long-term.
Donors reported improvements of recipient’s physical and emotional functioning 
after transplantation, which reflect a desired donation outcome, which is often a major 
motivation to donate. This improvement of recipient’s HRQoL was also, and perhaps 
more objectively, confirmed by the decreased influence of the recipient’s kidney disease 
on the donor’s life. Although the increase of recipient’s HRQoL after kidney transplan-
tation is known from previous studies (29, 30), the donor perspective hereon was not 
prospectively studied before. Also, the influence of recipient’s kidney disease on the 
donor’s life, both before and after donation is a relatively new theme in transplantation 
literature, because most studies specifically focus on the influence of recipient graft 
failure or death.
A small proportion of donors experienced negative donation consequences (de-
creased HRQoL, adverse effects on the donor-recipient relationship, or regret). Future 
research should identify risk factors of donor’s HRQoL after donation and develop 
interventions for (potential) donors at risk. Furthermore, in order to prevent unrealistic 
expectations, consultations of healthcare professionals with potential donors should 
focus on evidence-based information regarding the potential consequences of kidney 
donation, discussion of alternative treatment options, expectations of the transplanta-
tion for the recipient, and on the preferences and values of the potential donor.
This multi-center study in a large and representative population of kidney donors gives 
insight into the course of HRQoL from before to 12 months post-donation, and evalu-
ates donor-perceived consequences of donation with regard to their own, recipient, and 
mutual functioning. Ideally, a study like this one should include a relevant control group. 
However, a comparable control group of eligible donors who eventually do not donate 
was not available. Instead, HRQoL results were compared with population norms and 
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clinically relevant differences between time points were assessed to frame results. The 
group of donors whose recipient experienced graft failure or death was very small 
(3-6%), which is a very good outcome, but complicates the reliable assessment of the 
influence of recipient complications on donors’ HRQoL course. Future research should 
examine long-term consequences of donation. Most donors included had the Dutch 
nationality. Also, the healthcare setting of kidney donors in the Netherlands, in terms of 
access to care and regulations for health insurance, is well-organized and available to all 
inhabitants. Therefore, the generalization of findings has to be studied.
In conclusion, for most donors, the donation procedure has few negative conse-
quences. Concerning HRQoL changes, small temporary decreases returned to baseline 
within one year post-donation and scores remained at or above population norms. The 
clinically relevant and persistent impact of donation on fatigue, which has been previ-
ously reported, warrants specific attention. That a small subgroup of donors was found 
to experience negative HRQoL consequences, underlines the relevance for further 
research into predictors of these outcomes, which would enable improved screening 
and potential interventions in those at-risk donors.
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supplement 1. Consequences of living kidney donation: a prospective multicenter study
The questions below are about how you, as a donor, rate the wellbeing of the recipient. Please rate the 
wellbeing of the recipient by placing a checkmark on the scale. The better the wellbeing of the recipient, 
the further to the right the checkmark is placed.
(Remark: In kidney exchange programs, your kidney was donated to an unknown person. When the questions 
below refer to ‘the recipient’, please rate for your own recipient.) 
1. How do you rate the relationship with the recipient at the present time? 
Very poor Very good0 1 2 3 4 5 6 7 8 9 10
2. How do you rate the physical functioning of the recipient at the present time? 
Very poor Very good0 1 2 3 4 5 6 7 8 9 10
3. How do you rate the emotional wellbeing of the recipient at the present time? 
Very poor Very good0 1 2 3 4 5 6 7 8 9 10
4. In your opinion, how many limitations does the recipient currently experience in day-to-day life due to 
the kidney disease or the transplantation? 
Many
limitations
No
limitations0 1 2 3 4 5 6 7 8 9 10
The questions below concern the impact that the recipient’s kidney disease or transplantation has on your 
own life at the present time: 
5. To what extent is your life currently influenced by the recipient’s kidney disease or transplantation?
No
influence
Large 
influence0 1 2 3 4 5 6 7 8 9 10
6. To what extent do you currently feel responsible for the wellbeing of the recipient?
Not
responsible
Very
responsible0 1 2 3 4 5 6 7 8 9 10
7. Do you currently take over tasks from the recipient, which he or she cannot accomplish due to the kid-
ney disease or transplantation?
No tasks Many tasks0 1 2 3 4 5 6 7 8 9 10
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supplement 2. Perceived Donation Consequences Scale
Below you find a number of statements about the donation. Please indicate for each statement 
to what extent it applies to your situation.
Supplement 2. Perceived Donation Consequences Scale 
 
Below you find a number of statements about the donation. Please indicate for each statement   
to what extent it applies to your situation. 
 
  
Totally 
disagree Disagree 
Don’t 
agree/ 
Don’t 
disagree Agree 
Totally 
agree 
1. My own quality of life has improved due to 
the donation. 
 
1 2 3 4 5 
2. The response of my spouse and/or children 
has not been as positive as I had expected.  
 
1 2 3 4 5 
3. The response of relatives to the donation 
has not been as positive as I had expected. 
 
1 2 3 4 5 
4. If I had to make the choice again, I would 
certainly choose to donate a kidney. 
 
1 2 3 4 5 
5. In retrospect the surgery was worse than 
anticipated. 
 
1 2 3 4 5 
6. I still frequently experience physical 
symptoms like pain and fatigue due to the 
donation. 
 
1 2 3 4 5 
7. My expectations before the donation were 
realistic. 
 
1 2 3 4 5 
8. Relations within the family/ with my 
partner have changed for the worse since 
the donation. 
 
1 2 3 4 5 
9. I would always recommend others to 
donate a kidney. 
 
1 2 3 4 5 
10. I found it difficult to get used to the idea 
that I only have one kidney. 
 
1 2 3 4 5 
11. My recovery from surgery took longer than 
I expected. 
 
1 2 3 4 5 
12. The relationships with family and friends 
have improved due to the donation. 
 
1 2 3 4 5 
13. I have not been able to resume all my day-
to-day routines. 
 
1 2 3 4 5 
14. I still find myself quite preoccupied by the 
donation. 
 
1 2 3 4 5 
15. The physical effects of the donation were 
greater than I expected. 
 
1 2 3 4 5 
16. The concerns I had before the donation 
proved unfounded.  
1 2 3 4 5 
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Totally 
disagree Disagree 
Don’t 
agree/ 
Don’t 
disagree Agree 
Totally 
agree 
17. I am concerned about the performance of 
my remaining kidney in the future. 
 
1 2 3 4 5 
18. My faith or personal beliefs have been 
strengthened though the donation. 
1 2 3 4 5 
19. I am concerned about how the kidney I 
donated will function in the future. 
1 2 3 4 5 
 
The questions below concern the recipient of your kidney. 
 
In kidney donor exchange procedures your kidney has been donated to an unknown person. When 
asked about the recipient, please rate for your ‘own’ recipient. If you don’t know the recipient (in 
altruistic donation) you can skip these questions and proceed to the next page. 
 
 
  
Totally 
disagree Disagree 
Don’t 
agree/ 
Don’t 
disagree Agree 
Totally 
agree 
20. The quality of life of the recipient has 
improved due to the donation. 
 
1 2 3 4 5 
21. The disease burden of the recipient in daily 
life has been reduced. 
 
1 2 3 4 5 
22. The risks for the recipient as a consequence 
of the kidney disease have been reduced 
due to the donation. 
 
1 2 3 4 5 
23. My relationship with the recipient has 
changed for the worse due to the donation. 
 
1 2 3 4 5 
24. The relationship with the recipient has 
been put under pressure. 
 
1 2 3 4 5 
25. I expected more appreciation and attention 
from the recipient. 
 
1 2 3 4 5 
26. The recipient is very grateful for the 
donation. 
 
1 2 3 4 5 
27. Relatives of the recipient (e.g., family 
members) are very grateful for the 
donation. 
 
1 2 3 4 5 
28. I’m finding it difficult to let go of my care 
for the recipient after the donation. 
 
1 2 3 4 5 
29. My relationships with relatives of the 
recipient have changed for the worse due 
to the donation. 
1 2 3 4 5 
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abstraCt
Background: Cognitions surrounding living organ donation, including the motivation 
to donate, expectations of donation, and worries about donation, are relevant themes 
during living donor evaluation. However, there is no reliable psychometric instrument 
assessing all these different cognitions. This study developed and validated a question-
naire to assess pre-donation motivations, expectations, and worries regarding donation, 
entitled the Donation Cognition Instrument (DCI).
Methods: Psychometric properties of the DCI were examined using exploratory factor 
analysis for scale structure and associations with validated questionnaires for construct 
validity assessment. Results: From seven Dutch transplantation centers, 719 potential 
living kidney donors were included. The DCI distinguishes cognitions about donor 
benefits, recipient benefits, idealistic incentives, gratitude, and worries about donation 
(Cronbach’s α .76-.81). Scores on pre-donation cognitions differed with regard to gender, 
age, marital status, religion, and donation type. With regard to construct validity, the 
DCI was moderately correlated with expectations regarding donor’s personal well-being 
and slightly to moderately to health-related quality of life.
Conclusions: The DCI is found to be a reliable instrument assessing cognitions sur-
rounding living organ donation, which might add to pre-donation quality of life mea-
sures in facilitating psychosocial donor evaluation by healthcare professionals.
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introduCtion
According to international guidelines for psychosocial donor evaluation, it is essential 
for transplant professionals to discuss the motivations and expectations of potential 
donors, as well as possible worries about donation (1-4). They state that the motivation 
for donation must be clearly altruistic and genuine, and that the decision to donate 
must be well-informed and without pressure from the environment (4-6). Further, ex-
pectations of the donation should be realistic with regard to transplantation outcomes 
for the recipient, possible physical consequences for the donor, and possible impact on 
relationships (1-3). However, psychosocial guidelines do not indicate how to operation-
alize and assess these cognitions (5).
Generally, the motivation for donation is based on wishing to improve the quality 
of life of the recipient or being idealistic, based on a feeling of moral duty or religious 
convictions (7-9). In addition, donors could be motivated by potential personal benefits, 
such as a higher self-esteem or an increase of their own quality of life due to the im-
provement of the recipient’s health (10, 11).
Previous studies on the expectations of living kidney donors showed that donors 
generally have quite realistic expectations about the donation, mainly based on personal 
benefits and on improving the quality of life of the recipient (12-15). Donors generally 
did not expect gratitude for the donation consisting of financial or symbolic rewards (13).
A small proportion of donors also experiences ambivalence about the donation deci-
sion because of worries about temporary limitations due to the surgery, postsurgical 
pain, their future health, the results of medical examinations, or recipients’ health or 
lifestyle (11, 16-21). In addition, potential donors in kidney exchange procedures have 
also been found to potentially worry about waiting times, kidney quality equity, and the 
retraction from reciprocal donation by the donor of a matching couple (22).
Unrealistic cognitions (e.g., unrealistic expectations on recipient outcomes or motiva-
tions based on a desire for recognition) could increase the risk of poor psychosocial 
outcomes after donation, and therefore be a contra-indication.
Most of the limited knowledge on pre-donation cognitions of potential donors is 
based on qualitative research by means of focus groups or interviews (23) or retrospec-
tive assessments (24). Also, some cross-sectional studies have been performed using 
the Living Donation Expectancies Questionnaire (LDEQ), which focuses on pre-donation 
expectations of personal well-being after donation (14). These studies have shown that 
expecting benefits from the donation (e.g., personal growth) is related to higher levels 
of optimism and worse mental health (14). Although the LDEQ is a valid instrument to 
assess pre-donation expectations with regard to donor’s personal well-being, it does 
not include either recipient-related expectations or motivations and worries about 
donation.
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Although current guidelines for psychosocial donor evaluation underline the need 
to assess pre-donation cognitions and mention unrealistic cognitions as a relative or 
absolute contraindication to donation (25-27), no assessment methods or criteria are 
provided. Current practice is mainly based on a clinical perspective. Evidence-based 
instruments to reliably assess pre-donation cognitions would aid clinicians in defining 
which cognitions could be unrealistic and predictive of adjustment problems after do-
nation. Therefore, the aim of the current study was to develop a short but comprehen-
sive questionnaire to assess different types of pre-donation cognitions (expectancies, 
motivations, and worries).
materials and metHods
Procedure
A pilot study was conducted in one Dutch transplantation center (Radboud university 
medical center) in 2010-2011 to develop a new questionnaire on donation cognitions, 
followed by a multicenter study in seven Dutch transplantation centers (Radboud 
university medical center, University Medical Center Utrecht, Leiden University Medi-
cal Center, University Medical Center Groningen, Maastricht University Medical Center, 
Academic Medical Center Amsterdam, and VU University Medical Center Amsterdam).
All potential donors attending the first information consultation were invited to par-
ticipate in the study through an information letter. Exclusion criteria were not being able 
to read or write the Dutch language and refusal to sign informed consent. After signing 
informed consent, potential donors who would like to participate in the study were asked 
if they preferred a paper or a digital format of the questionnaire booklet. The Ethics Com-
mittee of the Radboud university medical center decided that the study did not fall under 
the scope of the Medical Research Involving Human Subjects Act. Therefore, approval by 
an ethics committee was not indicated for this study, because of the absence of any risk for 
the participants. In all participating centers, the board approved the execution of the study.
item generation and scale construction of the donation cognitions 
questionnaire 
Questionnaire items to assess pre-donation cognitions were generated from the literature 
and clinical practice. The resulting items were judged on comprehensibility and relevance by 
healthcare professionals and kidney transplantation researchers. In a pilot study, this ques-
tionnaire was evaluated by a small group of potential donors to test its feasibility, relevance, 
and readability. After revision, the final questionnaire consisted of 46 items, of which 28 
assessed agreement with statements about different motivations and expectations of dona-
tion, including two open response items, measured on a 5-point Likert scale (1=strongly 
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disagree-5=strongly agree), and 18 items on worries about the donation, including three 
open response items, measured on a 4-point Likert scale (1=not at all-4=very much).
other instruments
The following validated questionnaires were used to assess the cross-sectional construct 
validity of the newly developed questionnaire on pre-donation cognitions.
Donation expectations
Donor expectations regarding personal well-being were assessed by the Living Dona-
tion Expectancies Questionnaire (LDEQ) (14). The LDEQ consists of 42 items starting with 
‘As an organ donor, …’, measured on a 5-point Likert Scale (strongly disagree-strongly 
agree), distinguishing six scales: Interpersonal Benefits (e.g., ‘I expect to be respected and 
admired by family and friends’), Personal Growth (e.g., ‘I expect to improve my lifestyle 
and take better care of my health’), Spiritual Benefits (e.g., ‘I expect my donation to be 
seen as a way of honoring my God’), Quid Pro Quo (e.g., ‘I expect preferential treatment 
by the recipient after donation’), Health Consequences (e.g., ‘I expect to experience a 
great deal of pain and discomfort’), and Miscellaneous Consequences (e.g., ‘I expect 
to have more financial problems’). Higher scores represent higher expectations in that 
domain. Cronbach’s alpha in the present study varied between .65 (Quid Pro Quo and 
Miscellaneous Consequences) and .93 (total LDEQ).
Health-related quality of life (HRQoL)
Physical functioning: The physical functioning of potential donors was assessed by the 
Physical Health Composite score and its subscales of the RAND Short Form-36 Health Status 
Inventory (RAND SF36) (28) and the short version of the Checklist Individual Strength-
Fatigue (CIS) (29, 30). The RAND SF36 is a widely used 36-item questionnaire assessing 
eight aspects of HRQoL, of which four assess physical health and are summarized into a 
composite score: Physical Functioning, Role Limitations due to Physical Health Problems, 
Pain, and General Health Perceptions. The Hays norm-based scoring algorithm was ap-
plied, using item response theory with raw scores being transformed into T-scores with an 
average of 50 and a standard deviation of 10 in the general population (28). Higher scores 
represent better HRQoL. Cronbach’s alpha varied between .61 (General Health Perceptions) 
and .86 (Role Limitations due to Physical Health Problems). The short version of the CIS 
assesses fatigue by means of 4 items (e.g., ‘I feel tired’) on a 7-point scale (1=strongly agree 
7=strongly disagree). Higher scores represent more fatigue. Cronbach’s alpha was .86.
Psychological functioning: The psychological functioning of potential donors was 
assessed using the RAND SF36 Mental Health Composite and its subscales (28), the 
Hospital Anxiety and Depression Scale (HADS) (31), and neuroticism as assessed with 
the NEO Personality Inventory-Revised (NEO-PI-R) (32, 33).
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Of the RAND SF36, four subscales assess mental health, which are summarized into 
a composite score: Emotional Well-being, Role Limitations due to Emotional Problems, 
Social Functioning, and Energy (28). Cronbach’s alphas varied between .71 (Social Func-
tioning) and .87 (Mental Health Composite). The HADS is a widely used, short screening 
questionnaire for symptoms of anxiety and depression (31), consisting of two seven-
item subscales with a score range of 0 to 21. Higher scores represent more anxiety or 
depression. Cronbach’s alpha varied between .73 (Depression) and .83 (total HADS). The 
NEO-PI-R assesses the personality characteristic of neuroticism by means of eight items 
on a 5-point Likert scale (32, 33). Higher scores represent higher sensitivity for stressful 
situations. Cronbach’s alpha was .77.
social-relational functioning: Social-relational functioning of donors was assessed 
with the Interpersonal Sensitivity Measure (IPSM) (34) and the Inventory for Social Reli-
ance (ISR) (35). Two subscales of the IPSM were used, Interpersonal Awareness (7 items; 
e.g., ‘I worry about the effect I have on other people’) and Timidity (8 items; e.g., ‘I will 
do something I do not want to do rather than offend or upset someone’) (34). Scores 
were rated on a 4-point Likert scale, with higher scores representing more interpersonal 
awareness and timidity. Cronbach’s alpha was .80 for Interpersonal Awareness and .65 
for Timidity. The Perceived Support scale of the ISR assessed the level of perceived social 
support by means of 5 items, rated on a 4-point Likert scale, with higher scores repre-
senting better interpersonal functioning (36). Cronbach’s alpha was .87.
statistical analyses
Not normally distributed scales were transformed with (reflected) logarithmic transfor-
mations. The suitability of the data for principal component analysis was evaluated by 
the Barlett’s Test of Sphericity (37) and Kaiser-Meyer-Olkin (KMO) measure of sampling 
adequacy (38, 39). Two Principal Component Exploratory Factor Analyses with Promax 
rotation and Kaiser Normalization for scale structure assessment were conducted, one 
on donor motivation and expectation items and one on the items on donor worries, as 
these were formulated and scored distinctively. The selection of factors was based on the 
Eigenvalues, Cattell’s scree test, and factor interpretability. Of the resulting factors, internal 
consistency was assessed by Cronbach’s α. Factors were transformed into subscale scores 
by averaging the included items when at least two-third of the items were filled in. To 
examine whether cognitions about donation were associated with demographic and 
donation-related characteristics, depending on the measurement level, correlational 
analyses (e.g., age), Independent Samples T-tests (using Welch’s t-test in case of violation 
of homogeneity of variances) (e.g., marital status), or One-Way Analyses of Variance (e.g., 
educational level) were conducted. Pearson and Spearman correlation coefficients with 
the LDEQ and HRQoL were calculated for construct validity. A p-value below .05 was 
considered significant. Data analyses were conducted using IBM SPSS Statistics 20.0 (40).
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results
Participant characteristics
The questionnaire was sent to 940 potential donors, of which 719 were returned (re-
sponse rate: 76%). The majority (57%) of the 221 potential donors not returning the 
questionnaire withdrew from the donation procedure because of medical reasons (58%), 
preference for another living donor (20%), donor personal reasons (17%), or availability 
of a post-mortal donor (6%). Demographic characteristics did not differ between par-
ticipants and refusers (Table 1). Both sexes were almost equally represented in the study 
(57% was female), the mean age of the participants was 54.2 (SD=11.4; range 19-76) 
years, and most had secondary level education (64.4%). The majority (79.6%) intended 
to donate directly to a recipient they knew.  
table 1. Demographic characteristics of the potential donors (N=719)
Characteristic mean ± sd (range) n (%)
Age Mean ± sd (range) 54.2 ± 11.4 (19-76)
Gender (% female) 57%
Marital statusa
Single 21.7% 
With partner 78.3% 
Educational levela
Primary education 4.8% 
Secondary education 64.4% 
Tertiary education 30.8% 
Donation type 
Direct 79.6% 
Kidney exchange procedure 12.2% 
Anonymous 8.2% 
Donor-recipient relationship
Spouse 29.3% 
Parent 17.9% 
Sibling 18.5% 
Child 5.6% 
Other - related 4.3% 
Other - unrelated 16.1% 
Anonymous 8.2% 
Being religiousa 52.4%
a added after pilot study (n = 624)
Values given are mean ± SD or percentages
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exploratory principal component analysis of the donation cognitions 
questionnaire 
Donation Cognition Instrument-Motivation and Expectations (DCI-ME)
Principal component analysis was permitted (KMO=.75, Bartlett p<.001) on the 25 items 
assessing donor motivations and expectations (the item ‘I have no specific expectations 
of the donation’ was excluded from analysis and the two open response options did 
not indicate any relevant missing motivations and expectations). Based on factor load-
ings below .40 or cross-loadings of more than .20, three items were excluded from the 
final questionnaire, resulting in the 22-item Donation Cognition Instrument- Motivation 
and Expectations (DCI-ME) (Table 2). Four factors were distinguished, explaining a total 
variance of 52.8%, namely Donor Benefits (7 items, cognitions on improving donor’s 
own well-being), Recipient Benefits (6 items, cognitions on improving recipient’s well-
being), Idealistic Incentives (6 items, cognitions about living according to one’s ideals 
or religious convictions), and Gratitude (3 items, cognitions on expressions of gratitude 
from the recipient or others). Scales were normally distributed, except for the Recipient 
Benefits scale, which was transformed using reflected logarithmic transformation. De-
scriptive statistics are presented in Table 2, showing cognitions about Recipient Benefits 
being most commonly reported (M=4.57, SD=0.4 on a 5-point scale) and cognitions 
about Donor Benefits least commonly (M=1.96, SD=0.7). The internal consistency varied 
between .76 and .81. Intercorrelations between the subscales revealed non-significant 
to moderate associations (.14≤r.≤30).
table 2. Principal Components Analysis with Promax Rotation on the Donation Cognition Instrument–Mo-
tivations and Expectations (DCI-ME) (n=719)a
itemb donor 
benefits
recipient 
benefits
idealistic 
incentives
gratitude
Factor i Factor loadings
5 I wish to improve my relationship with the 
recipient through the donation.
0.81 -0.02 -0.09 0.04
6 I wish to improve my relationship with others (for 
instance family members of the recipient) through 
the donation.
0.73 -0.13 0.01 0.03
19 I expect my relationship with the recipient to 
improve as a result of the donation.
0.73 -0.08 -0.04 0.20
20 I expect my relationship with family members/
friends (for example of the recipient) to improve as 
a result of the donation.
0.70 -0.11 0.08 0.17
4 I wish to donate in order to improve the quality of 
my own life.
0.70 0.28 -0.06 -0.28
18 I expect my own quality of life to improve as a 
result of the donation.
0.68 0.21 0.04 -0.16
24 I expect to receive a contribution (immaterial or 
symbolic) for the donation.
0.45 -0.14 0.03 0.17
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table 2. Principal Components Analysis with Promax Rotation on the Donation Cognition Instrument–Mo-
tivations and Expectations (DCI-ME) (n=719)a (continued)
itemb donor 
benefits
recipient 
benefits
idealistic 
incentives
gratitude
Factor ii
17 I expect the health risks for the recipient to 
decrease significantly as a result of the donation.
0.02 0.71 -0.08 0.19
16 I expect the disease burden of the recipient in 
everyday life to decrease significantly.
0.04 0.70 -0.15 0.21
3 I wish to donate in order to reduce the health risks 
for the recipient.
-0.03 0.66 0.11 -0.13
2 I wish to donate in order to reduce the disease 
burden of the recipient in everyday life.
-0.03 0.65 0.12 -0.04
1 I wish to donate in order to improve the quality of 
life of the recipient.
-0.10 0.61 0.14 -0.11
15 I expect the quality of life of the recipient to 
improve greatly.
-0.02 0.61 -0.21 0.36
Factor iii
11 I wish to make a contribution to a better world. 0.08 -0.06 0.72 0.03
10 I am acting in accordance with my religion or beliefs. 0.02 0.00 0.71 -0.17
12 Other donors are an example for me of love for 
one’s fellow humans.
0.03 0.07 0.68 0.12
13 I am glad to be able to help someone. -0.16 0.17 0.60 0.11
25 I expect to be strengthened in my religious or 
other beliefs as a result of the donation.
0.24 -0.12 0.50 0.00
26 I expect that I will serve as a good example for 
others through the donation.
0.07 0.07 0.48 0.29
Factor iv
23 I expect relatives of the recipient to be very 
grateful for the donation.
0.04 -0.05 0.10 0.83
22 I expect the recipient to be very grateful for the 
donation.
0.06 0.00 0.03 0.82
21 I expect that as a result of the donation, I will be 
able to make a real difference for the recipient.
0.03 0.18 0.08 0.55
excluded items
7 I wish to help a stranger/ acquaintance/friend/
family member.
-0.26 -0.06 0.42 0.16
8 I am doing this out of love for the recipient. 0.11 0.36 0.18 -0.19
9 I find it self-evident to do this for a fellow human 
being.
-0.03 0.30 0.41 -0.04
mean (sd) (range 1-5)c 1.96 (0.72) 4.57 (0.41) 2.87 (0.84) 3.44 (1.03)
Cronbach’s alpha .81 .78 .76 .77
% variance explained 22.1 13.9 8.9 7.9
a factor loadings on corresponding factors are in boldface type
b item number of original questionnaire, with item 14 and 26 being open response items
c higher means correspond with more cognitions in that domain
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Donation Cognition Instrument-Worries (DCI-W)
Principal component analysis was permitted (KMO=.73, Bartlett p<.001) on the 15 donor 
worries about themselves, the recipient, or future relationship changes (the three open 
response options did not indicate relevant missing worries). Five items were excluded 
for having a kurtosis higher than 10 (‘I am worried about the reaction of my relatives 
to the donation’; ‘I am worried that my relationship with the recipient will deteriorate’; 
‘I am worried that there will be more pressure and more tension in the relationship’; ‘I 
am worried that the relations within the family and/or relationship will change for the 
worse following the donation’; ‘I am worried that the division of roles within the family 
and/or relationship will change for the worse following the donation’). One item had a 
factor loading below .40, resulting in a 9-item Donation Cognition Instrument-Worries 
(DCI-W) (Table 3). One factor could be distinguished, which was normally distributed 
after logarithmic transformation, explaining a total variance of 33.5%. Donors in general 
reported minimal worries about the donation (M=1.47, SD=0.3 on a 4-point scale). The 
internal consistency was .74. Non-significant to small correlations between the DCI-W 
and subscales of the DCI-ME were found (r-values varying from .04 to .18).
table 3. Principal Components Analysis with Promax Rotation on the Donation Cognition Instrument–Wor-
ries (DCI-W) (n=719)a
itemb worries about 
the donation
Factor i Factor loadings
3 I am worried about the operation. 0.72
4 I am worried about the physical consequences of the donation, such as a possible 
infection or pain.
0.70
7 I am worried that the kidney will be rejected by the recipient. 0.64
10 I am worried about the high expectations of the recipient regarding the transplant. 0.57
9 I am worried that the recipient will have the idea that s/he should always remain 
grateful.
0.53
2 I am worried about the results of the medical tests. 0.51
5 I am worried about the reaction of my partner and/or children to the donation. 0.51
1 I am worried that I will feel guilty if I decide not to go ahead with the donation. 0.49
12 I am worried that there will be constant pressure to be grateful. 0.46
excluded item
8 I am worried about the lifestyle of the recipient after the transplant, for instance 
smoking or engaging in risky sports.
0.31
mean (sd) (range 1-4)c 1.47 (0.33)
Cronbach’s alpha .74
% variance explained 33.5
a factor loadings on corresponding factor are in boldface type
b item number of original questionnaire, as stated on page 12, 5 items were not included in the PCA
c higher means correspond with more worrying
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table 5. Correlation coefficients of the Donation Cognition Instrument subscales DCI-ME and DCI-W with 
validated questionnaires ab
dCi-me dCi-w
donor
benefits
recipient
benefits
idealistic
incentives
gratitude worries 
about 
donation
living donation expectancies questionnaire (ldeq)
Interpersonal Benefit .47*** -.03 .32*** .37*** .32***
Personal Growth .44*** .07 .37*** .28*** .28***
Spiritual Benefit .38*** .06 .52*** .23*** .14**
Quid pro Quo .45*** -.02 .26*** .35*** .26***
Health Consequences .34*** -.17*** .12** .15** .43***
Miscellaneous Consequences .21*** -.23*** .13** .01 .30***
Physical Functioning
rand short Form-36 Health status inventory (rand sF36)
Physical Functioning .00 .07 .01 .08* -.10**
Role Limitations - Physical Health Problemsc -.14*** .00 -.02 -.08* -.15***
Pain .00 .07 .01 .03 -.15***
General Health Perceptions -.07 .11** .03 .04 -.29***
Physical Health Composite -.06 .10** .03 .04 -.26***
short Cis Fatigue
Fatigue .09* -.11** -.09* -.07 .30***
Psychological functioning
rand short Form-36 Health status inventory (rand sF36)
Emotional Well-being -.13** .12** -.02 .04 -.37***
Role Limitations - Emotional Problemsc -.05 .08* .02 .05 -.14***
Energy/Fatigue -.05 .12** .05 .04 -.32***
Social Functioning -.09* .05 -.07 -.01 -.32***
Mental Health Composite -.09* .13** .00 .03 -.37***
Hospital anxiety and depression scale (Hads)
Anxiety .12** -.07 .02 .04 .44***
Depression .10** -.10** -.05 .01 .24***
social-relational functioning
neo Personality inventory–revised (neo Pi r)
Neuroticism - Vulnerability .15*** -.16*** -.02 -.01 .35***
interpersonal sensitivity measure (iPsm)
Interpersonal Awareness .12** -.07 .05 .04 .42***
Timidity .08* -.06 .12** .03 .27***
inventory for social reliance (isr)
Perceived Support -.06 .08* -.01 -.04 -.18***
a DCI-ME: Donation Cognition Instrument - Motivations and Expectations; DCI-W: Donation Cognition In-
strument- Worries (higher scores correspond to more cognitions in that domain); LDEQ: Living Donation 
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relationship of pre-donation cognitions with demographic and donation-
related variables
Significantly higher scores on donor benefit cognitions were reported by potential 
donors with a steady partner (t(609)=-2.37, p=.02), and those with a religious conviction 
(t(610)=-2.01, p=.045). Higher scores on recipient benefit cognitions were associated 
with a higher age (r=.08, p=.04). More idealistic incentives were reported by religious 
(t(612)=-6.96, p<.001) and anonymous (F(2,706)=9.96, p<.001) potential donors. 
Expectations of gratitude were reported more by males than females (t(691.52)=6.35, 
p<.001). No significant associations were found between worries about donation and 
demographic or donation-related variables (p-values>.19) (Table 4).
Construct validity of the donation Cognition instrument
Correlation coefficients of the DCI with the only other questionnaire assessing pre-do-
nation expectations (LDEQ) and HRQoL measures are presented in Table 5. Correlations 
between the DCI and LDEQ subscales were mostly moderate (40% of correlation coef-
ficients between .30-.50) or small (40% between .10-.30), whereas only non-significant 
(67% between .00-.10) to small correlations (33%) were found for the recipient benefits 
subscale of the DCI and the LDEQ. Higher scores on donor benefit cognitions showed 
small associations with worse psychological and social-relational functioning. Higher 
scores on recipient benefit cognitions were slightly associated with better physical and 
psychological functioning. More idealistic incentives showed only a small association 
with more timidity, whereas correlations for gratitude did not reach the .10 threshold. 
More worries showed moderate correlations with worse psychological and social-
relational functioning, and small correlations with worse physical functioning.
disCussion
Guidelines for psychosocial donor evaluation advise an appraisal of cognitions regarding 
the donation, including donor motivation, expectations, and worries about donation. 
Expectancies Questionnaire (higher scores correspond to more expectations on that domain); RAND SF36: 
RAND Short Form-36 Health Status Inventory (higher scores correspond to better HRQoL); CIS, Checklist In-
dividual Strength (higher scores correspond to more fatigue); HADS, Hospital Anxiety and Depression Scale 
(higher scores correspond to more anxiety or depression); NEO PI-R, NEO Personality Inventory – Revised 
(higher scores correspond to more neuroticism); IPSM, Interpersonal Sensitivity Measure (higher scores cor-
respond to more interpersonal sensitivity); ISR, Inventory for Social Reliance (higher scores correspond to 
better interpersonal functioning)
b *p<.05, **p<.01, ***p<.001
c Spearman correlation coefficients
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However, no instruments or criteria on how to judge these cognitions are provided. To 
meet this need, the Donation Cognition Instrument was developed. Five factors could be 
distinguished, measuring cognitions regarding donors’ own HRQoL improvement (Do-
nor Benefits), recipient’s wellbeing improvement (Recipient Benefits), living according 
to one’s ideals or religious convictions (Idealistic Incentives), expectations of gratitude in 
exchange for donation (Gratitude), and donation worries. Reliability of the DCI was veri-
fied by high internal consistency. Validity of the DCI was supported by small to moderate 
relationships with pre-donation cognitions and HRQoL, supporting the potential added 
value of the DCI for psychosocial evaluation in potential living organ donors.
Pre-donation motivations and expectations were mainly based on improving the 
recipient’s health, which is in line with previous research showing that donors are more 
focused on recipient’s functioning than on their own health (9). Expectations of grati-
tude for donation were also common. Potential donors mentioned their own HRQoL 
improvement less often as a primary motivation to donate, and generally indicated few 
worries about the consequences of donation. This may be due to the fact that the ques-
tionnaires were completed at the beginning of the donor evaluation procedure, when 
the wish to donate dominates. Possibly, worries about surgery or recipient outcomes 
arise later when the surgery is planned.
Gender differences on pre-donation cognitions were found, with males expecting 
more gratitude for donation. This is in line with research on the existing expectancies 
questionnaire (LDEQ), which found men to score higher on the subscale Quid Pro Quo, 
which also encompasses expecting something in return for the donation (14). Further, 
religious and anonymous donors reported more idealistic motivations. This was to be 
expected due to the presence of religious convictions in this scale and the fact that 
anonymous donors have been found to donate out of their ideals with regard to helping 
others (24, 41).
The validation of the DCI with the other validated questionnaire on pre-donation 
expectations regarding donor’s personal well-being (LDEQ) (14) showed a small to 
moderate overlap between most subscales. The low associations between recipient 
benefit cognitions and the LDEQ subscales indicate that the previous instrument does 
not yet assess these cognitions. Considering that they were the most often reported 
donor motivations or expectations and were related to better pre-donation HRQoL sup-
ports the potential value of this new, more encompassing instrument. To provide first 
indications that the DCI measures something additional to HRQoL, validity was assessed 
between the DCI and physical, psychological, and social-relational functioning. More 
worries were moderately associated with a worse pre-donation HRQoL. This is in line 
with research showing that HRQoL is related to worrying in other health conditions (42). 
The overall small associations between pre-donation cognitions and HRQoL support the 
notion of unique dimensions of potential donor’s attitudes being assessed by the DCI.
Pre-donation cognitions of potential living organ donors 99
4
Strengths of the current study include the large sample from seven transplantation 
centers, the use of validated questionnaires, and the applicability of the questionnaire 
for other donor populations due to the generalized formulation of items. The generaliz-
ability of the results is limited to the Dutch living kidney donor population and needs to 
be confirmed in alternative donor populations from other countries. Further, because the 
questionnaires were administered at the beginning of the donor evaluation, responses 
might be influenced by social desirability to positively influence healthcare profession-
als in the donation decision (8). Last, recent studies indicate that non-altruistic donor 
motives and expectations about finances and insurance are relevant themes for donor 
evaluation that are currently not included in the DCI. Future studies could add items on 
these themes to optimize the DCI.
At this moment no golden standard or longitudinal studies on donor cognitions are 
available, and possible risk or resilience factors for longer-term donor functioning are 
not yet clearly defined. Therefore, no valid cutoff criteria for the DCI could be formulated 
based on this cross-sectional study. Future prospective studies should examine the 
potential of the DCI to predict longer-term adjustment problems in living donors and 
to identify unfavorable cognitions that are contra-indications for donor eligibility (1, 27). 
Through this, donors who might benefit from psychosocial interventions could be iden-
tified. However as a first step in this process, the construct validity indices used in this 
study indicate the potential of the DCI to systematically assess pre-donation cognitions 
in clinical practice that might add to existing questionnaires on donor expectations and 
HRQoL. Further, the DCI could provide potential donors more insight into their own mo-
tivations, expectations, and worries and might aid in the process of donation decision-
making. Lastly, it could offer discussion themes for healthcare professionals during 
donor evaluation consultation, when potential donors report unfavorable motivations, 
unrealistic expectations or excessive worries about donation. In these cases, means and 
standard deviations provided from current study could be used as norm scores, because 
of the large and representative sample that was used. To conclude, the Donation Cogni-
tion Instrument is a reliable instrument to assess pre-donation cognitions, which has the 
potential to become part of the psychosocial donor evaluation to aid donor decisions 
and suggest donor intervention needs.
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abstraCt
The psychosocial evaluation of kidney donor candidates relies mostly on the clinical 
viewpoint of transplant professionals, because evidence-based guidelines for donor 
eligibility are currently lacking. However, the accuracy of these clinical risk judgments is 
as yet unknown. Therefore, the current prospective multicenter study examined the ef-
fectiveness of the psychosocial evaluation by transplant professionals and the potential 
value of donor self-report measures in optimizing the donor evaluation. The predictive 
value of pre-, intra-, and post-donation factors to impaired longer-term health-related 
quality of life (HRQoL) of kidney donors was studied. Transplant professionals (nephrolo-
gists, coordinating nurses, social workers, and psychologists) filled in risk estimation 
questionnaires on kidney donor candidates. Further, 230 kidney donors from seven 
Dutch transplantation centers completed questionnaires (e.g., on HRQoL) before, and 
6 and 12 months after donation. Both higher risk judgments of transplant professionals 
and donor self-report measures, particularly of poorer baseline physical and psycho-
logical functioning, significantly predicted impaired longer-term HRQoL after donation. 
This endorses the effectiveness of the psychosocial donor evaluation by professionals, 
and the additional value of donor self-report measures in optimizing the psychosocial 
evaluation. Consequently, donor eligibility decisions could be more reliable and tailored 
interventions for donors at risk could be provided.
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introduCtion
The recent increase in the number of living donor kidney transplantations has led to 
more research on donor wellbeing, including donor decision-making (e.g., motivation, 
expectations, and worries) and health-related quality of life (HRQoL) (1-7). Previous 
research indicates that most donors recover well after surgery. However, a subgroup of 
donors experiences sustained HRQoL difficulties (2, 6), potentially caused by donor or 
recipient complications (8-10), unmet donation expectations (11, 12), or social-relational 
problems (13). An accurate psychosocial evaluation enables the early identification of 
problems and the provision of counseling to prevent donation-related difficulties (14). 
Currently, evidence-based guidelines for psychosocial eligibility screening are scarce 
(15, 16), because only little research is available on predictors for longer-term HRQoL us-
ing baseline, intra- and post-operative measures (17-19). The most consistent risk factor 
of impaired HRQoL after donation has been poor baseline psychological functioning (6), 
whereas limited evidence has been found for a broad range of demographic, medical, 
and psychosocial risk factors, including being single, donor complications, and recipi-
ent functioning (4, 20, 21). Because of the lack of large prospective prediction studies, 
the psychosocial donor evaluation relies mostly on the clinical viewpoint of transplant 
professionals. However, the accuracy of these clinical judgments is as yet unknown. 
Also, procedures are not consistent across donation programs (22). A standardized 
evidence-based psychosocial evaluation would enable transparent eligibility decisions 
and interventions for donors with a high-risk profile, but more knowledge about the 
most important predictors of poor HRQoL after donation is necessary.
Summarizing, due to a shortage of large prospective prediction studies, psychosocial 
donor screening is currently mainly based on clinical risk assessments. The accuracy of 
these clinical judgments of transplant professionals and the possible value of donor 
self-report measures in eligibility screening must be examined. The current prospective 
study examines the value and relative contribution of risk estimations by transplant 
professionals, donor self-report measures, and pre-, intra-, and post-donation factors in 
predicting both short- and longer-term HRQoL of kidney donors.
materials and metHods
Procedure
All potential donors from seven Dutch transplantation centers (Radboud university 
medical center, University Medical Center Groningen, Leiden University Medical Center, 
Academic Medical Center Amsterdam, University Medical Center Utrecht, VU University 
Medical Center Amsterdam, and Maastricht University Medical Center) were invited to 
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participate in the study after their first screening visit (2011-2015). Transplant profes-
sionals routinely involved in donor evaluation (nephrologists, coordinating nurses, 
social workers, and psychologists) filled in a short questionnaire on their risk estimation 
for poorer donor HRQoL after donation. Also, potential donors completed a screening 
questionnaire either by email or on paper. If donation took place, donors received a 
similar questionnaire six and twelve months after surgery. Illiteracy was the only exclu-
sion criterion. The Radboud university medical center Ethics Committee decided that 
the study did not fall under the scope of the Medical Research Involving Human Sub-
jects Act. Therefore, approval by an ethics committee was not indicated, because of the 
absence of any risk for the participants. In all participating centers, the board approved 
the study. All participants signed informed consent. The clinical and research activities 
being reported are consistent with the Declaration of Helsinki and the Declaration of 
Istanbul.
Participants
Transplant professionals
On 533 potential donors (91% of participating donors), 1,048 risk estimation question-
naires were completed by coordinating nurses (n=489), medical social workers (n=339), 
nephrologists (n=201), and psychologists (n=19).
Potential donors
In total, 588 potential donors participated (75% response rate), of whom 361 (61%) 
actually donated a kidney. The mean time between screening and donation was 7.0±5.2 
months (range 1-39 months). Reasons for exclusion from the donation procedure are 
presented in Figure 1. Complete data of 230 donors were available, excluding par-
ticipants filling out the questionnaires more than three months after the intended time 
(Figure 1).
measures
Predictor variables
Demographic and pre-, intra- and post-operative health characteristics
Donor demographic characteristics as well as pre-, intra- and post-operative health 
characteristics (e.g., physical comorbidity, hospital stay, complications) were assessed. 
Data on recipient’s pre-transplantation treatment and post-transplantation outcome 
(i.e., graft failure or death) were derived from the Dutch Organ Transplantation Registra-
tion system (23).
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Risk estimations by transplant professionals
Transplant professionals indicated their risk estimation of poorer longer-term donor 
physical and psychosocial functioning on a 10-point Scale; higher scores represented 
a higher risk of an unfavorable course. Physical risk estimations were represented in a 
single item. Psychosocial risk estimations were represented in a summary score based 
on 1) motivations, expectations, and worries about donation; 2) social support and 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Invited donors: N=788 
Non-response or donor refused 
participation: n=67 (9%) 
Donor nephrectomy:  
n=361 (61%) 
No donor nephrectomy: n=227 (39%) 
 
Exclusion from donation procedure: 
 
Medical reasons n=84 (37%) 
Another potential living donor was preferred n=27 (12%) 
Personal reasons n=18 (8%)  
Other reasons n=14 (6%) 
 
 
In donor evaluation procedure when data collection was 
closed n=11 (5%) 
Recipient’s kidney function was not sufficiently impaired 
to schedule transplantation n=50 (22%) 
 
Recipient was not able to receive a transplant n=14 (6%) 
 
Post-mortal donor became available n=9 (4%) 
 
 
 
Completed 6 months 
assessment: N=275 (76%) 
Donation <6 months before close of data 
collection: n=13  (4%) 
6 months assessment was completed >9 
months after donation: n=8 (2%) 
Did not complete 6 months assessment, 
but completed 12 months assessment: n= 
21 (6%) 
 
 
Completed baseline assessment: 
n=588 (75%) 
 
Completed 12 months 
assessment: N=250 (69%) 
Complete data sets available: 
N=230  (64%) 
Donation 6-12 months before close of data 
collection: n=33 (10%) 
12 months assessment was completed >15 
months after donation: n=11 (3%) 
Study drop out: n=23 (7%) 
 
(Temporary) Exclusion from 
donation procedure: n=133 (17%) 
Figure 1. Study Flow Chart
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recipient-related factors; and 3) past and 4) current psychological functioning (Figure 
2). Because risk estimations were not always completed by all four disciplines, an aver-
age risk estimation per donor was calculated; in secondary analyses, risk estimations of 
specific disciplines were explored (estimations of psychologists were excluded because 
of the small sample size).
Transplant Professionals Questionnaire: Risk estimation of potential kidney donors 
I   Physical functioning  
Current physical functioning:  
 
 
 
 
II  Motivation and expectations 
 
 
  Not at all  A little Somewhat Strongly Unknown 
1. The donation is a well-considered choice. 1 2 3 4  
       
2. The donor expects that      
       
 …  his/her quality of life will improve after the donation. 1 2 3 4  
       
 …  the recipient’s quality of life will improve after the 
donation. 
1 2 3 4  
       
 …  the relationship with the recipient will improve after the 
donation  
1 2 3 4  
       
3. The donor’s expectations about the donation are realistic. 1 2 3 4  
       
4. The donor is worried about the donation. 1 2 3 4  
       
In light of the motivation and expectations, how high do you estimate the risk of an unfavorable course after the 
donation? 
 
 
 
III  Social environment 
 
 
  Not at all  A little Somewhat Strongly Unknown 
1. The donor’s loved ones are positive about the donation. 1 2 3 4  
       
2. If problems arise in connection with the donation, there are 
enough people to whom the donor could turn for help.  
1 2 3 4  
       
3. The donor indicates that he/she has a good relationship 
with the recipient (if applicable). 
1 2 3 4  
4. The donor indicates that he/she can communicate well with 
the recipient about the donation (if applicable). 
1 2 3 4  
In light of the social factors, how high do you estimate the risk of an unfavorable course after the donation? 
 
 
IV  Emotional symptoms – present 
 
 
  Not at all  A little Somewhat Strongly Unknown 
To what extent does the donor currently experience emotional 
difficulties, such as anxiety or depressed mood?  
1 2 3 4  
       
In light of current emotional difficulties, how high do you estimate the risk of an unfavorable course after the 
donation? 
 
 
 
 
no risk 
 
very high 
risk 
 
          
          
 
no risk 
 
very high 
risk 
 
          
          
 
very  
poor 
very 
good 
          
          
 
no risk very high 
risk 
          
          
 
Figure 2. Transplant professionals’ risk estimation questionnaire of poorer longer-term donor functioning
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Pre-donation donor measures 
Donation decision-making
Donation decision-making was assessed by the Donation Cognition Instrument (DCI) 
(7) and the Living Donation Expectancies Questionnaire (LDEQ) (24).
The DCI consists of two parts: Motivation and Expectations (DCI-ME; 22 items) and 
Worries (DCI-W; 9 items). The DCI-ME assesses donor motivations and expectations, such 
as Donor Benefits (‘I expect my own quality of life to improve as a result of the dona-
tion’); Recipient Benefits (‘I wish to donate in order to improve the quality of life of the 
recipient’); Gratitude (‘I expect the recipient to be very grateful for the donation’); and 
Idealistic Incentives (‘I wish to make a contribution to a better world’) on a 5-point scale. 
The DCI-W concerns worries about donation (e.g., ‘I am worried about the operation’), 
measured on a 4-point scale.
The LDEQ examines expectancies regarding donor’s personal well-being (42 items), 
starting with ‘As an organ donor, I expect…’, measured on a 5-point scale. Six domains 
are distinguished: Interpersonal Benefits (e.g., ‘...to be seen as heroic’); Personal Growth 
(e.g., ‘...to feel proud of myself’); Spiritual Benefits (e.g., ‘...to have a stronger religious 
faith’); Quid Pro Quo (e.g., ‘...preferential treatment by the recipient after donation’); 
Health Consequences (e.g., ‘...to experience a great deal of pain and discomfort’); and 
Miscellaneous Consequences (e.g., ‘...to have more financial problems’). Higher scores 
represent higher expectancies (24).
 
V  Emotional symptoms – past 
 
 
  Not at all  A little Somewhat Strongly Unknown 
To what extent has the donor experienced emotional difficulties, 
such as anxiety or depressed mood, in the past (over a longer 
period of time)? 
1 2 3 4  
       
In light of emotional difficulties in the past, how high do you estimate the risk of an unfavorable course after the 
donation?  
 
 
 
 
Total score of risk estimation 
 
 
To what extent is this donor at risk for an unfavorable course after donation and for developing emotional or physical 
symptoms and difficulties after the donation?  
 
 
 
Comments 
 
 
Please note down any comments of relevance for your risk estimation.  
 
 
 
Figure 2. Transplant professionals’ risk estimation questionnaire of poorer longer-term donor functioning 
no risk very high 
risk 
 
          
          
 
no risk very high 
risk 
 
          
          
 
Figure 2. Transplant professionals’ risk estimation questionnaire of poorer longer-term donor functioning
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Health-related quality of life (HRQoL)
HRQoL: Physical functioning was assessed using the RAND Short Form-36 Health 
Status Inventory (RAND SF36; 25) and the Checklist Individual Strength-Fatigue Scale 
Short Version (CIS; 26).
The RAND SF36 is a 36-item questionnaire assessing eight HRQoL-dimensions. Four 
dimensions measure physical health: Physical Functioning, Role Limitations due to 
Physical Health Problems, Pain, and General Health Perceptions; summarized in the 
Physical Health Composite Score. The Hays norm-based scoring algorithm was applied, 
transforming raw scores into T-scores (M=50±10 in the general population). Higher 
scores represent better HRQoL (25).
The CIS short version (4 items) assesses fatigue (e.g., ‘I feel tired’). Higher scores repre-
sent more fatigue (26).
HRQoL: Psychological functioning was assessed using four subscales of the RAND 
SF36 : Emotional Well-being, Role Limitations due to Emotional Problems, Social Func-
tioning, and Energy; summarized in the Mental Health Composite Score (25).
Additionally, the NEO Personality Inventory-Revised–Neuroticism scale (eight items) 
assesses the neuroticism personality characteristic on a 5-point scale (‘I can handle myself 
pretty well in crisis’)(27). Higher scores represent higher sensitivity for stressful situations.
HRQoL: social-relational functioning was measured using the Interpersonal Sensi-
tivity Measure (IPSM)(28) and the Inventory for Social Reliance (ISR)(29).
Of the IPSM, the subscales Interpersonal Awareness (7 items; e.g., ‘I worry about the 
effect I have on other people’) and Timidity (8 items; e.g., I will do something I do not 
want to do rather than offend or upset someone’) were assessed on a 4-point scale. 
Higher scores represent greater interpersonal awareness or timidity (28).
Perceived support was assessed using the Perceived Social Support scale (5 items) of 
the ISR (e.g., ‘When I am tense or under pressure, there is somebody to help me’). Scores 
are rated on a 4-point Likert scale. Higher scores represent lower perceived support (29).
Recipient functioning: Donor perspectives on the donor-recipient relationship quality, 
current physical and emotional recipient functioning , and the influence of recipient’s 
kidney disease on the donor’s life were assessed using 10-point scales (e.g., ‘To what 
extent is your life influenced by the recipients’ kidney disease?’).
Post-donation outcome measures 
Physical and psychological HRQoL six and twelve months post-donation were the outcome 
measures, assessed by the RAND SF36 Physical and Mental Health Composite Scores (25).
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statistical analyses
First, the association of donor demographic characteristics, pre-, intra- and post-oper-
ative donor and recipient health status, transplant professionals’ risk estimations, and 
baseline donor measures with HRQoL at 6 and 12 months post-donation was examined 
using Pearson correlations. Positive correlations indicate that higher predictor values 
were related to better post-donation HRQoL. To examine the relative contribution of 
potential predictors, all variables that showed significant correlations to HRQoL at six or 
twelve months post-donation were included in hierarchical multiple regression analyses 
for that outcome. To study the specific role of transplant professionals’ judgments of 
donor risk and donor measures in predicting post-donation HRQoL, pairwise regression 
analyses were conducted with donor demographic characteristics and pre-, intra- and 
post-operative donor and recipient health status (Block 1) and either transplant profes-
sionals’ risk estimations or donor self-report measures (Block 2) as predictor variables of 
physical or psychological HRQoL 6 or 12 months post-donation. If baseline physical or 
psychological HRQoL was a significant predictor, subsequent analyses were conducted 
to examine whether specific HRQoL aspects predicted the outcome. Third, the additional 
contribution of transplant professionals’ risk judgments and donor self-report measures 
on top of the other category was assessed.
A p-value below .05 was considered significant, but trend-significant predictors 
(p<.10) were also reported in the tables. Data were analyzed using IBM SPSS software 
version 22 (30).
results
donor characteristics
Demographic characteristics and pre-, intra- and post-operative health status of 230 
included donors are reported in Table 1. There was an almost equal gender representa-
tion (59% female), with a mean age of 55.1 (SD=10.7; range 23-76) years, and mostly a 
secondary level education (62%). The majority (83%) donated directly to a recipient they 
knew. Donors stayed on average 5 days in the hospital, with 35 donors (15%) experienc-
ing either Grade I (n=19; 8%), Grade II (n=14; 6%) or Grade III-b (n=2; 1%) complications 
(31). In recipients, 11 (6%) kidneys were rejected and 6 (3%) recipients died after kidney 
transplantation. There were no major donor complications; none of the donors died or 
had to receive dialysis treatment during the data collection period.
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table 1. Demographic characteristics and pre-, intra-, and post-operative health status of donors (N=230)
Characteristic descriptives
Donor baseline characteristics
Age Mean ± SD (range) years 55.1 ±10.7 (23-76) years
Gender 
Female 59% 
Male 41% 
Marital statusa
Single 19% 
Steady partner 81% 
Educational levelb
Primary education 5% 
Secondary education 62% 
Tertiary education (higher vocational/university) 33% 
Donation type 
Direct 83% 
Kidney exchange procedure 8% 
Anonymous 9% 
Donor-recipient relationship
Spouse 30% 
Parent 20% 
Sibling 18% 
Child 3% 
Other – related (e.g., uncle) 17% 
Other – unrelated (e.g., friend) 3% 
Anonymous 9% 
Religious affiliationb
Religious 53% 
Non-religious 47% 
Donor health status
Surgery type
Mini-incision donor nephrectomy 15%
Laparoscopy 85%
Hospital stay (days) 4.57 ± 1.6 (range 1-14) days
Donor complicationsc
No complications 85% 
Grade I 8% 
Grade II 6% 
Grade III a - 
Grade III b 1% 
Grade IV a - 
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Predictors of poorer longer-term Hrqol
Physical HRQoL six and twelve months after donation
Poorer physical HRQoL after donation was related to higher transplant professionals’ 
physical risk judgments as well as multiple donor self-report measures (see Table 2).
Demographic and pre-, intra- and post-operative health status 
Demographic characteristics and health status explained only 3% and 6% of variance of 
physical HRQoL six and twelve months post-donation, respectively, with no individual 
variables being consistent predictors.
Transplant professionals’ risk estimations 
A higher transplant professionals’ risk estimation of a donor’s physical functioning was 
associated with poorer physical HRQoL at six (β=-.21, p=.01; F(6,170)=1.98, p=.07) and 
twelve months post-donation (β=-.27, p<.001; F(6,170)=4.05, p=.001), adding 4% and 
7% of the explained variance, respectively. Regarding specific disciplines, at six months 
after donation, higher risk estimations of coordinating nurses (β=-.22, p=.02) and 
medical social workers (β=-.27, p=.003) predicted worse physical HRQoL, and at twelve 
months all disciplines (.-20≤β≤=-.31, .04≤p≤.001).
Donor measures
Significant predictors of poorer physical HRQoL six months post-donation were a lower 
baseline physical HRQoL (β=.44, p<.001) and donor estimations of more recipient limita-
tions in daily life (β=.17, p=.01), adding 33% to the total explained variance F(12,166)=.48, 
p<.001. For poorer physical HRQoL twelve months post-donation, a lower baseline 
table 1. Demographic characteristics and pre-, intra-, and post-operative health status of donors (N=230) 
(continued)
Characteristic descriptives
Grade IV b - 
Grade V - 
Recipient complications
Graft failure 
Yes 6% 
No 94% 
Patient death
Yes 3% 
No 97% 
a n=228
b n=229
c Categorisation according the Clavien-Dindo classification system (Dindo et al. 2004)
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table 2. Correlation and multivariable regression coefficients of the prediction of poorer physical health-
related quality of life (physical health composite RAND SF-36) six and twelve months after living kidney 
donation
 Predictors rand sF36 Physical 
health 
six months after donation
rand sF36 Physical health 
twelve months after 
donation
Correlational 
analyses
regression 
analyses
Correlational 
analyses
regression 
analyses
r p β p r p β p
block 1
Demographic characteristics 
Gender (0=male, 1=female) -.10 .15 -.12 .09Ɨ
Age .05 .46 -.03 .67
Marital status (0=single, 1=partner) .14 .038ǂ .14 .06ǂ .02 .80 .01 .93
Educational level: (0=no, 1=yes)
primary education .00 .99 -.02 .82 
secondary education -.03 .65 .01 .88 
tertiary education .03 .63 .00 .96 
Work situation (0= not working, 1=working) -.10 .16 -.06 .37
Being religious (0= no, 1=yes) .09 .22 .00 .95
History of psychological complaints (0=no,1=yes) -.07 .33 .02 .80
Donation Type: (0=no, 1=yes)
direct .04 .61 .01 .84 
kidney exchange procedure -.10 .15 -.09 .22 
anonymous .06 .36 .07 .29 
Donor-recipient relationship: (0=no, 1=yes)
spouse -.07 .32 -.08 .27 
parent-child -.02 .76 -.07 .29 
child-parent .01 .85 .07 .29 
sibling .07 34 .06 .38 
other emotionally related -.01 .85 .06 .40 
other genetically related -.03 .68 -.08 .28 
Donor health status
Donor baseline health status
Physical comorbidity (0=no, 1=yes) -.08 .27 -.05 .49
Body Mass Index -.09 .20 -.11 .12
Systolic blood pressure .08 .23 .13 .07Ɨ
Diastolic blood pressure1 .09 .22 .13 .07Ɨ
Donor baseline behavioral factors
Smoking (0=no, 1=yes) -.07 .33 .01 .90
Alcohol use (0=no, 1=yes) .10 .15 .10 .15
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Table 2. Correlation and multivariable regression coefficients of the prediction of poorer physical health-related 
quality of life (physical health composite RAND SF-36) six and twelve months after living kidney donation 
(continued)
 Predictors rand sF36 Physical 
health 
six months after donation
rand sF36 Physical health 
twelve months after 
donation
Correlational 
analyses
regression 
analyses
Correlational 
analyses
regression 
analyses
r p β p r p β p
Donor intra- and post-operative characteristics
Surgery type (0=MIDN, 1=LAP) .03 .63 .04 .56
Nephrectomy side (0=left) -.04 .58 .03 .69
Hospital stay (days) .04 .59 .16 .02ǂ
Donor complications2
No complications .01 .87 -.13 .06 
Grade I .03 .65 -.13 .07 
Grade II .04 .62 -.18 .01ǂ 
Grade III .01 .87 -.13 .06 
Recipient health status
Recipient baseline health status
Pretransplant treatment recipient: (0=no, 1=yes)
Pre-emptive .05 .52 .00 .96 
Haemodialysis -.01 .93 .01 .87 
Peritoneal dialysis -.10 .16 .00 .97 
Transplantation .07 .31 .05 .53 
Recipient post-transplantation complications
Graft failure (0=no) 13 .08 .01 .85
Patient death (0=no) .08 .27 .03 .71
Block 2
Risk estimation transplant professionals (VAS)
Mean physical risk estimation (all transplant 
disciplines)
-.21 .005§ -.21 .01§ -.31 <.001¶ -.27 <.001§
Nephrologist -.05 .71 -.04 .76 .24 .04ǂ -.20 .04ǂ
Coordinating nurse -.20 .01ǂ -.22 .02ǂ .26 .001§ -.31 .001§
Medical Social Worker -.29 .001§ -.27 .003§ .27 .002§ -.25 .01§
Donor baseline self-report measures: Donor Cognitions
donation Cognition instrument (dCi)
Donor Benefits -.08 .26 -.09 .21
Recipient Benefits1 -.01 .87 -.02 .77
Idealistic Incentives .11 .11 .05 .44
Gratitude .10 .14 .06 .37
Worries about the donation1 -.10 .16 -.14 .054Ɨ
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Table 2. Correlation and multivariable regression coefficients of the prediction of poorer physical health-related 
quality of life (physical health composite RAND SF-36) six and twelve months after living kidney donation 
(continued)
 Predictors rand sF36 Physical 
health 
six months after donation
rand sF36 Physical health 
twelve months after 
donation
Correlational 
analyses
regression 
analyses
Correlational 
analyses
regression 
analyses
r p β p r p β p
living donation expectancies questionnaire (ldeq)
Interpersonal Benefit -.01 .92 -.02 .80
Personal Growth .07 .34 .05 .52
Spiritual Benefit .05 .49 -.02 .82
Quid Pro Quo .07 .40 .05 .51
Health Consequences -.10 .20 -.11 .16
Miscellaneous Consequences -.07 .34 -.05 .51
Donor baseline self-report measures: Donor HRQoL
Physical functioning
Baseline physical HRQoL (RAND SF36 PCS) 1 .53 <.001¶ .44 <.001¶ .48 <.001¶ .37 <.001§
Subscales physical HRQoL (RAND SF36)
Physical functioning1 .35 <.001¶ .15 .06Ɨ .33 <.001¶ .13 .10
Physical role limitations .21 .002§ .08 .28 .21 .002§ .08 .29
Pain1 .29 <.001¶ .11 .14 .29 <.001¶ .09 .22
General health perceptions .43 <.001§ .21 .02Ɨ .40 <.001¶ .21 .02Ɨ
Checklist individual strength (Cis)
Fatigue1 -.39 <.001¶ -.13 .11 -.32 <.001¶ -.09 .31
Psychologial functioning
rand short Form36 Health status inventory mCs
Emotional functioning1 .35 <.001¶ .02 .80 .31 <.001¶ .04 .68
neo Personality inventory – revised (neo Pi r)
Neuroticism -.24 .001§ -.05 .52 -.32 <.001¶ -.12 .15
Social-relational predictors
interpersonal sensitivity measure (iPsm)
Interpersonal awareness .13 .06Ɨ .04 .63 .21 .002§ .02 .76
Timidity -.03 .70 .03 .70
inventory for social reliance (isr)
Social support .05 .51 .02 .79
Donor estimation of wellbeing recipient before transplantation
Quality of donor-recipient relationship1 .07 .35 .13 .07Ɨ
Physical functioning recipient .14 .06Ɨ .11 .14
Emotional functioning recipient .08 .31 .09 .23
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physical HRQoL (β=.37, p<.001) remained a significant predictor, adding a variance of 
22%, F(12,166)=5.38, p<.001. Looking into the specific aspects of physical HRQoL, the 
general health perceptions subscale was the only significant predictor at both six (β=.21, 
p=.02) and twelve months (β=.19, p=.03) after donation.
Psychological Hrqol six and twelve months after donation
Poorer post-donation psychological HRQoL was related to higher transplant profession-
als’ psychological risk estimations as well as various categories in the donor measures 
(Table 3).
Demographic characteristics and pre-, intra- and post-operative health status
Demographic characteristics and health status explained 21% and 22% of the variance 
of psychological HRQoL six and twelve months post-donation, respectively. The only 
consistent predictor was having a child-parent donor-recipient relationship, which was 
a protective factor for poorer psychological HRQoL twelve months after donation (in 
transplant professionals model: β=-.23, p=.002; in donor measures model: β=-.19, p=.02).
Transplant professionals’ risk estimations 
A higher risk estimation by transplant professionals regarding donor’s psychosocial 
functioning added 2% and 1% of the variance to the prediction of poorer psychological 
Table 2. Correlation and multivariable regression coefficients of the prediction of poorer physical health-related 
quality of life (physical health composite RAND SF-36) six and twelve months after living kidney donation 
(continued)
 Predictors rand sF36 Physical 
health 
six months after donation
rand sF36 Physical health 
twelve months after 
donation
Correlational 
analyses
regression 
analyses
Correlational 
analyses
regression 
analyses
r p β p r p β p
Limitations of recipient in daily life .16 .03ǂ .17 .01ǂ .02 .81 .06 .41
Influence of kidney disease of the recipient on 
donor’s life
.17 .02ǂ .03 .64 .16 .03ǂ .03 .69
Donor feelings of responsibility for wellbeing 
recipient
.14 .06Ɨ .09 .26
Donor taking over workload of recipient .14 .07Ɨ .05 .54
Ɨ p<.10, ǂ p<.05, §p<.01, ¶p<.001. Positive scores indicate that predictors are related to better physical func-
tioning.
LAP: laparoscopic donor nephrectomy, MIDN: mini-incision donor nephrectomy.
1Variables that were not normally distributed and were transformed using logarithmic or reflected transfor-
mation, 2Categorisation according the Clavien-Dindo classification system (Dindo et al. 2004)
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table 3. Correlation and multivariable regression coefficients of the prediction of poorer psychological 
health-related quality of life (mental health composite RAND SF36) six and twelve months after living kid-
ney donation
Predictors
rand sF36 mental Health
six months after donation
rand sF36 mental Health
twelve months after 
donation
Correlational
analyses
regression
analyses
Correlational
analyses
regression
analyses
r p β p r p β p
block 1
Demographic characteristics
Gender (0=male, 1=female) -.20 .003§ -.15 .051 -.16 .02ǂ -.10 .19
Age .03 .66 -.04 .52
Marital status (0=single, 1=partner) .15 .03ǂ .16 .045Ɨ .08 .26 .09 .27
Educational level: (0=no, 1=yes)
primary education -.08 .25 -.05 .50 
secondary education .04 .58 .00 .97 
tertiary education .00 .97 .02 .78 
Work situation (0= not working, 1=working) -.09 .22 -.03 .63
Being religious (0=no, 1=yes) .09 .20 .05 .51
History of psychological complaints (0=no,1=yes) -.25 <.001¶ -.21 .01ǂ -.17 .02ǂ -.14 .07
Donation Type: (0=no, 1=yes)
direct .13 .07Ɨ .02 .87 .16 .02ǂ .06 .58 
kidney exchange procedure -.01 .91 .00 .95 -.03 .71 .07 .38 
anonymous -.14 .047ǂ -.27 .40 -.17 .02ǂ .20 .55 
Donor-recipient relationship: (0=no, 1=yes)
spouse -.03 .63 -.04 .64 -.06 .36 .02 .85 
parent-child -.04 .59 .02 .79 -.06 .42 .02 .80 
child-parent .11 .10 .17 .03ǂ .18 .01ǂ .22 .004§ 
sibling .08 .25 .15 .08Ɨ .08 .22 .13 .12 
other emotionally related .02 .82 .11 .19 .11 .13 .15 .08Ɨ 
other genetically related .05 .47 .08 .28 .01 .92 .03 .71 
Donor health status
Donor baseline health status
Physical comorbidity (0=no, 1=yes) -.01 .83 -.08 .23
Body Mass Index .04 .61 .03 .71
Systolic blood pressure .16 .02ǂ .13 .22 .18 .01ǂ .10 .32
Diastolic blood pressure1 .13 .051Ɨ .04 .69 .16 .02ǂ .09 .40
Donor baseline behavioral factors
Smoking -.08 .26 -.04 .54
Alcohol use .06 .40 .07 .33
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table 3. Correlation and multivariable regression coefficients of the prediction of poorer psychological 
health-related quality of life (mental health composite RAND SF36) six and twelve months after living kid-
ney donation (continued)
Predictors
rand sF36 mental Health
six months after donation
rand sF36 mental Health
twelve months after 
donation
Correlational
analyses
regression
analyses
Correlational
analyses
regression
analyses
r p β p r p β p
Donor intra- and post-operative characteristics
Surgery type (0=MIDN, 1=LAP) .06 .38 .09 .20
Nephrectomy side (0=left) .04 .55 .06 .41
Hospital stay (days) .23 .001§ -.14 .07 .14 .052 Ɨ .09 .26
Donor complications2
No complications .07 34 .08 .23 
Grade I .08 .23 .04 .80 .05 .48 .27 .11 
Grade II .13 .06Ɨ .32 .09 .12 .08Ɨ .27 .16 
Grade III .08 .27 .17 .49 .09 .19 .09 .70 
Recipient health status
Recipient baseline health status
Pretransplant treatment recipient: (0=no,1=yes)
Pre-emptive -.02 .75 -.01 .86 
Haemodialysis .01 .93 .02 .74 
Peritoneal dialysis .01 .93 -.07 .32 
Previous transplantation .05 .54 .12 .11 
Recipient post-transplantation complications
Graft failure (0=no) .01 .85 .02 .79
Patient death (0=no) .04 .55 .05 .51
block 2
Risk estimation transplant professionals (VAS)
Mean psychosocial risk estimation (all transplant 
disciplines)
-.27 <.001¶ -.15 .053Ɨ -.23 .001§ -.17 .03Ɨ
Nephrologist -.29 .01ǂ -.17 .25 -.28 .02 Ɨ -.17 .25 
Coordinating nurse -.25 .001§ -.05 .61 Ɨ -.20 .01 Ɨ -.17 .11 
Medical Social Worker -.26 .002§ -.21 .02 Ɨ -.20 .03 Ɨ -.20 .03Ɨ 
Donor baseline self-report measures: Donor Cognitions
donation Cognition instrument (dCi)
Donor Benefits -.13 .07Ɨ -.13 .07Ɨ
Recipient Benefits1 .11 .11 .11 .10
Idealistic motivations .16 .02ǂ .12 .14Ɨ .03 .70 -.04 .62
Gratitude .16 .02ǂ .02 .79 .14 .04ǂ .04 .62
Worries about the donation1 -.18 .01ǂ -.08 .40 -.25 <.001¶ .00 .99
120 Chapter 5
table 3. Correlation and multivariable regression coefficients of the prediction of poorer psychological 
health-related quality of life (mental health composite RAND SF36) six and twelve months after living kid-
ney donation (continued)
Predictors
rand sF36 mental Health
six months after donation
rand sF36 mental Health
twelve months after 
donation
Correlational
analyses
regression
analyses
Correlational
analyses
regression
analyses
r p β p r p β p
living donation expectancies questionnaire (ldeq)
Interpersonal Benefit -.06 .46 -.09 .24
Personal Growth -.05 .51 -.05 .53
Spiritual Benefit .01 .86 -.04 .62
Quid Pro Quo .03 .69 .04 .63
Health Consequences -.19 .01ǂ .14 .52 -.20 .01ǂ .22 .31
Miscellaneous Consequences -.18 .02ǂ .13 .53 -.20 .01ǂ -.17 .40
Donor baseline self-report measures: Donor HRQoL
Physical functioning
rand short Form36 Health status inventory PCs
Baseline physical functioning1 .40 <.001¶ .13 .15 .38 <.001¶ .14 .14
Checklist individual strength (Cis)
Fatigue1 -.44 <.001¶ -.14 .14 -.39 <.001¶ -.05 .64
Psychological functioning
Baseline mental HRQoL (RAND SF36) 1 .53 <.001¶ .26 .02ǂ .55 <.001¶ .31 .01ǂ
Subscales mental HRQoL (RAND SF36)
Emotional wellbeing .51 <.001¶ .31 .004ǂ .51 <.001¶ .30 .01ǂ
Emotional role limitations .21 .002§ .03 .69 .20 .003§ .09 .26
Vitality .46 <.001¶ .08 .46 .49 <.001¶ .11 .30
Social functioning1 .34 <.001¶ .00 .98 .37 <.001¶ .07 .49
neo Personality inventory – revised (neo Pi r)
Neuroticism .32 <.001¶ .06 .55 .37 <.001¶ .09 .37
Social-relational predictors 
interpersonal sensitivity measure (iPsm)
Interpersonal awareness .28 <.001¶ .04 .73 .30 <.001¶ .06 .58
Timidity .13 .07Ɨ .00 .99 .16 .02ǂ .01 .95
inventory for social reliance (isr)
Social support .06 .42 .10 .26 .20 .004§ .04 .66
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HRQoL at six (β=-.15, p=.053; F(18,160)=2.71, p<.001) and twelve months after donation, 
(β=.17, p=.03; F(18,160)=2.61, p=.001). Higher risk estimations of medical social work-
ers (6 months: β=-.21, p=.02; 12 months: β=-.20, p=.03) significantly predicted worse 
psychological HRQoL after donation.
Donor measures
Of donor measures, poorer baseline psychological HRQoL was the only significant 
predictor of poorer psychological HRQoL six (β=.26, p=.02; F(32,120)=3.15, p<.001) and 
twelve months post-donation (β=.31, p=.01; F(32,120)=3.08, p<.001), adding 25 and 23% 
explained variance. Looking into the specific aspects of psychological HRQoL, poorer 
emotional well-being was the only significant predictor at both six (β=.31, p=.004) and 
twelve (β=.30, p=.01) months post-donation.
Relative contribution of transplant professionals’ risk estimations and donor measures 
Both transplant professionals’ risk estimations and donor measures added significant 
variance to the prediction of physical and psychological HRQoL on top of demographic 
variables and health status. The additional value of transplant professionals’ risk esti-
table 3. Correlation and multivariable regression coefficients of the prediction of poorer psychological 
health-related quality of life (mental health composite RAND SF36) six and twelve months after living kid-
ney donation (continued)
Predictors
rand sF36 mental Health
six months after donation
rand sF36 mental Health
twelve months after 
donation
Correlational
analyses
regression
analyses
Correlational
analyses
regression
analyses
r p β p r p β p
Donor estimation of wellbeing recipient before transplantation
Quality of donor-recipient relationship1 .10 .18 .12 .10
Physical functioning recipient .14 .07Ɨ .10 .19 .16 .03ǂ .14 .06Ɨ
Emotional functioning recipient .02 .79 .09 .26
Limitations of recipient in daily life .01 .95 .06 .46
Influence of kidney disease of the recipient on 
donor’s life 
.17 .02ǂ .03 .71 .22 .003§ .10 .29
Donor feelings of responsibility for wellbeing 
recipient
.10 .17 .06 .54 .17 .03ǂ .04 .69
Donor taking over workload of recipient .01 .94 .09 .21
Ɨ p<.10, ǂp<.05, §p<.01, ¶p<.001. Positive scores indicate that predictors are related to a better mental HRQoL
LAP: laparoscopic donor nephrectomy, MIDN: mini-incision donor nephrectomy.
1Variables that were not normally distributed and were transformed using logarithmic or reflected trans-
formation
2Categorisation according the Clavien-Dindo classification system (Dindo et al. 2004)
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mations on top of donor measures was limited in predicting both physical (0-2%) and 
psychological HRQoL (0-1%), while using donor measures added 17-28% of explained 
variance in physical and 23% in psychological HRQoL on top of transplant professionals’ 
risk estimations (see Figure 3 and Figure 4).
To rule out the infl uence of potential bias by specifi c drop-out, analyses of donors 
with complete assessments were repeated in donors completing only the six (n=275) 
or twelve (n=250) months assessment. This led to very similar results (correlations>.97 
with predicted values).
 
3% 
4% 
28% 
Explained variance of physical functioning  
6 months after donation  
demographic and medical 
factors 
transplant professionals 
risk estimations 
donor self-report measures 
 
6% 
7% 17% 
Explained variance of physical functioning  
12 months after donation 
demographic and medical 
factors 
transplant professionals risk 
estimations 
donor self-report measures 
Figure 3. Relative contribution of donor demographic/medical factors, transplant professionals’ risk es-
timations, and donor self-report measures on the explained variance of physical functioning 6 and 12 
months after donation
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disCussion
Currently, the psychosocial donor evaluation is mainly based on clinical judgments 
of transplant professionals. An evidence-based evaluation would enable transparent 
eligibility decisions and interventions for donors with a high-risk profi le. This study 
examined the eff ectiveness of the current psychosocial donor evaluation by transplant 
professionals, and the potential improvement of the evaluation using donor self-report 
measures. Results showed that both transplant professionals’ risk judgments and donor 
 
22% 
1% 
23% 
Explained variance of psychological functioning  
6 months after donation 
demographic and medical 
factors 
transplant professionals risk 
estimations 
donor self-report measures 
 
21% 
2% 
23% 
Explained variance of psychological functioning  
12 months after donation 
demographic and medical 
factors 
transplant professionals risk 
estimations 
donor self-report measures 
Figure 4. Relative contribution of donor demographic/medical factors, transplant professionals’ risk esti-
mations, and donor self-report measures on the explained variance of psychological functioning 6 and 12 
months after donation 
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self-report measures predicted longer-term donor HRQoL, which endorses the quality of 
the professionals’ evaluation. Importantly, using donor self-report measures improved 
the predictive value of professionals’ risk assessments.
The finding that donor self-report measures optimize transplant professionals’ eligi-
bility screening, confirms previous research indicating that patient-reported outcomes 
(PROs) can improve the quality of clinical decision-making and efficiency of consultations 
(32, 33). In addition, self-report questionnaires could provide (potential) donors insight 
into donation decision-making, and evaluate the donation experience. Nevertheless, 
donor self-report measures could not replace professionals’ risk assessments because 
of the potential influence of socially desirable responses due to an often strong desire 
for donation.
In line with previous studies, baseline HRQoL levels were shown to best predict longer-
term HRQoL in the current study (34, 35). Possibly, the other variables (e.g., pre-donation 
cognitions) contribute indirectly to post-donation HRQoL through their association with 
baseline HRQoL. Impaired longer-term donor physical functioning was predicted by 
higher risk estimations of all transplant professionals, while only medical social workers 
predicted longer-term psychological functioning. This could indicate that donors prefer 
to share psychosocial problems with social workers, but it could also reveal potential 
time constraints to discuss psychosocial issues during consultations.
Based on the current study, evidence-based criteria could be added to donor screen-
ing guidelines. In order to examine the potential role of an encompassing number of 
PROs, a large amount of questionnaires was used in the current study. However, based 
on the results, in clinical practice screening could be conducted in a stepwise fashion, 
using a short screening questionnaire to obtain an indication of HRQoL before starting 
the donor evaluation (e.g., the RAND SF36, which takes about 10 minutes to complete). 
These results could be integrated into eligibility screening consultations with transplant 
professionals, to increase awareness or clarification of possible problems in potential 
donors. If a risk profile (lowered HRQoL) is found, additional assessments could identify 
specific donation-related problems to offer tailored interventions.
This study provides good indications of the most important factors in donor eligibility 
screening. Nonetheless, the results may have been influenced by a number of factors. 
The 75% response rate might limit generalizability of the findings to the total donor 
population. However, the selection bias is probably limited because the most prominent 
reason for non-participation was exclusion from the donation procedure by profession-
als (17%). Also, the screening questionnaire was completed at the beginning of the do-
nor evaluation, in order to prevent the exclusion of donors later on in the trajectory, and 
provide support to high-risk donors. At this time, the motivation to donate dominates 
and probably fewer worries about the surgery are experienced in comparison with the 
weeks before surgery. Consequently, an additional donor self-report screening could 
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be useful when surgery is planned, to provide interventions for donors experiencing 
distress. Also, there was a large variability in time (M= 7 months) between screening and 
donation, which could be representative for the kidney donor population.
The Dutch healthcare setting of kidney donors cannot automatically be generalized to 
other healthcare settings in terms of access to care and regulations for health insurance, 
which are well-organized and available to all inhabitants. Future studies should examine 
this generalization of findings. Finally, although we aimed to include an encompass-
ing set of predictors, there might be other predictors of longer-term HRQoL of kidney 
donors. Future research should include these potential predictors (e.g., ambivalence and 
coercion) and validate those that were identified in the current study (36). Lastly, donor 
HRQoL could not always be predicted at baseline (e.g., in the case of other life events). 
Therefore, flexibility in donor follow-up needs to be warranted.
In conclusion, the psychosocial donor evaluation conducted by professionals is 
effective in predicting longer-term donor HRQoL. Donor self-report measures, with 
particularly poorer baseline physical and psychological functioning, could optimize the 
psychosocial evaluation of professionals. This can improve reliable donor eligibility deci-
sions and tailored interventions for high-risk donors.
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abstraCt
Background: A subgroup of the kidney donor population experiences adjustment 
problems during or after the donation procedure (e.g., anxiety or fatigue). There is a 
need for evidence-based interventions that decrease donation-related difficulties. In the 
current study, a guided and tailored Internet-based Cognitive-Behavioral Therapy (ICBT) 
intervention for donors was developed and the feasibility and perceived effectiveness 
were evaluated.
Methods: Focus group interviews with donors and healthcare professionals were con-
ducted to identify intervention themes and to map attitudes towards internet-based in-
terventions. Donation-related treatment modules, assignments, and psycho-education 
were integrated within an existing disease-generic ICBT intervention. Eight (potential) 
donors with a risk profile (i.e., impaired mental HRQoL) received and evaluated the 
intervention.
Results: Different intervention themes were derived from the focus group interviews 
(e.g., physical limitations, and donation-specific emotional and social-relational prob-
lems). Participants were satisfied about the intervention content and the therapeutic 
relationship, and indicated an improvement on domains of their treatment goals.
Conclusions: This study showed positive evaluations concerning both feasibility and 
perceived effectiveness of the tailored ICBT intervention in (potential) kidney donors, in 
line with previous studies using comparable ICBT treatment protocols in other popula-
tions. Future research should examine the possibilities of integrating the intervention 
into psychosocial care for kidney donors.
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introduCtion
Because of the increase in the number of living donor kidney transplantations during 
the past years, research on the need for psychosocial care of kidney donors has ex-
panded. An important aspect of these studies is the identification of characteristics of 
donors who might benefit from psychosocial interventions before or following donation 
(1-3). In order to apply for living kidney donation, potential donors need to have a good 
physical and mental health-related quality of life (HRQoL). Previous research has shown 
that in general, the HRQoL of actual donors is equal to or above that of the general 
population, and either stays stable or returns to baseline within six to twelve months 
post-donation (4-6). However, it has also been shown that a proportion of donors (up 
to 35%) develops adjustment problems during or after the donation procedure, such as 
anxiety, fatigue, or pain (5, 7, 8).
Within the current healthcare protocols for (potential) living kidney donors, psycho-
social care before and after donation is not systematically embedded. Screening of 
donor eligibility is mainly based on medical criteria and although the need for psycho-
social screening is increasingly recognized (9, 10), this is currently not conducted in an 
evidence-based manner. Also, although there generally is a medical donor follow-up 
up to 12 months post-donation, both short-term (up to 6 months after donation) and 
longer-term (e.g., 12 months or longer after donation) psychosocial donor follow-up is 
often lacking, even though recent guidelines do recommend this (11). Reasons for this 
include a scarcity of large prospective studies showing pre-donation predictive factors 
of impaired HRQoL after donation. The few large prospective studies conducted have 
mainly shown worse pre-donation mental and physical functioning to be predictive of 
worse HRQoL-outcomes after donation, next to a number of individual risk and resilience 
factors which might be used to tailor treatment to the specific profile of the individual 
donor (3, 5, 6, 12). Tailored interventions, specified to the individual characteristics, 
preferences, and needs of (potential) donors to improve health or change behavior, 
are scarce. However, because of the differences in donor characteristics and the type 
of difficulties before or after donation, such as pre-donation worries or post-donation 
fatigue symptoms, tailored interventions could be useful for donors at risk for longer-
term adjustment problems.
Currently, a small number of interventions for (potential) donors are available, which 
mostly focus on donor recruitment (13). Further, one intervention is available for poten-
tial donors who are scheduled for surgery, using pre-donation motivational interviewing 
in two telephonic sessions to reduce ambivalence towards donation. Results of the RCT 
on the effectiveness of this intervention were positive, with a decline in ambivalence 
before donation in the intervention group, and better physical functioning, shorter 
recovery times, less anxiety, and fewer unexpected donation-related family problems 
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three months after donation (14). To our knowledge, no psychosocial interventions for 
(potential) donors with a risk profile for a variety of donation-related difficulties are 
available. Therefore, there is a need for evidence-based interventions that focus on 
decreasing difficulties in potential donors during the donor screening procedure or 
negative consequences after donation (15, 16).
Cognitive-behavioral therapy is a worldwide used evidence-based psychological in-
tervention, which is used to treat mental health conditions, focusing on the replacement 
of maladaptive cognitions and coping strategies by more positive cognitions and behav-
iors. To this aim, different techniques are used, including the training of problem-solving 
skills, relaxation training, stress management, and cognitive restructuring, which entails 
changing unhelpful cognitions into helpful ones (17, 18). Previous research showed 
that cognitive-behavioral therapy that is provided via the internet (Internet-based 
Cognitive-Behavioral Therapy or ICBT) could be as effective as face-to-face treatments 
in the improvement of physical and psychological functioning in patients with mental 
and physical health problems (19-21). One component that has proven to be associated 
with the effectiveness of ICBT is online guidance by a therapist during the treatment, 
for example by means of e-mail messages providing motivating remarks and feedback 
on assignments (22-24). Additionally, there is increasing evidence that the tailoring 
of interventions to the specific risk and resilience factors of individuals increases the 
effectiveness of (I)CBT (25-27). The advantages of cognitive-behavioral interventions 
using the internet in comparison to face-to-face treatment in the hospital include that 
individuals can follow the treatment from their own homes, which improves the applica-
tion of learned techniques directly in their own environment, and that treatment can be 
followed in their own time, improving flexibility and preventing travel costs and waiting 
times (28).
In conclusion, current psychosocial care for (potential) living kidney donors at risk for 
long-term adjustment problems is limited and not evidence-based. Guided and tailored 
ICBT could be a valuable addition to current psychosocial care for living donors, in 
providing pre-donation support or short-term or longer-term psychosocial follow-up 
for donors with a risk profile. The current study describes the development of a guided 
and tailored ICBT intervention for (potential) donors, and examines the satisfaction with 
and feasibility of this intervention in a pilot study in a small group of (potential) donors.
materials and metHods
development of the guided and tailored iCbt intervention for donors
Three steps have been taken to develop the guided and tailored ICBT intervention for 
(potential) kidney donors and test it’s feasibility.
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1. Focus group interviews
Three focus group interviews were conducted with donors from two transplantation cen-
ters from different parts of the Netherlands, in order to provide a good representation of 
the Dutch donor population in terms of socio-demographic characteristics and cultural 
background (Radboudumc Nijmegen and Academic Medical Center Amsterdam). Also, 
one focus group interview with transplant professionals was conducted (nephrologists, 
nurses, and medical social workers) in one transplantation center (Radboudumc). The 
aim of these focus groups was to identify possible themes that would be considered 
relevant by (potential) donors and transplant professionals to be included in a donor-
specific intervention, and to map general attitudes towards internet-based interven-
tions. A health psychologist with background experience in group therapy guided 
all focus group interviews as a mediator and another psychologist was present as an 
observer. Focus group interviews were audio and video recorded. Participants (potential 
donors as well as transplant professionals) signed informed consent at the start of the 
interviews. The medical ethics committee of the Radboudumc Nijmegen approved the 
study (NL.50145.091.14).
The focus group interviews started with questions about the possible physical limita-
tions and psychological consequences before and following donation, the influence of 
the donation on social relationships and daily functioning, and the ways by which donors 
handled potential problems in their functioning. Also, questions were asked about the 
perceived potential need for additional psychosocial care and the themes on which this 
care should be focused according to both donors and transplant professionals. Further, 
the attitudes of both groups towards ICBT interventions were explored.
2. Evaluation and adjustment of existing ICBT interventions for patients with somatic 
conditions
Before the start of the current study, our research group developed a generic guided 
and tailored ICBT intervention, based on evidence-based face-to-face CBT for patients 
with chronic somatic conditions. The effectiveness of this ICBT intervention was demon-
strated in a randomized controlled trial in different patient populations (27, 29). Based 
on the themes identified in the focus group study and previous (intervention) studies 
in living kidney donors, the existing generic ICBT intervention was adjusted to incor-
porate specific donation-related treatment modules, exercises, and psycho-education, 
resulting in the ICBT intervention for donors. This ICBT intervention is a therapist guided 
intervention, tailored to the individual treatment goals of donors.
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3. Feasibility testing of the ICBT intervention
Research procedure feasibility study
Individuals who donated a kidney for transplantation or were registered as a (potential) 
donor from November 2014 to August 2015 were invited to participate in the study by 
means of an information letter. When (potential) donors were interested in participating 
in the study, a two-step procedure was followed. After signing informed consent, they 
were asked to fill in several questionnaires to provide a risk categorization based on their 
current mental HRQoL or psychological distress (see next paragraph). Participants with 
a psychological risk profile were invited to participate in the pilot intervention study, in 
which they received the ICBT intervention. After finishing the intervention, participants 
received a questionnaire to evaluate the ICBT intervention. Next to these subjective do-
nor evaluations, the intervention was evaluated more objectively with technical usage 
data on the dedication to the intervention and the intervention duration.
Screening questionnaires
Screening questionnaires were used to make a risk categorization based on current 
mental HRQoL or psychological distress, assessed with the RAND Short Form-36 Health 
Status Inventory - Mental Health Subscale (RAND SF36)(30), and the Hospital Anxiety 
and Depression Scale (HADS)(31). A psychological risk profile was defined as RAND SF36 
Mental Health subscale scores ≤ 48 or HADS anxiety or depression scores ≥ 5).
The RAND SF36 is a 36-item questionnaire assessing eight HRQoL-dimensions. Four 
dimensions measure psychological functioning: Emotional Well-being, Role Limitations 
due to Emotional Problems, Social Functioning, and Energy. These are summarized in 
the Mental Health Composite Score, which was used in the screening. Higher scores 
represent higher mental HRQoL (30).
The HADS consists of 7 items measuring anxiety (e.g., ‘I get a sort of frightened feeling 
as if something awful is about to happen’) as well as 7 items on depressive symptoms 
(e.g., ‘I feel as if I am slowed down’). Scores are rated on a 4-point scale; higher scores 
represent more anxiety or depressive symptoms (31).
Intervention tailoring questionnaires
To tailor the ICBT intervention to individual treatment goals, additional questionnaires 
were used to identify specific problem areas of functioning, distinguishing Physical 
functioning (RAND SF36 PCS30), Fatigue (Checklist Individual Strength-Fatigue Scale 
Short Version; 32), Neuroticism (NEO Personality Inventory- Revised- Neuroticism; 33), 
Social-relational functioning (Interpersonal Sensitivity Measure (34) and the Inventory 
for Social Reliance (35)).
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iCbt intervention evaluation measures
Satisfaction with the ICBT intervention
The information provision before the intervention, the degree to which expectations 
of the intervention were met, the general satisfaction with the intervention, the donor 
beliefs about a sustainable effect of the intervention, and the extent to which donors 
would recommend the intervention to relatives were evaluated directly after finishing 
the intervention. Furthermore, the dedication towards the intervention and the effect 
of the intervention on treatment goals were evaluated. All evaluations were made on 
a 4-point scale (1=no, 4=certainly). Higher scores represent more satisfaction with the 
intervention, more active participation in the intervention, and more effect of the inter-
vention on treatment goals.
Feasibility of the ICBT intervention
The comprehensibility and usefulness of the assignments and psycho-educational texts 
were assessed using a 7-point scale (0=very poor-6=very good).
Therapeutic relationship
The therapeutic relationship during the ICBT intervention was assessed using the 
Working Alliance Inventory (WAI) and the Internet-Specific Therapeutic Relationship 
Questionnaire (ITRQ).
The WAI assesses the working alliance concepts of therapeutic relationships, consist-
ing of three subscales, namely agreement on therapy goals, on therapy tasks, and the 
development of a strong relational bond between patient and therapist, assessed on a 
1-5 scale (1=never to 5= always)(36, 37).
The ITRQ measures internet-specific aspects of the therapeutic relationship during 
internet-based interventions, consisting of two 4-item subscales: Internet-specific time 
and attention (which assesses time lag aspects of communication and receiving suf-
ficient attention from the ICBT therapist) and Internet-specific reflection and comfort 
(which comprises the sharing of information with the therapist and home as the treat-
ment environment) on a 1-10 scale (1=totally disagree - 10= totally agree)(38).
usage of the iCbt intervention
To gain insight into the use of the intervention website with objective parameters, the 
frequency of logins per donor and the total intervention duration were assessed.
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results
intervention development
1. Focus group interviews
Participants 
Focus group interviews were conducted with 13 donors post-donation, of whom 69% 
were female and who had a mean age of 58.8 years (age range: 30-74 years). Most donors 
had donated directly to the person they knew (77%), but also kidney donor exchange 
(8%) and altruistic (15%) donors were represented. In the focus group interview with 
transplant professionals, one nephrologist, one coordinating nurse, and three medical 
social workers participated, with a mean work experience in the field of transplantation 
of 6.0 years (range 3-13 years) (see Table 1 for participants’ characteristics).
table 1. Demographic characteristics of donors and transplant professionals participating in the focus 
group interviews and pilot study of the ICBT intervention
Characteristics
mean ± sd (range) 
n (%)
Participants of the focus group interviews
donor characteristics (n=13)
Female gender 9 (69%)
Age 58.8 ± 11.5 years (range: 30-74)
Donation type
Direct 10 (77%) 
Kidney exchange 1 (8%) 
Altruistic 2 (15%) 
Time since donation 2.4 ± 1.7 years (range: 0.6-7.0 )
donation professionals characteristics (n=5)
Type professional
Nephrologist 1 (20%) 
Donation coordinating nurse 1 (20%) 
Medical social worker 3 (60%) 
Work experience in transplantation care 6.0 ± 4.2 years (range: 3-13 years)
Participants of pilot study on the ICBT intervention
(Potential) donor characteristics (n=8)
Female gender 5 (63%)
Age 58.6 ± 11.4 years (range: 38-74)
Donation type
Direct 6 (75%) 
Kidney exchange 1 (13%) 
Altruistic 1 (13%) 
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Intervention themes
In the focus group interviews, donors and transplant professionals identified a number 
of themes that were considered to be useful to include in donor interventions. These 
included high levels of fatigue and related concentration problems, pain, problems 
with getting back to work, dealing with the simultaneous presence of the donor’s own 
temporary limitations after surgery and limitations for the recipients, worries about the 
recipient (e.g., graft failure or re-hospitalization), dealing with waiting times for trans-
plantation after being eligible for donation, the influence of donation on family life and 
relationships, and sharing donation experiences with other (potential) donors. These 
themes were used for the adjustment of the existing ICBT intervention. Finally, despite 
overall satisfaction with the consultations with medical social workers during eligibility 
screening, donors indicated a need to optimize the follow-up contacts after donation, 
with more attention for psychosocial issues.
2. Feasibility testing of the ICBT intervention
Participants pilot study
Ninety-nine individuals (47 potential donors and 52 donors) were invited to participate 
in the pilot study. Of these, 14 potential donors (30% response rate) and 24 donors (46% 
response rate) completed the screening questionnaire, of which 16 donors (42%) had a 
higher risk profile. Three of these donors indicated that they experienced only minor dif-
ficulties and were not interested in the intervention, and five donors did not respond to 
the invitation for intervention. Two potential donors and six donors received the tailored 
ICBT intervention to reduce donation-related distress, of whom 5 were female and 3 
were male. Age varied from 38 to 74 years, with a mean age of 59±11 years. Of potential 
donors, one was on the kidney exchange program and one intended to donate directly 
to the person he/she knew; of the donors, 5 donated directly to the person they knew 
and one donated anonymously (Table 1).
Procedure of the ICBT intervention
After signing informed consent, participants were invited for a face-to-face appoint-
ment with their therapist, to get acquainted and formulate treatment goals based on 
the screening questionnaire or current causes of distress. The intervention was provided 
by one therapist with a Master’s degree on clinical psychology and a clinical registration 
as Health Psychologist. The intervention consisted of five different treatment modules 
with focus on the following items: physical limitations, fatigue, negative mood, social 
functioning, and donation-related problems in daily life (see Figure 1). After the face-
to-face consultation with their therapist, an instruction of the use of the website was 
provided by telephone by a research assistant. Afterwards, the (potential) donor could 
log on to the secure website to start with the ICBT intervention that was tailored to 
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their own treatment goals. Assignments and psycho-educational texts related to the 
treatment goals were placed on the website by the therapist and completed online by 
the (potential) donor. The therapist provided personalized feedback on the exercises 
weekly via a message box and donors could reply to the therapist or ask questions via 
this message box. After finishing the personalized modules, the treatment was ended 
with a final treatment module about relapse prevention and the formulation of long-
term goals. See Figure 1 for the structure of the intervention.
Within the group of eight participants, all five treatment modules were applied at least 
once; two donors worked on negative mood and donation-related problems in daily life, 
two donors on negative mood and fatigue, one donor on physical limitations and social 
functioning, one donor on fatigue and social functioning, one donor on negative mood, 
and one donor on fatigue. The intervention had a mean duration of 11.6 weeks (range 
3-18 weeks). Two potential donors followed the intervention before donation (time until 
donation was M=1.5±0.4 months), and six donors after donation (time between dona-
tion and intervention was M=6.4±3.6 months).
Evaluation of the intervention
Participants were satisfied with the ICBT intervention (M=7.7, range: 6-8 on a 0-10 scale). 
On 1-4 scales they reported that the intervention met their expectations (M=3.4), that 
they had received appropriate information before the start of the treatment (M=4.0), 
and that they thought that the treatment effect would persist on the longer-term 
(M=3.4). Most donors would recommend the ICBT intervention to future donors (M=3.6). 
With regard to the dedication to the treatment, participants reported that they usually 
conducted the assignments that the therapist sent them (M=3.0), and that they worked 
on the treatment goals intensively (M=3.3), practicing the assignments and integrating 
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the learned strategies in daily life (M=3.1). Most participants did not have a fixed mo-
ment of time to conduct the assignments (M=2.0). Participants reported a perceived 
effectiveness of the intervention, by indicating an improvement on the domains of their 
treatment goals (M=3.2). On a scale from 0-6, donors reported that the assignments were 
easily understandable (M=5.1), had an appropriate length (M=4.4), and were considered 
useful (M=4.4). The user friendliness was evaluated with a 7.0 on a 10-point scale (Table 
2).
table 2. Results pilot study of the ICBT intervention
mean ± sd (range)
generic satisfaction with the iCbt intervention
I am satisfied with the ICBT intervention (0-10) 7.7 ± 0.8 (6-8)
The intervention met my expectations (1-4) 3.4 ± 0.7 (2-4)
I received appropriate information before the start of the intervention (1-4) 4.v0 ± 0.0 (4-4)
I have faith that the treatment effect would persist on the longer-term (1-4) 3.4 ± 0.9 (2-4)
I would recommend the ICBT intervention to relatives who consider to donate a kidney 
(1-4)
3.4 ± 1.1 (1-4)
Perceived effectiveness of the intervention
Due to the intervention, my functioning on the domains of my treatment goals improved 3.2 ± 0.7 (2-4)
dedication to the intervention
During the intervention, I conducted all the assignments completely (1-4) 3.0 ± 1.1 (1-4)
I worked vey intensively on my treatment goals (1-4) 3.3 ± 0.7 (2-4)
I practiced and integrated the learned strategies into daily life (1-4) 3.1 ± 0.4 (2-4)
I made time for the intervention at a fixed moment on the day (1-4) 2.1 ± 0.6 (1-3)
The intervention contributed to an improvement on dealing with problems related to the 
domains of my treatment goals (1-4)
3.1 ± 0.6 (3-4)
I think the assignments were generally easily understandable (0-6) 5.1 ± 1.4 (2-6)
I think the assignments had an appropriate length (0-6) 4.3 ±1.0 (3-6)
I think the assignments were useful (0-6) 4.4 ± 1.1 (3-6)
Which grade would you give to the user friendliness of the website? (1-10) 7.0 ± 1.4 (4-8)
the therapeutic relationship
Working alliance (WAI)
Agreement on therapy goals (1-5) 4.2 ± 0.6 (3.0-.4.8)
Agreement on therapy tasks (1-5) 3.8 ± 1.0 (1.8-4.8)
Relational bond between patient and therapist(1-5) 4.4 ± 0.6 (3.5-5.0)
Internet-specific aspects of the therapeutic relationship (itrq)
The time lag aspects of communication and receiving sufficient attention from the 
E-coach therapist (1-10)
8.9 ± 1.1 (7.5-10.0)
Sharing of information with the therapist and the home as the treatment environment 
(1-10)
7.8 ± 2.2 (5.0-10.0)
ITRQ, Internet-Specific Therapeutic Relationship Questionnaire. WAI, Working Alliance Inventory.
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The therapeutic relationship during the ICBT intervention was evaluated very posi-
tively, with a high agreement on therapy goals (M=4.2) and on therapy tasks (M=3.8), 
and the development of a strong relational bond between patient and therapist (M=4.4) 
on a 1-5 scale. Also, internet-specific aspects of the therapeutic relationship were rated 
very positively, such as the ITRQ subscale ‘Internet-specific time and attention’ that 
describes time lag aspects of communication and receiving sufficient attention from the 
ICBT therapist (M=8.9), and the subscale ‘Internet-specific reflection and comfort’ that 
includes the sharing of information with the therapist and the home as the treatment 
environment (M=7.8) on a 1-10 scale (Table 2).
Usage of the ICBT intervention
Concerning the usage of the ICBT intervention by donors, the mean number of logins 
per donor was M=29.1 (range=3-55), with a duration of M=9.4 minutes per login (range 
0.5-128). The number of assignments that was completed by donors was M=22.9 (range 
5-36), and the mean number of messages they sent to their therapist was M=13.6 (range 
1-24). The mean total intervention duration was M=7.1 hours (range 0.7-19.7 hours).
With regard to the usage of the website by the psychologist who guided the interven-
tion, the mean time duration of one login of the therapist was M=47.0 minutes. The 
therapist sent an average of 15 (range 3-25) messages per donor.
disCussion
In the present study, a therapist-guided internet-based CBT intervention was developed, 
tailored to the specific needs of (potential) kidney donors. The feasibility and perceived 
effectiveness of the intervention was evaluated in a small group of (potential) kidney 
donors, showing positive evaluations with regard to satisfaction with the intervention, 
perceived effectiveness, user-friendliness, and therapeutic relationship.
An existing tailored ICBT intervention that has been found effective in patients with 
different somatic conditions (27, 29) was slightly adapted to the specific characteristics 
of the donor population, based on focus group interviews. Relevant themes deduced for 
the content of the intervention included physical difficulties, work resumption problems, 
and emotional and social-relational problems. Accordingly, donor-specific treatment 
modules, assignments, and psycho-educational texts on the themes that were derived 
from the focus group interviews were included in the ICBT intervention. The attitude 
towards an internet-based intervention for (potential) kidney donors was mainly posi-
tive. After a first short screening on elevated levels of psychological distress, a small, but 
representative group of (potential) kidney donors with a higher risk profile followed and 
evaluated the ICBT intervention. Participants were satisfied about the information provi-
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sion, the content, and the usefulness of the ICBT intervention, and were very positive 
about the possibility to build a strong relationship with their therapist. Also, the user 
friendliness was evaluated positively and participants indicated an improvement on the 
domains of their treatment goals. Thus, this pilot study provides promising indications 
for a useful and acceptable potential addition to psychosocial care for kidney donors.
The use of web-based interventions in healthcare has been increasing during the last 
decades. For (potential) kidney donors, web-based interventions could be very suitable 
by saving time and costs related to travelling towards the transplantation center. The 
positive evaluation of the ICBT intervention could be a result of the tailored interven-
tion approach, which has the advantage of matching the intervention to the needs and 
characteristics of that specific donor. Both the focus groups interviews in the current 
study as well as previous literature indicated that most kidney donors experience no or 
a limited degree of problems before or after donation. However, when (potential) kidney 
donors do experience difficulties, these are mostly very specific for the situation of that 
donor and it is hard to develop a generic intervention protocol that could be used for all 
donors. With the tailoring approach, each kidney donor at risk can receive the optimal 
intervention. Also, the very positive evaluation of the contact with the therapist could 
have contributed to the positive evaluation of the guided ICBT intervention by (poten-
tial) kidney donors.
Due to the novelty of the internet-based approach of donor coaching, the current 
study was conducted in a small group of (potential) kidney donors, to test the satisfac-
tion and feasibility of the newly developed intervention. In future research, the ICBT 
intervention should be evaluated in a larger sample of (potential) kidney donors. 
Furthermore, the current study merely focused on the subjective evaluation of the 
intervention to examine its feasibility before applying it to a larger donor population. In 
the next step, it would be useful to demonstrate the effectiveness of the intervention in 
comparison to usual psychosocial care for (potential) kidney donors, assessing pre- and 
post-intervention outcomes prospectively (27, 29).
(Potential) Kidney donors with mild to moderate levels of distress were invited to 
follow the ICBT intervention. Some donors indicated that they experienced only minor 
difficulties, and were therefore not interested in following the intervention. In future 
research, valid cut-off criteria to screen for psychological distress have to be examined, 
to formulate evidence-based inclusion criteria. Also, for the participation in ICBT inter-
ventions, general computer skills as well as some knowledge on the use of internet are 
necessary.
In conclusion, from the donor perspective the newly developed ICBT intervention 
was developed based on the results of focus groups and evaluated positively, both in 
terms of feasibility (procedure, content, user-friendliness) and perceived effectiveness. 
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Future research should examine the added value of the intervention and the possibility 
to integrate it into the current psychosocial care for kidney donors.
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Living donor kidney transplantation is currently the preferred treatment for patients with 
end-stage renal disease, because of a better health-related quality of life (HRQoL) after 
transplantation than during dialysis treatment, and higher patient and graft survival 
rates as compared to deceased donor kidney transplantation. Most living kidney donors 
experience only temporary physical limitations after surgery and do not encounter 
sustained difficulties in physical or psychosocial functioning at the longer-term. How-
ever, previous research shows that a subgroup of donors experiences donation-related 
adjustment problems during or after the donation procedure, such as anxiety or fatigue. 
To date, no evidence-based guidelines exist to identify donors at risk of developing 
adjustment problems after donation, due to the limited number of large prospective 
prediction studies available. Therefore, the psychosocial donor evaluation is now mainly 
based on the clinical judgments of transplant professionals. The prognostic value of 
these judgments is currently unknown. Furthermore, no interventions for donors with a 
risk profile or donors who experience adjustment problems are available.
Consequently, the main purpose of the research performed in this thesis was to as-
sess and identify potential risk and resilience factors for longer-term impaired donor 
functioning, resulting in a psychosocial screening instrument. This screening can be 
used to identify donors at risk who might need additional psychosocial support during 
the donation procedure. Secondly, a tailored internet-based intervention for donors at 
risk of longer-term adjustment problems was developed and evaluated in a small group 
of donors.
Chapter 2 of this thesis comprises a systematic review and meta-analysis summariz-
ing the existing literature on HRQoL of living kidney donors. Both the current state-of-
knowledge on the course of HRQoL from before to after donation and potential risk fac-
tors for poorer longer-term functioning after donation were described. Results indicated 
that HRQoL of donors (i.e., physical, psychological, and social-relational functioning) was 
comparable with or sometimes even better than that of the general population before 
donation. HRQoL decreased shortly after donation (1-2 months after donation). During 
the first year after donation, HRQoL generally returned to baseline levels or remained 
slightly reduced, which was particularly reflected in elevated levels of fatigue. Concern-
ing risk factors for poorer longer-term functioning after donation, a limited number 
of prospective prediction studies was available, describing a large variety of potential 
predictors in relatively small study cohorts. From these studies, baseline psychological 
functioning was considered to be the most consistent predictor for longer-term HRQoL 
after donation. However, the review also demonstrated that more systematic research 
on a comprehensive set of potential predictors of longer-term HRQoL after donation in 
large research samples is required to develop reliable screening tools.
In Chapter 3, the results of a prospective study in a large group of kidney donors from 
seven Dutch transplantation centers are presented on the course of HRQoL on three dif-
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ferent time points; before donation, 6 and 12 months after donation. Both generic quality 
of life instruments as well as donation-specific questionnaires were applied to examine 
a systematic overview of donor’s HRQoL. The generic HRQoL assessments indicated that 
donor physical HRQoL was comparable before and after donation, but fatigue levels 
were somewhat elevated up to twelve months after donation. Mental HRQoL decreased 
up to six months after donation, but returned to baseline levels at twelve months after 
donation. Clinically relevant HRQoL changes between the three assessment points were 
only found for fatigue. These results were in line with those of previous studies, as was 
described in our meta-analysis (Chapter 2). Concerning donation-specific measure-
ments, the experienced longer-term physical and relational consequences of donation 
were limited, although many donors reported some degree of post-donation worries, 
and 14% of donors reported feelings of regret towards the donation decision. Related 
donors perceived a strong improvement of physical and emotional functioning of their 
recipient by the donation, and their own life was less influenced by the recipient’s kidney 
disease after transplantation. The donor-recipient relationship was perceived positively 
at all time points. To conclude, both generic and donation-specific measures offer valu-
able information about the course of HRQoL before and after living kidney donation and 
generally provide a positive view on the impact of the kidney donation on the wellbe-
ing of the donor. However, somewhat elevated fatigue levels were experienced after 
donation, and a small number of donors reported post-donation worries and feelings of 
regret about the donation decision.
Guidelines on psychosocial evaluation mostly include the assessment of the decision-
making process about the donation, by examining the donor’s motivation for donation, 
the expectations of donation and potential worries about the donation. However, there 
were no validated tools to assess all these potential cognitions regarding organ dona-
tion using one questionnaire. Therefore, in Chapter 4, a new questionnaire to measure 
pre-donation cognitions about the donation (i.e., the motivation for donation, the 
expectations of donation, and worries about donation) was developed and validated in 
a large group of potential kidney donors from seven Dutch transplantation centers (The 
Donation Cognition Instrument (DCI). The 31-item questionnaire was found to consist of 
five categories of cognitions, namely donor benefits, recipient benefits, idealistic incen-
tives, expectations of gratitude, and worries about donation. Cognitions about recipient 
benefits were most commonly reported and cognitions about the donor’s own benefit 
least commonly. The questionnaire was found to be a reliable psychometric instrument, 
as indicated by high internal consistency among the subscale items. Furthermore, small 
to moderate relationships between pre-donation cognitions and HRQoL were found, 
which supports the validity and endorses the potential added value of this new instru-
ment for psychosocial evaluation in potential living organ donors.
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To date, no systematic evaluation of potentially relevant predictors has been con-
ducted, including both donor demographic, medical, and psychosocial factors (e.g., 
pre-donation cognitions) pre-, intra- and post-donation, and recipient characteristics. 
Consequently, the psychosocial donor evaluation is currently mainly based on the clini-
cal judgments of transplant professionals, of which the accuracy is unknown. Chapter 
5 describes the effectiveness of the psychosocial donor evaluation by transplant profes-
sionals, and the potential value of donor self-report measures in optimizing this psycho-
social evaluation. Next to clinical risk assessments by transplant professionals, the role of 
a comprehensive account of pre-, intra-, and post-donation characteristics of the donor, 
and donor self-report measures in the prediction of impaired longer-term HRQoL of liv-
ing kidney donors was examined. Results indicated that clinical judgments of transplant 
professionals predicted a significant part of the longer-term HRQoL of donors, which 
endorses the current psychosocial donor evaluation. Furthermore, the addition of donor 
self-report questionnaires significantly increased the explained variance in HRQoL after 
donation as compared to the clinical judgments of transplant professionals alone, with 
baseline physical and psychological functioning being the most important predic-
tors. Combining clinical judgments and self-report questionnaires explain short- and 
longer-term post-donation HRQoL. Consequently, the integration of donor self-report 
measures in the current psychosocial donor evaluation by transplant professionals 
could optimize the psychosocial donor evaluation. Knowledge on the most important 
risk factors for impaired longer-term donor HRQoL could identify donors with a high-risk 
profile, who could benefit from additional support during the donation procedure in 
order to prevent or minimize post-donation adjustment problems.
As a follow-up of the identification of risk factors for longer-term adjustment prob-
lems, evidence-based interventions are needed to provide additional psychosocial 
support for donors at risk. Chapter 6 describes the transition from donor assessment 
to donor intervention, and comprises the development and evaluation of a guided and 
tailored internet-based cognitive behavioral (ICBT) intervention for (potential) donors 
with a high-risk profile. Based on literature review and focus group interviews with 
donors and transplant professionals, an existing ICBT intervention for patients with 
somatic conditions was adjusted to make it feasible for the donor population, includ-
ing specific donation-relevant topics such as decision-making regarding the donation, 
returning to daily life, feelings of guilt, and social-relational difficulties after donation. 
This ICBT intervention was developed for donors with a high-risk profile, indicated by 
elevated levels of adjustment problems using a short screening questionnaire. In a 
small pilot study, eight (potential) donors received a face-to-face consultation with their 
therapist, in which treatment goals were formulated, after which the intervention was 
offered via the internet. Donors evaluated the feasibility and perceived effectiveness 
of this intervention positively. These promising results demonstrate that an evidence-
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based psychosocial screening and intervention protocol could be easily implemented 
in clinical practice, because no standardized psychosocial care is currently structurally 
available for this group.
In conclusion, the studies described in this thesis demonstrate that HRQoL of living 
kidney donors is generally reduced shortly after donation, but is mostly comparable to 
general population norms at the longer-term after donation. Clinically relevant HRQoL 
changes between the three assessment points were only found for fatigue. The current 
psychosocial donor evaluation by transplant professionals is able to predict longer-term 
physical and psychological wellbeing of donors. The incorporation of donor self-report 
measures could optimize this psychosocial evaluation by transplant professionals. Poor-
er baseline physical and psychosocial functioning are the most consistent predictors for 
longer-term adjustment problems, but also cognitions around the donation decision, 
medical factors, and social-relational characteristics could be useful to be included in 
the donor eligibility screening, in order to offer concrete suggestion on how to inter-
vene. Based on this study, it could be recommended to include a short screening on 
pre-donation physical and psychosocial functioning to the psychosocial donor evalua-
tion. When a donor would show an elevated risk of developing longer-term adjustment 
problems based on this screening, a more extensive questionnaire assessment could 
be feasible, to identify specific areas of functioning that could benefit from additional 
support during the donation procedure. For donors with a high-risk profile, tailored ICBT 
interventions seem a promising addition to current donor care, to provide additional 
psychosocial guidance during the donation procedure. Future research should examine 
the (cost)-effectiveness of the developed intervention and the possibilities of imple-
mentation of the psychosocial screening in current psychosocial donor care.
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There is an ongoing disparity between the number of transplantable donor kidneys 
that are needed, and the supply of organs from deceased donors. Because of this donor 
shortage, and due to better transplantation outcomes for the recipient, the number of 
living donor kidney transplantations has increased in recent years (1). While most living 
kidney donors recover well after surgery, a subgroup experiences adjustment problems 
during or after the donation procedure (2, 3).
Due to the scarcity of large prospective studies examining predictors of longer-term 
impaired donor functioning, the psychosocial donor evaluation is nowadays mainly 
based on the clinical judgment of transplant professionals. However, the prognostic 
value of these judgments is currently unknown. Furthermore, there are almost no 
evidence-based interventions available for donors who experience donation-related 
problems during the donor eligibility screening procedure or after donation. Conse-
quently, the studies described in this thesis focus on the comprehensive assessment and 
identification of risk and resilience factors for longer-term impaired donor functioning 
(Chapters 2-5), and on the development of an intervention for donors with a high-risk 
profile (Chapter 6). The main findings of the studies described in this thesis are sum-
marized in Chapter 7. The current chapter discusses the methodological considerations, 
recommendations for future research, and clinical implications of the findings.
the course of health-related quality of life before and after donation
In Chapter 2 of this thesis, a systematic evaluation of results of previous studies on HRQoL 
before and after kidney donation is provided. Results indicate that HRQoL (e.g., physical, 
psychological, and social-relational functioning) is lower during the early postoperative 
recovery period. During the first year after donation, HRQoL generally returns to base-
line levels or remains slightly reduced, the latter of which was particularly reflected in 
elevated fatigue levels. Despite this slight decrease in different aspects of functioning, 
longer-term HRQoL is still comparable to population norms, due to the relatively high 
HRQoL levels before donation in this population.
Previous studies mostly used generic HRQoL instruments, and did not capture spe-
cific relevant donation-related domains of donor functioning prospectively (2, 12, 13). 
Therefore, in Chapter 3 of this thesis, both generic and donation-specific prospective 
measurements are used to describe the HRQoL course from before donation up to 
twelve months after donation in a large group of kidney donors. In line with previous 
studies, as were summarized in our meta-analysis in Chapter 2, generic HRQoL showed 
a temporary decrease shortly after donation, but returned to baseline levels within 12 
months after donation, with the exception of fatigue. Combined with the relatively lim-
ited physical and relational consequences of donation and the positive consequences 
regarding recipient functioning and the diminished impact of the disease on the 
donor’s life, this indicates that in general donation has no major long-term negative 
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HRQoL consequences. These donor outcomes, together with the expected beneficial 
clinical outcomes for the recipient supports the use of living donors for transplantation. 
The cause of the elevated fatigue levels remained unclear, and needs to be studied in 
future research. Potential factors influencing fatigue are ageing, living with one kidney, 
or too early resumption of daily activities by donors who are not familiar with physical 
limitations. This finding of heightened fatigue levels in donors indicates the need to 
specifically monitor fatigue after donation and to target fatigue in interventions, for 
example by cognitive behavioral therapy. Despite the fact that HRQoL is not negatively 
affected in most donors, some donors do experience longer-lasting HRQoL deteriora-
tions, worries, or regret after donation. For this subgroup, it is relevant to know the most 
relevant predictors of such adjustments problems, in order to enable prevention or early 
identification and treatment of donors at risk.
The percentage of donors that reported substantial feelings of regret about the do-
nation decision was somewhat higher in the current study than in previous research 
(≤14% versus 6%) (14-18). Previously, regret about the donation was mostly examined 
by qualitative research methods using interviews, or using a single question about 
the presence of feelings of regret about the donation during donor follow-up (19). In 
the current study, the Decision Regret Scale was applied, which is a multidimensional 
quantitative assessment method. This instrument was previously used in different popu-
lations measuring regret after healthcare decisions (e.g., menopausal women deciding 
whether or not to choose hormone replacement therapy, and breast cancer patients 
deciding whether or not to proceed with adjuvant therapy after the primary surgical 
intervention). Regret scores of these patient populations were in the same range as the 
percentage of donors that experienced substantial feelings of regret. The results sug-
gest that using this multidimensional measurement of regret potentially provides more 
information about the extent to which donors experience regret.
The results on the course of HRQoL indicate that psychosocial follow-up consultations 
might be advisable for donors experiencing adjustment problems. Currently, the extent 
to which psychosocial follow-up care is available for living kidney donors differs be-
tween transplantation centers. Some centers provide standard psychosocial follow-up, 
while others offer the possibility to contact the transplantation center in the event that 
a donor experiences difficulties. The results of studies showing that donor subgroups ex-
perience psychosocial problems after donation, justify the importance of psychosocial 
follow-up appointments with medical social workers or psychologists for donors who 
experience donation-related problems. In order to prevent or treat these problems at an 
early stage, it is relevant to identify donors at risk of longer-term psychosocial problems 
by means of a psychosocial donor evaluation either before or after donation.
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donor risk assessment
In this thesis, an encompassing psychosocial screening instrument is developed and 
validated. As part of this screening instrument, different pre-donation cognitions could 
be identified using the newly developed Donation Cognition Instrument (DCI), namely 
cognitions about donor and recipient benefits, idealistic incentives, expectations of 
gratitude, and worries about donation. The systematic assessment of these cognitions 
could be a valuable addition to generic pre-donation HRQoL measures in facilitating 
psychosocial donor evaluation by healthcare professionals, and could provide themes 
for discussion during donor counseling.
In line with the limited number of prospective prediction studies in kidney dona-
tion samples as summarized in our meta-analysis (Chapter 2), worse baseline physical 
and psychological functioning were found to be the strongest predictors of impaired 
HRQoL in the longer term after donation when taking an comprehensive set of pre-, 
intra-, and post-donation socio-demographic, medical, and self-report predictors into 
account. It might be advisable to include these potential risk factors in donor screening, 
using a short screening on baseline physical and psychosocial functioning, and a more 
extended assessment to identify specific problem areas in high-risk donors.
Psychosocial donor assessments early in the donation procedure may improve aware-
ness of elevated donation-related distress levels, and provide an early identification of 
potential donors at risk of longer-term adjustment problems after donation. In this way, 
donors with a high-risk profile could be offered additional psychosocial care during 
or after the donation procedure to prevent the onset or deterioration of longer-term 
donation-related distress.
Psychosocial screening could provide pro-active care to patients instead of reactive 
care as a part of personalized medicine to identify vulnerable patients in an early stage. 
Also, it could facilitate the communication about mental health problems between 
patients and healthcare providers, and could therefore be efficient and effective in pre-
venting longer-term problems (20). The results from the studies reported in this thesis 
are promising in enabling improved psychosocial risk assessment of potential donors. 
Besides the advantages of psychosocial donor assessments, there are also some pos-
sible hindering factors, such as the personnel costs involved in interpreting screening 
results and guiding donors at risk, the time investment of donors and potential donors, 
and potential false-positive results that require follow-up. Future research into the 
specificity and sensitivity of adding a short stepwise screening tool to the psychosocial 
donor evaluation in practice, in order to allow early identification of donors with a high-
risk profile, should show whether the advantages weigh up to the disadvantages and 
provide a cost-effective means to prevent psychosocial problems on the longer-term 
after kidney donation (21).
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donor risk assessment by transplant professionals
Because of the low number of large prospective prediction studies on the identification 
of risk factors for impaired longer-term functioning, the psychosocial donor evaluation 
is currently mainly based on the clinical judgments of transplant professionals. These 
judgments are generally based on one or two consultations with the donor. Impaired 
longer-term physical functioning of donors was predicted by higher risk estimations 
of all transplant professionals, while impaired longer-term psychological functioning 
could be predicted by medical social workers, but not by nephrologists and donation 
coordinating nurses. This suggests that the global estimation of physical functioning 
or limitations could be conducted by all disciplines, but that donors could be reluctant 
to disclose mental health concerns to their physician and may prefer to share these 
problems with medical social workers. However, these differences could also be caused 
by the fact that physicians and coordinating nurses have limited time to discuss psycho-
social issues during their consultations (22), or the idea of donor candidates that they 
will be rejected to donate when they disclose mental health concerns with physicians. 
Future research should disentangle the specific components of the clinical consulta-
tions of different health professionals that are necessary to assess a valid physical or 
psychosocial risk profile.
The finding that donor self-report questionnaires added significantly to the explained 
variance in HRQoL after donation is in accordance with results of previous research, 
stating that so-called patient-reported outcomes or PROs are an important addition to 
medical care, because they offer patients the opportunity to express their own subjec-
tive perception of their health and wellbeing (23, 24). Also, when these patient-reported 
outcomes are assessed repeatedly, they could be useful to evaluate the subjective 
benefit of medical procedures for patients (25-27).
Psychosocial interventions
Previous studies and our current prospective study have concluded a possible added 
value of psychosocial interventions for living kidney donors who experience psycho-
social adjustment problems during or after the donation procedure (28-30). Currently, 
however, the number of interventions that are available for donors is very limited. This is 
potentially caused by the donation-specific problems that are reported by donors, which 
makes it difficult to build on existing interventions. Also, donation-related problems dif-
fer between donors, asking for a personalized approach in donor interventions, tailoring 
the intervention to the needs of the specific donor. Previous research indicated several 
advantages of internet-based interventions in comparison to face-to-face consultations, 
such as reduced travelling time and costs, following the intervention from one’s own 
home, and reducing potential barriers to seeking psychological support from mental 
health providers as well as possible higher cost-effectiveness (31). As concluded from 
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previous research, tailoring interventions to patient and disease characteristics, thera-
peutic guidance and optimal timing of the intervention could enhance the effectiveness 
of the treatment (32, 33).
The positive evaluation of the feasibility and perceived effectiveness of a guided 
and tailored ICBT intervention incorporating specific donation-related topics in a small 
group of donors (Chapter 6) show the potential added value of tailored and guided in-
terventions for donors with a high-risk profile. As this study did not compare the tailored 
and guided approach to a non-tailored and non-guided approach, it is still unknown 
whether the perceived effectiveness of the intervention is attributable to these working 
mechanisms and has to be examined in future studies.
methodological considerations
Although overall promising, the results of the studies described in this thesis warrant 
careful consideration. First, the current prospective study on the course of HRQoL did not 
include a control group with which to compare the results of psychosocial functioning 
before and after donation. A reliable control group for the donor population is difficult 
to select. For example, donors are not comparable to the general population, because 
they are generally healthier than the normal population when they are perceived as 
suitable donors and surgery is planned (34, 35). After surgery, their health is temporarily 
worse than before donation because of the recovery from surgery. Donors who were 
eligible for donation but did not donate may not be representative because potential 
psychosocial or physical factors could have influenced the decision to stop the donation 
procedure. Finally, potential donors who are excluded from donation are not a reliable 
control group because exclusion from donation is found to have a major impact on the 
psychosocial functioning of rejected donors, for example leading to the experiencing of 
feelings of guilt towards their intended recipient (36).
Second, the current study aimed to examine the predictive value and relative contri-
bution of a comprehensive number of predictors on longer-term HRQoL in living kidney 
donors. Although the sample size of the current study was relatively large, more statis-
tical power might be needed to examine the predictive value of all possible relevant 
predictors. Also, differences between subgroups of donors regarding potential predic-
tors of longer-term HRQoL (e.g., different donor-recipient relationships) could not be 
reliably examined because of the small sample sizes of these different subgroups. Future 
research should examine potentially different predictors of longer-term HRQoL in these 
subgroups, to determine whether screening instruments have to be tailored to different 
donor subgroups. Furthermore, due to the limited number of surgical complications 
in donors and recipients, the predictive value of these complications on longer-term 
HRQoL could not be examined reliably in the current study. As previous studies have 
indicated them as potential risk factors for impaired longer-term HRQoL, a donor who 
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experiences complications after surgery or whose recipient experiences complications 
might be monitored as a potential high-risk donor, so that additional psychosocial care 
can be provided if this is needed.
Third, despite the large and comprehensive set of pre-, intra-, and postoperative 
predictors included in the prospective study, there are some potentially relevant predic-
tors of longer-term HRQoL that were not examined in the current study. For example, 
ambivalence towards the donation decision or the extent to which coercion was expe-
rienced by the donor’s or recipient’s relatives could be potential predictors that have to 
be studied in future research. Also, including additional objective assessments of donor 
wellbeing, such as the assessment of donor functioning by donor’s relatives, could be 
valuable in future research.
Fourth, in previous research an interaction between donor and recipient wellbeing 
before and after the donation was demonstrated (37-40). Although the current study 
included consequences of donation and transplantation for the recipient as perceived 
by the donor, no recipient’s assessments of their own HRQoL before and after trans-
plantation were included. Future research examining the course of HRQoL of donors 
and their recipients before and after donation and transplantation could provide more 
information about the interaction of donor and recipient functioning.
Fifth, the Dutch structure of the donation and transplantation healthcare setting can 
potentially not be generalized towards those of other countries. In the Netherlands, 
well-organized regulations are in place on financial compensation for donors. Therefore, 
the number of donors facing severe financial problems through kidney donation is lim-
ited, while negative financial experiences are reported in studies from other countries 
(41-43).
Sixth, the feasibility of the ICBT intervention and the satisfaction with the intervention 
were evaluated in a small group of kidney donors. Although the evaluation of the content 
and structure of the intervention was very promising, future research should examine 
the effectiveness, including the cost-effectiveness, of the intervention in this population 
using a randomized controlled trial. Also, longer-term follow-up effects of the interven-
tion should be studied. Lastly, the working mechanisms of the ICBT intervention and 
the value of tailored versus non-tailored interventions for treatment effects have to be 
studied, in line with previous studies showing the effectiveness of ICBT interventions in 
somatic conditions (44). A validated screening tool is also necessary for the application 
of tailored interventions in order to identify donors at risk and define treatment goals. In 
the current study, the cut-off values for inclusion in the intervention were relatively mild, 
so donors with moderate to more severe problems were invited to participate in the 
intervention to test its feasibility for this group. In future research, the inclusion criteria 
need to be further validated to include those donors that optimally benefit from the 
intervention.
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Clinical implications 
The results of the studies described in the current thesis have several implications for 
clinical practice.
As impaired baseline physical and psychological functioning were found to be the 
most consistent predictors of impaired longer-term HRQoL after donation, a first short 
screening on physical and psychological functioning before donation could be conduct-
ed to provide a risk stratification of potential donors (low risk, moderate risk or high risk). 
If a potential donor experiences poor physical or psychological functioning, additional 
assessments could be conducted to examine specific problem areas of functioning to 
focus interventions. Donors could be referred to psychosocial healthcare professionals 
(e.g., medical social workers or psychologists) to provide additional psychosocial sup-
port. Moreover, concerning the elevated fatigue levels found in the longer term after 
donation in both previous studies and the current study it is important that donors 
are informed about the potential persistence of fatigue symptoms during the donor 
eligibility screening. Furthermore, post-donation monitoring of fatigue and providing 
interventions that focus on (or pay attention to) fatigue could be indicated.
With regard to the timing of psychosocial assessments, it could be useful to include 
donor assessments at different time points during the donation procedure. Assessments 
at the start of the donation procedure could examine pre-donation difficulties and iden-
tify potential donors at risk early in the donation procedure. Furthermore, at the time 
surgery is planned, assessments could identify potential cognitions about the surgery 
that were not experienced earlier in the donation procedure. Lastly, assessments com-
bined with physical monitoring consultations in the hospital after the donation could 
identify those donors that experience difficulties during the recovery period.
Lastly, in the ICBT treatment, an experienced health psychologist in the area of 
donation-related difficulties guided the ICBT interventions of the donors, which could 
have added to the beneficial treatment effects. Because of the specific donation-related 
problems that occur, therapist experience with the donor population is recommended. 
Potentially, a stepped-care approach could be feasible for donor psychosocial care (45), 
in which donors with moderate psychological complaints are guided by medical social 
workers, and donors with more severe psychosocial symptoms are guided by psycholo-
gists.
Future research
Based on the results reported in this thesis, recommendations for future research can be 
formulated. Potential donors need to receive detailed information about the potential 
risks and consequences of the donation. Possibly, however, potential donors who have 
registered in the transplantation centers are not receptive to this information, because 
they have already made the decision to donate and are reluctant to reconsider this deci-
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sion in the context of the potential risks of donation (45, 46). The actual decision-making 
process probably occurs earlier, and it is difficult to evaluate this process because do-
nors are not connected to the transplantation centers at that point in time (47). As 
ambivalence towards the donation decision has been found in previous studies to be 
a potential predictor of impaired longer-term donor functioning (48), it is relevant to 
study this decision-making process more extensively, for example by means of inter-
views or questionnaire studies on donors who consider to donate. Possible donors could 
be recruited by websites providing information about kidney donation procedures and 
consequences.
As in most studies in living kidney donors, we used self-report assessments of pre-
donation cognitions and HRQoL before and after donation. Structured donor assess-
ments could reveal the presence of contra-indications for donation, such as severe 
psychiatric comorbidity. There is currently no global consensus on absolute and relative 
contra-indications for donation, and more long-term prospective prediction studies 
could provide useful information regarding this issue. Moreover, the concealment of 
information about potential contra-indications for donation or the emphasis on desired 
behaviour during donor eligibility screening consultations could lead to an unrealisti-
cally positive donor profile (49). It is known from previous studies that subjective as-
sessments do not always reflect the actual cognitions and behaviour of people, and that 
their behaviour could also be influenced by implicit (more reflexive, and unconscious) 
cognitive processes. In future research, implicit cognitions could be assessed as part 
of the donor eligibility screening. For example, the extent to which donors experience 
coercion to donate could be assessed (50), to test whether an attentional bias towards 
coercion-related words could be found in donors who experience coercion. Also, fear 
about the donor surgery could be assessed (51), to study whether donors with higher 
levels of fear show more surgery-avoidant behaviour than donors who do not experi-
ence fear towards the surgery. It would be interesting to examine whether such more 
implicit measures would add to the prediction of longer-term HRQoL.
Differences in predictors of longer-term HRQoL between different types of donors 
were not examined in the current study, partly due to the insufficient size of donor 
subgroups such as altruistic (anonymous) donors. However, the number of transplanta-
tions with kidneys from altruistic donors is increasing. In altruistic donation, anonymity 
between the donor and the recipient is preserved before surgery (52). By not knowing 
the recipient, altruistic donors are free of coercion, and do not experience concerns 
about the recipient’s functioning. Generally, altruistic donors are not informed about 
the health status of the recipient after transplantation in The Netherlands. Most donors 
and recipients are satisfied with this anonymity (53). However, some altruistic donors 
or recipients of a kidney from an altruistic donor wish to become acquainted with their 
recipient or donor after the transplantation. Future research should examine the pros 
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and cons of sharing information about the wellbeing of altruistic donors and their recipi-
ents, and the potential influence of being informed about the health state of the other 
person on donor and recipient’s HRQoL. Second, there is an increase in the number of 
recipients who do not have a living donor, and post an appeal for potential donors on 
public social media websites, such as Facebook (54). It would be important to examine 
in future research whether the HRQoL consequences for these donors and recipients 
are different from standard donor-recipient couples, and whether specific screening or 
follow-up procedures for these donors are needed.
The current study assessed consequences of donation for donors and predictors of 
HRQoL up to twelve months after donation. Future research should examine long-term 
HRQoL consequences of donation for donors and recipients and predictors for long-term 
adjustment problems. Furthermore, the generalization of the results found towards liv-
ing donors of (parts of ) other organs (e.g., living liver donors) could be examined.
Concerning interventions for donors with a high-risk profile for long-term adjustment 
problems, future research should examine the effectiveness, including cost-effective-
ness, of internet-based versus face-to-face interventions. Also, whether therapist guid-
ance improves both adherence rates and the effectiveness of the intervention in this 
population can be assessed by comparing guided versus unguided ICBT, next to the 
comparisons of internet interventions to more blended care or face-to-face treatments. 
Furthermore, the application of the intervention for different donor subgroups, e.g. 
regarding cultural background or educational level, has to be evaluated.
Lastly, besides the donation itself, being excluded from donation due to medical 
reasons (which involves about half of all donor candidates) could also have negative 
psychosocial consequences for living donor candidates in the longer term. For example, 
feelings of guilt towards the recipient and their relatives by being physically unable 
to donate could influence the wellbeing of registered donors. It would be relevant to 
examine the consequences of exclusion from donation on longer-term HRQoL of these 
rejected donors.
ConClusions
The aim of the research performed in this thesis was to enable identification of potential 
donors at risk for longer-term adjustment problems early in the donation procedure by 
developing and validating a psychosocial screening instrument. Furthermore, a tailored 
and guided internet-based cognitive behavioral therapy intervention to treat donors 
at risk of longer-term adjustment problems was developed and evaluated. The main 
conclusions drawn from the studies described in this thesis are as follows: 
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1) Shortly after donation, health-related quality of life levels of donors are reduced 
but are generally comparable to general population norms longer after donation. 
Fatigue levels remain somewhat elevated across donors, but are still in the range of 
the general population.
2) Higher risk estimations by transplant professionals as well as donor self-report mea-
sures of their physical and psychological wellbeing independently contribute to the 
prediction of impaired longer-term donor health-related quality of life.
3) Incorporating information from donor self-reported measures in the donor screen-
ing procedure can improve the identification of donors with a risk profile.
4) Baseline physical and psychosocial functioning are the most consistent predictors 
for longer-term adjustment problems, but cognitions around the donation decision, 
medical factors, and social-relational characteristics could also be useful factors for 
donor screening to identify donors at risk.
5) Tailored internet-based cognitive behavioral therapy interventions for donors with 
a risk profile seem to be a promising addition to current donor care, as a means of 
providing additional psychosocial guidance during the donation procedure.
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dutCH summary
Chronische nieraandoeningen verlopen in vijf fases, waarbij de nierfunctie steeds verder 
afneemt en lichamelijke klachten van patiënten ontstaan. De vijfde fase van de nier-
aandoening wordt ook wel het eindstadium nierfalen genoemd, waarbij de nierfunctie 
minder dan 10% bedraagt. In deze fase is een nierfunctie-vervangende behandeling 
noodzakelijk, namelijk dialyse of niertransplantatie. Dialyse is een intensieve behande-
ling waarbij het bloed gefilterd wordt, waardoor afvalstoffen en overtollig vocht uit het 
lichaam worden verwijderd. Veel patiënten die dialysebehandeling ondergaan ervaren 
lichamelijke klachten, moeten een streng dieet volgen en mogen maar een zeer be-
perkte hoeveelheid vocht innemen; bovendien zorgt deze behandeling niet voor een 
verbetering van de nierfunctie. Na een niertransplantatie verbetert zowel de nierfunctie 
als ook de levensverwachting en kwaliteit van leven van de patiënt aanzienlijk meer 
dan tijdens dialysebehandeling. Daarom is transplantatie momenteel de behandeling 
van voorkeur voor patiënten met eindstadium nierfalen. Niertransplantatie kan plaats-
vinden met een nier afkomstig van een overleden donor of van een levende donor. De 
uitkomsten van de transplantatie en kwaliteit van leven van de ontvanger zijn over het 
algemeen beter na levende donor niertransplantatie dan bij transplantatie met een nier 
van een overleden donor. Ook is de wachtlijst voor een nier van een overleden donor 
nog steeds erg lang, waardoor patiënten gemiddeld 2 tot 3 jaar op een donororgaan 
moeten wachten. Levende donor niertransplantaties gaan buiten de wachtlijst om en 
hierdoor is de wachttijd vaak veel korter en kunnen patiënten voor de start van de dialy-
sebehandeling getransplanteerd worden. Het aantal levende donor niertransplantaties 
is de laatste decennia sterk toegenomen. In Nederland worden momenteel zelfs meer 
patiënten getransplanteerd met een nier van levende donor dan met een nier van een 
overleden donor.
Mensen die zich aanmelden als nierdonor hebben zelf geen direct voordeel van de 
nierdonatie, maar ondergaan een operatie om een voor hen bekende nierpatiënt (vaak 
partner, familielid of vriend; relationele donor) of onbekende nierpatiënt (altruïstische 
donor) te helpen. In het geval van relationele donatie ervaren donoren meestal wel 
positieve indirecte gevolgen van de nierdonatie, doordat de ontvanger lichamelijk en 
emotioneel gezien opknapt na de transplantatie en activiteiten die voorheen niet mo-
gelijk waren nu wel weer kunnen plaatsvinden. Uit voorgaand onderzoek is bekend dat 
de meeste nierdonoren goed herstellen na hun donatie en geen lichamelijke of emoti-
onele klachten ervaren op de langere termijn. Er is echter een kleine groep donoren die 
wel klachten ervaart voorafgaand aan of na de donatie, zoals spanningsklachten ten 
aanzien van de operatie of aanhoudende vermoeidheid na de donatie. Om het risico 
op deze problemen zoveel mogelijk te voorkomen worden mensen die zich aanmelden 
als donor uitgebreid gescreend om te bepalen of iemand al dan niet voor donatie in 
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aanmerking komt. Op het gebied van de lichamelijke screening is al veel onderzoek uit-
gevoerd, maar er is nog zeer beperkt onderzoek verricht naar psychosociale kenmerken 
waarop donoren zouden moeten worden onderzocht tijdens de screening voor donatie. 
Ook zijn er geen psychosociale behandelingen beschikbaar voor mensen die problemen 
ervaren voorafgaand aan of na de donatie.
Het doel van dit proefschrift was om risicofactoren en beschermende factoren voor 
de ontwikkeling van langere termijn problemen bij nierdonoren te identificeren. Deze 
factoren zouden kunnen worden geïntegreerd in een screeningsinstrument waarmee 
bepaald kan worden welke donoren aanvullende ondersteuning nodig hebben gedu-
rende de donatieprocedure. Daarnaast werd een psychosociale behandeling voor do-
noren met een verhoogd risico op problemen na de donatie ontwikkeld en geëvalueerd 
in een kleine groep donoren.
In Hoofdstuk 2 gaven we een overzicht van voorgaande studies naar de kwaliteit van 
leven van donoren voorafgaand aan en na de nierdonatie. We hebben daarbij zowel de 
bevindingen ten aanzien van het beloop van kwaliteit van leven (lichamelijk, emotio-
neel en sociaal functioneren) van donoren van voor tot na de donatie als risicofactoren 
voor een verminderde kwaliteit van leven na donatie samengevat. De resultaten lieten 
zien dat de kwaliteit van leven van donoren voorafgaand aan de donatie vergelijkbaar 
of zelfs beter is dan de algemene populatie. Kort na de donatie (1-2 maanden na de 
operatie) was de kwaliteit van leven op een lager niveau dan voor de donatie, maar 
in de maanden daarna keerde deze in het algemeen terug op het niveau van voor de 
donatie. Een uitzondering hierop was vermoeidheid, waarvan in meerdere studies werd 
gevonden dat deze na de donatie langer aanhield.
Er waren slechts weinig studies beschikbaar die risicofactoren voor een verminderde 
kwaliteit van leven na de nierdonatie hadden bestudeerd, en de studies die gedaan 
waren gingen over kleine groepen donoren en bekeken een grote verscheidenheid aan 
risicofactoren. Deze studies boden voorzichtige aanwijzingen dat lichamelijk en emoti-
oneel functioneren voorafgaand aan de donatie mogelijk de belangrijkste voorspellers 
zouden kunnen zijn voor langere termijn kwaliteit van leven na de donatie. Maar om 
betrouwbare uitspraken te doen over mogelijke factoren die het langere-termijn func-
tioneren van donoren zouden kunnen voorspellen was meer systematisch onderzoek in 
grotere groepen donoren noodzakelijk. De onderzoeken uitgevoerd in het kader van dit 
proefschrift zijn daarom hierop gericht.
In Hoofdstuk 3 onderzochten we het beloop van kwaliteit van leven van voor de 
donatie tot 1 jaar na de donatie van een grote groep van 230 nierdonoren afkomstig 
uit zeven Nederlandse transplantatiecentra. Om een zo omvattend mogelijk beeld te 
krijgen van relevante aspecten van kwaliteit van leven die spelen rondom nierdonatie 
bij leven werden hierbij zowel algemene vragenlijsten naar kwaliteit van leven gebruikt 
Dutch Summary 175
A
als ook meer donatie-specifieke vragenlijsten. Uit de algemene kwaliteit van leven 
vragenlijsten kwamen vergelijkbare resultaten als uit het overzicht van eerder onder-
zoek was gebleken. Zo bleek dat het algemene lichamelijke functioneren van donoren 
vergelijkbaar was tussen de drie meetmomenten, maar dat donoren 6 en 12 maanden 
na de donatie meer vermoeid waren dan voor de operatie. Ook bleek het emotioneel 
functioneren van de donoren 6 maanden na donatie verminderd te zijn ten opzichte van 
voor de donatie, maar was deze na 1 jaar teruggekeerd op het niveau van voor de do-
natie. Klinisch relevante veranderingen in kwaliteit van leven werden alleen gevonden 
voor vermoeidheid. Uit de donatie-specifieke vragenlijsten bleek dat de lichamelijke 
veranderingen en veranderingen in de relatie tussen de donor en ontvanger na de 
donatie beperkt waren, maar dat de meerderheid van de donoren zich op bepaalde 
momenten na de donatie zorgen hebben gemaakt over zichzelf of de ontvanger. Een 
aantal donoren rapporteerde 1 jaar na donatie gevoelens van spijt rondom de beslis-
sing om te doneren. Verder gaven donoren die gedoneerd hadden aan iemand die ze 
kenden (relationele donoren) aan dat het lichamelijk en emotioneel functioneren van 
de ontvanger van hun nier sterk verbeterd was na de niertransplantatie, en dat hun 
eigen leven minder werd beïnvloed door de nieraandoening van de ontvanger dan 
voorafgaand aan de donatie. De relatie tussen de donor en ontvanger werd positief 
beoordeeld op alle meetmomenten. Uit deze studie kunnen we concluderen dat zowel 
algemene als ook donatie-specifieke meetinstrumenten waardevolle informatie bieden 
omtrent het functioneren van donoren. Beide geven aan dat de kwaliteit van leven van 
donoren in het algemeen niet tot nauwelijks negatief wordt beïnvloed door de donatie, 
hoewel een minderheid van donoren verhoogde niveaus van vermoeidheid, zorgen en 
gevoelens van spijt ten aanzien van de donatie rapporteert.
Tijdens de psychosociale screening voor de donatie wordt, naast het algemene emo-
tionele functioneren, doorgaans ook de besluitvorming rondom de wens om te willen 
doneren besproken, waaronder de motivatie om te willen doneren, de verwachtingen 
van de donatie en mogelijke zorgen over de donatie die een rol spelen. Er is op dit 
moment echter geen betrouwbaar instrument dat alle drie deze thema’s in kaart brengt, 
waardoor het niet mogelijk is om dit systematisch uit te vragen en om de voorspellende 
waarde hiervan te onderzoeken voor de kwaliteit van leven van donoren. Daarom werd 
een nieuwe vragenlijst ontwikkeld die deze thema’s meet en werd de betrouwbaarheid 
van dit nieuwe meetinstrument onderzocht in een grote groep van 719 potentiële 
donoren uit zeven transplantatiecentra in Nederland. Dit onderzoek is beschreven in 
Hoofdstuk 4. De nieuw ontwikkelde vragenlijst, getiteld ‘Donation Cognition Instru-
ment’ (in het Nederlands het ‘Donatie Cognitie Instrument’), bestaat uit 31 items en is 
onder te verdelen in vijf categorieën: motivatie en verwachtingen omtrent een verbete-
ring van het eigen welbevinden van de donor; 2) motivatie en verwachtingen rondom 
een verbetering van het welbevinden van de ontvanger; 3) idealistische motieven om 
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te doneren; 4) verwachtingen van dankbaarheid; en 5) zorgen rondom de donatie. 
Potentiële donoren gaven aan dat hun motivatie en verwachtingen van de donatie 
met name gericht waren op het verbeteren van het welbevinden van de ontvanger en 
minder op het verbeteren van hun eigen welbevinden. Er was een grote samenhang 
tussen de verschillende items uit de subschalen van de vragenlijst. Tevens werd een 
kleine tot middelmatige samenhang gevonden tussen de verschillende motivaties en 
verwachtingen rondom de donatie en algemene kwaliteit van leven. Het ‘Donation Cog-
nition Instrument’ bleek een betrouwbaar instrument om de besluitvorming rondom 
de donatie in kaart te brengen en kan daarom een toegevoegde waarde hebben op de 
huidige psychosociale screening voor donoren.
Omdat een kleine groep donoren aangeeft problemen te ervaren voorafgaand of na de 
nierdonatie is het belangrijk om risicofactoren voor de ontwikkeling van problemen in 
kaart te brengen. Omdat er nog weinig onderzoek is gedaan naar de mate waarin demo-
grafische, medische en psychosociale kenmerken van donoren en het functioneren van 
de ontvangers voorspellend zijn voor langere termijn problemen bij donoren, is de psy-
chosociale screening van donoren momenteel voornamelijk gebaseerd op de klinische 
indruk van zorgprofessionals. In hoeverre deze klinische indruk een goede inschatting 
geeft van het (toekomstige) functioneren van de donor is echter onbekend. Daarom 
werd onderzocht hoezeer de inschatting die zorgprofessionals maken ten aanzien van 
het risico van de donor op een minder goed functioneren na de donatie voorspellend 
was voor het daadwerkelijk functioneren van de donor. Ook werd onderzocht of vra-
genlijsten die door donoren zijn ingevuld zouden kunnen zorgen voor een optimali-
sering van de psychosociale screening. De resultaten zoals beschreven in Hoofdstuk 
5 laten zien dat de risico-inschattingen van zorgprofessionals voorspellend waren voor 
de daadwerkelijke kwaliteit van leven van donoren na de donatie. Dit bevestigt het 
belang en de juistheid van de klinische indruk als onderdeel van de donor screening. 
De toevoeging van donor zelfrapportage-vragenlijsten aan deze risico-inschattingen 
van zorgprofessionals zorgde voor een belangrijke verbetering van de voorspelling 
van langere-termijn problemen van donoren. Hierbij waren lichamelijke en emotionele 
klachten voorafgaand aan de donatie de belangrijkste voorspellers, wat de bevindingen 
uit de beperkte eerdere studies, zoals beschreven in Hoofdstuk 2, bevestigt. Daarnaast 
bleken verschillende specifieke cognitief-gedragsmatige factoren een (beperktere) 
rol te spelen in het voorspellen van kwaliteit van leven na donatie. Uit de resultaten 
kunnen we concluderen dat het opnemen van donor zelfrapportage-vragenlijsten de 
psychosociale screening van donoren kan verbeteren. Gebaseerd op de resultaten 
van dit onderzoek zou een stapsgewijze screening kunnen worden voorgesteld voor 
donoren, waarbij alle donoren een korte vragenlijst over lichamelijk en psychosociaal 
functioneren invullen tijdens de screening voor donatie of rondom de nacontrole na de 
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donatie. Als hieruit blijkt dat een donor een verhoogd risico heeft op problemen, dan 
zou een aanvullende screening kunnen worden uitgevoerd om te onderzoeken op welk 
gebied de donor problemen ervaart en welke psychosociale aspecten hierbij mogelijke 
aanknopingspunten bieden voor aanvullende ondersteuning.
Indien uit een screening zoals hierboven beschreven blijkt dat donoren een verhoogd 
risico op problemen hebben, dan zouden psychosociale interventies aansluitend op 
deze risicofactoren aanvullende ondersteuning kunnen bieden. Op basis hiervan is in 
Hoofdstuk 6 de ontwikkeling en evaluatie beschreven van een psychosociale behande-
ling via internet voor donoren met een verhoogd risico op langere-termijn problemen 
na de donatie. Om relevante thema’s voor de behandeling te vinden is gebruik gemaakt 
van de (relatief beperkte) kennis uit voorgaand onderzoek én zijn focusgroepen georga-
niseerd met donoren en zorgprofessionals om relevante thema’s voor de behandeling in 
kaart te brengen. Een bestaande generieke behandeling voor patiënten met chronische 
somatische aandoeningen, waarin ook voor donoren relevante thema’s zoals omgaan 
met lichamelijke beperkingen, vermoeidheid en angst centraal staan, werd met behulp 
van deze thema’s (bijvoorbeeld besluitvorming rondom donatie, terugkeren in het dage-
lijks leven na de donatie, schuldgevoelens en sociaal-relationele problemen) aangepast 
zodat deze optimaal passend was voor de meest voorkomende mogelijke problematiek 
van (potentiële) donoren. In een kleine studie onder acht donoren werd een eerste 
evaluatie gedaan van de gebruiksvriendelijkheid en tevredenheid met de ontwikkelde 
behandeling. Donoren met een verhoogd risico op problemen werd eerst een face-to-
face intakegesprek aangeboden waarin ze kennis maakten met hun therapeut en waarin 
doelen voor de behandeling werden geformuleerd. Hierna werd de gehele behandeling 
aangeboden via internet, waar donoren konden werken aan 1 of 2 behandelmodules, 
afhankelijk van hun behandeldoelen. Donoren konden een keuze maken uit de modules 
‘Lichamelijke beperkingen’, ‘Vermoeidheid’, ‘Negatieve stemming’, ‘Sociaal functioneren’ 
en ‘Algemene donatie-gerelateerde problemen’. Binnen deze modules kon de therapeut 
een keuze maken uit verschillende opdrachten en leesteksten, aansluitend op de doelen 
en uit de screening gebleken psychosociale sterke eigenschappen en aandachtspunten 
van de donor. De behandeling werd door de donoren positief geëvalueerd wat betreft 
de gebruiksvriendelijkheid en werkzaamheid. Deze resultaten zijn veelbelovend en 
laten zien dat een mogelijke implementatie van het zorgprotocol een toegevoegde 
waarde kan hebben in de psychosociale begeleiding van donoren.
De studies uit dit proefschrift richtten zich op het optimaliseren van de psychosociale 
zorg rondom de nierdonatie. De meeste donoren kunnen na de nierdonatie hun leven 
weer goed oppakken. Een minderheid ervaart echter wel enige problemen rondom de 
donatieprocedure, welke mogelijk met een goed onderbouwd zorgprotocol, bestaande 
uit een standaard screening en, indien geïndiceerd, een op de donor afgestemd begelei-
dingsprogramma ondersteund kan worden. In de toekomst zou onderzoek zich kunnen 
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richten op de (kosten)effectiviteit van het nieuwe eHealth zorgprotocol en zouden mo-
gelijkheden moeten worden verkend om de nieuwe zorgproducten te implementeren 
in de klinische praktijk voor nierdonoren.
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